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Abstract
Standard 2D cell culture does not recreate the complex features of the in vivo environment,
such as soluble factor gradients, cell migration into multiple planes, or cell-cell and cell-matrix
interactions.1–3 3D cell culture addresses these limitations by using 3D biomaterial scaffolds,
such as alginate hydrogels, to recreate the in vivo cell microenvironment in vitro.4,5 3D
platforms can be used to create gradients of soluble factors, vary the biomaterial substrate
stiffness, permit cell-matrix interactions or promote cell migration.6,7 Currently available
3D platforms are prone to the burst release of soluble factors from the biomaterials, making
it difficult to tightly control the soluble factor concentration.7 This limits the use of 3D
platforms for investigating processes such as patterned neuronal differentiation, or cell fate
specification in response to small changes in soluble factor concentration.
This project proposes a novel 3D alginate platform for patterned differentiation. The first
part of this thesis describes experiments to optimise alginate hydrogels for the encapsulation,
aggregation and differentiation of embryonic stem cells (ESCs), and demonstrates that encap-
sulated ESCs form embryoid bodies containing cells from the three germ layers. Exogenous
retinoic acid (RA) is used for in vitro neuronal differentiation protocols, but exogenous RA
is not stable in cell culture and is easily degraded by light. The second part of the thesis
outlines experiments to validate a cell-derived source of RA, which produces a stable con-
centration of RA in vitro and addresses the limitations of exogenous RA. The final section
describes the novel 3D platform that combines the results from the previous sections using an
adapted gradient maker protocol, to create 3D co-culture alginate tubes. The tubes support
patterned differentiation of ESCs in response to the concentration gradient of cell-derived
RA incorporated into the platform.
The novel 3D platform produced in this project contributes a novel tool to the field of
3D cell culture. The 3D platform is a tool for investigating ESC differentiation in response
to a 3D concentration gradient of a cell-derived source of retinoic acid. For experiments that
require a gradient of RA, the ability to maintain a stable source of RA over several days is
an advantage of using this 3D platform over the currently available alternatives. In addition,
alginate hydrogels are highly tunable. Thus, the ability to tune the scaffold properties, change
the cell types encapsulated, or introduce gradients of alternative soluble factors makes this a
versatile tool for 3D culture.
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Chapter 1. Literature Review
1.1 Background
For over a century, scientists have been investigating the development of the nervous system
in an attempt to understand the mechanisms of cell development. Ramon y Cajal’s demon-
stration that neuronal morphology differs for each type of neuron was a major driving force in
nervous system research.8 Tissue regeneration, the complex development of neural networks
and the restoration of function after trauma to the nervous system are of particular interest.
Disease or injury to the central nervous system (CNS) activates an inflammatory response
and disrupts homeostasis. If homeostasis is not restored, the cellular microenvironment con-
tinues to damage cell populations and leads to loss of function.9 Neurodegeneration, spinal
cord injury and traumatic brain injury have a devastating and debilitating effect on quality of
life and all three are underpinned by irreparable, irreversible damage to the CNS.10–12 Neural
plasticity and neurite outgrowth are widespread within the developing nervous system, but
mature axons have a limited capacity for growth and repair, and injured neurons are inca-
pable of self-regeneration thus leading to a long-term impairment after damage to the adult
nervous system.13,14 The limited regenerative capacity of the CNS, in combination with the
current lack of effective therapies to restore function after CNS injury, highlights an unmet
need for methods to enhance our understanding of tissue regeneration and cell development.
1.2 Overview of embryonic stem cell differentiation in vitro
1.2.1 Introduction to embryonic stem cells
The first mouse embryonic stem cell (ESC) line was isolated from the inner cell mass of an 3.5
day blastocyst in 1981.15 This breakthrough contributed to methods for generating human
ESCs and in 1998, the first human ESCs were isolated from in vitro fertilized embryos.16
ESCs are defined by their ability to differentiate into any cell in the body, and their ability
to indefinitely self-renew.1,17,18 Mouse ESCs are maintained in a pluripotent, undifferenti-
ated state in vitro by supplementing the culture medium with leukaemia inhibitory factor
(LIF), or factors acting on the LIF receptor pathway, to suppress differentiation of the stem
cells.19 LIF is insufficient to maintain pluripotency in human ESCs and instead, human
ESCs are cultured on fibroblast feeder layers, which release differentiation inhibiting factors
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to maintain an undifferentiated state.20,21 In the absence of any differentiation suppressing
factors, ESCs undergo spontaneous differentiation into cell types from the three embryonic
germ layers: endoderm, mesoderm and ectoderm.1,18,22 Cell fate specification can be con-
trolled by supplementing the culture medium with exogenous morphogens such as retinoic
acid (RA), bone morphogenetic proteins (BMPs), Wnt, Noggin or sonic hedgehog (Shh), to
induce differentiation toward a specific cell fate.4,23,24
Since ESCs were first isolated, they have been differentiated into a range of cell types in
vitro, including but not limited to hepatocytes, pancreatic cells, cardiomyocytes, neurons, and
glia.15,25–29 Their ability to generate cells from all three embryonic germ layers makes ESCs a
valuable tool for in vitro research. For example, mouse ESC lines have been used to generate
in vitro models of neuronal differentiation,24,30 embryogenesis,31,32 and neuronal functional
activity.33,34 Likewise, human ESCs have been used to generate an in vitro model of spinal
muscular atrophy for examining the mechanisms of the disease,35 and to generate functional
islet-cells for an in vitro model of diabetes.36The value of ESC models as a research tool
depends on the ability to consistently and efficiently differentiate ESCs toward a desired cell
fates, using well-defined and reproducible protocols. One commonly used method is embryoid
body (EB) suspension culture, which offers an easy, reproducible, and scalable method for
differentiating ESCs toward a range of cell types in vitro.
1.2.2 Embryoid body suspension culture for embryonic stem cell differentiation
EB suspension culture is a well characterised method for inducing ESC differentiation.22,31
In brief, ESCs are reseeded in suspension onto a non-coated tissue culture dish and cultured
for several days (for mouse ESCs) or weeks (for human ESCs) in the absence of differen-
tiation inhibiting factors.37 During the initial days in suspension the ESCs form spheroid,
multicellular aggregates called EBs, via cell-cell interactions.9,19,38 By adding signalling mor-
phogens to the medium, EBs can be directed to differentiate into specific cell types:22 RA
induces differentiation to neurons and astrocytes,15,39 ascorbic acid induces differentiation
to cardiomyocytes,30 and Activin A and Wnt3A promote hepatocyte differentiation.40 EB
suspension protocols offer limited control over the size of the EBs and consequently over the
diffusion of nutrients and/or morphogens into the EBs. In addition, the agglomeration of
EBs can lead to a necrotic core, limiting their utility in long-term culture and reducing the
control over ESC differentiation.22,41–43 These size and agglomeration factors can be con-
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trolled using hanging-drop or microwell methods of EB formation, where an exact number
of cells is aggregated in a small volume of liquid, or by using bioreactors to control the rate
of formation of EBs. These methods provide control the EB conditions, but are more labour
intensive and expensive compared to the suspension method.22,44
EBs mimic many aspects of embryogenesis including proliferation, morphogenesis, differ-
entiation, and region-specific differentiation into the three germ layers.19,38,43,45 As observed
in the developing embryo, EBs are highly organised structures with inherent and complex
signalling interactions that influence ESC differentiation.44 Once ESCs have aggregated to
form a multicellular EB, the outer layer differentiates into primitive endoderm and creates
a laminin- and collagen-rich basement membrane. Then apical-basal polarity is established,
followed by ESC differentiation into cell fates from the three germ layers.22,42,46 EB sus-
pension culture produces heterogenous cell populations and the differentiation efficiency of
EB protocols varies.19 The Wichterle and Peljto protocol typically generates 30-50% motor
neurons (MNs),47 a γ-aminobutyric acid (GABA) differentiation protocol generates approxi-
mately 86% GABAergic neurons,48 and another protocol only achieved 10% differentiation to
functional contracting cardiomyocyte.19 Some studies have reported protocols for increasing
the purity of the desired populations through mechanical dissociation,49 antibiotic selection,50
or cell sorting techniques.19,51 McCreedy et al., (2012) reported that enrichment of the MN
cultures by puromycin selection could increase purity to 58±1.5% MNs.28 However, as yet,
there are no protocols that increase the efficiency of EB differentiation to 100% purity.19
If the EB-derived cell populations are generated for transplantation, any carry-over of non-
target cells will have undesired effects within the host tissue and carry over of pluripotent
stem cells can lead to teratoma formation.50 Adverse or uncontrolled paracrine signalling
effects by the transplanted cells may also occur, and may counteract the clinical efficacy of
the transplant procedure.41,52
1.2.3 Limitations of embryoid body models of differentiation
EB models of ESC differentiation have provided valuable insight to the mechanisms of pat-
terned cell differentiation, but they cannot fully capture the process of embryogenesis.1 EBs
do not produce trophectoderm, which is required for the formation of the extraembryonic
tissues.53 To recreate the extraembryonic tissues and examine the effects of the cell mi-
croenvironment on ESC differentiation, some studies have combined EB culture with three-
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dimensional (3D) biomaterials scaffolds. In one study, mouse ESCs were differentiated into
EBs and then encapsulated into hydrogel scaffolds to induce patterned vasculogenic and car-
diogenic differentiation of individual EBs.54 Another study created an in vitro model of
gastrulation using mouse EBs, which were transferred to gelatin after differentiation. Their
results showed that to undergo self-organisation and axis formation, EBs require implan-
tation into an extracellular matrix (ECM)-like structure.55 A breakthrough study showed
that mouse EBs permitted to undergo prolonged differentiation in suspension culture spon-
taneously formed an organoid. The EB-derived organoid generated patterned differentiation
that recapitulated self-organisation in the neural tube, displayed apical-basal polarity and
expressed gene markers for diencephalon, spinal cord, and floor plate tissues.32,56 The study
showed that after extended culture, the organoids formed neuroepithelial cysts, induced floor
plate patterning and generated correct dorsoventral organisation.32 These 3D biomaterial or
organoid cultures have provided novel methods to investigate and control ESC differentiation
within EB cultures. Incorporating 3D cell culture with EB protocols may allow us to gain a
greater understanding of the mechanisms of cell fate specification.
1.3 Patterned differentiation during development determines stem cell fate
The nervous system is the result of temporo-spatially controlled cell differentiation, axonal
migration, and synapse formation.8 During neurogenesis, the neural tube differentiates and
undergoes specification of the rostro-caudal and dorso-ventral axes, through the actions of
morphogens including Noggin, fibroblast growth factors (FGFs), Wnts, β-catenins, BMPs,
Shh and RA.26,57,58 This specification is dependent on localised cross-activating and cross-
repressive gradients of signalling morphogens that induce intracellular signalling cascades
and activate transcription factors that determine cell fate specification.57–59 These localised
signalling gradients, and the temporo-spatial activation and inactivation of signalling cascades
are responsible for generating the diversity of cell types in the adult CNS.31,60,61
1.3.1 Retinoic acid is essential for nervous system development
RA is the most biologically active member of the retinoid family, a group of small lipophilic
molecules derived from vitamin A.62,63 RA plays a major role in patterning the rostro-caudal
and dorso-ventral axes, and is involved in neural differentiation, patterning the neural plate,
and axonal extension.63,64 Maternal vitamin A deficiency, and subsequently RA deficiency in
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the embryo, results in CNS abnormalities and structural malformations in the dorsal spinal
cord.63,65 Contrastingly, excess RA is teratogenic and results in severe malformation of
hindlimb regions and abnormalities in hindbrain development.66
Retinoids are not produced endogenously in mammals and must be absorbed from vitamin
A in food. Once absorbed, they are stored as retinyl esters in the liver, lungs, and kidneys.64,67
Retinoids are transported from these storage sites to cells by retinol, which circulates in
the blood bound to RA-binding protein 4. At the site of action, retinol is uptaken via
RA-binding protein 4 receptors, enters the cytoplasm and binds retinol-binding protein 1.
Within the cytoplasm, a two-step process metabolises retinol into RA: (1) retinol is oxidised
by retinol dehydrogenase and converted to retinaldehyde, and (2) retinaldehyde is oxidised
by retinaldehyde dehydrogenase to produce RA.64,68 During development, the first stage
of RA synthesis is primarily controlled by retinol dehydrogenase 10, expressed in the floor
plate and in somites near the developing spinal cord.69 The second stage is controlled by
three retinaldehyde dehydrogenases (Raldh1, Raldh2, Raldh3) which have distinct spatio-
temporal domains in the embryo.69 Raldh2 is the most well-defined of the retinaldehyde
dehydrogenases: it is expressed within the mesenchyme just after gastrulation, and is later
expressed in MNs, the meninges and the roof plate of the spinal cord.64,69 Raldh2 is the only
retinaldehyde dehydrogenase known to play a role in spinal cord development and all RA
synthesis before E8.5 is regulated by Raldh2. After this stage, Raldh1 and Raldh3 contribute
to RA synthesis in the eyes and olfactory system.67,69
In animal models of development, null mutants for retinaldehyde dehydrogenases have
a range of developmental defects: Raldh1-/- mutants show defects in dorsal retina forma-
tion, Raldh3-/- mutants develop nasal and ocular deficits, and Raldh2-/- mouse mutants ex-
hibit abnormal MN specification and forebrain development.67,69 In loss-of-function Raldh2
chick mutants there is a loss of posterior rhombomeres (5-7) and an expansion of anterior
rhombomeres (2-4). Experiments in a loss-of-function Raldh2 mouse model determined that
Raldh2 is almost solely responsible for RA production during embryogenesis.63,70 Applying
exogenous RA to mutant embryos can rescue the animal from some of the above defects and
allow normal development from the day of rescue onwards: for example, Raldh2-/- mouse
mutants can be rescued from lethality by supplementation with exogenous RA at E7.5.65
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1.3.2 Mechanism of retinoic acid-induced gene transcription
RA influences cell fate specification by regulating gene expression through its actions on
retinoic acid receptors (RARs). RA binds cellular RA binding proteins in the cytoplasm
and enters the cell nucleus, where it acts by binding to transcription factor nuclear RARs
(subtypes: α, β, γ).64 In their unbound form, RARs form heterodimers with retinoid X
receptors (RXRs; subtypes α, β, γ) and bind to RA-response elements, deoxyribonucleic
acid (DNA) sequences that repress gene transcription. Upon RA binding to the RAR/RXR
receptor complex, a conformational change in the receptor recruits co-activators in place
of the RA-response element repressors, and the co-activators bind the RAR region of the
receptor complex that contains the RA ligand site.71 Once co-activators are recruited, they
initiate signalling cascades to modulate RA-RAR downstream targets involved in neuronal
differentiation and cell patterning.64,68,71
RARs form heterodimers with RXRs and there is wide heterogeneity in RAR/RXR dimers
due to the combinations of their α, β, and γ subunits.72 RXRs were orphan receptors until a
metabolite of RA, 9-cis-RA, was identified as their physiological ligand.73 9-cis-RA can bind
to both RARs and RXRs and activates downstream signalling cascades of both receptors,
whereas RA can only bind to RARs.74,75 The in vivo concentration of 9-cis-RA in the spinal
cord is 30-fold lower than the concentration of RA, and is only detectable when embryos are
exposed to teratogenic concentrations of RA. In Raldh2-/- embryos, RA deficiency could be
rescued using 9-cis-RA at concentrations 4-fold higher than the concentration of RA required
to rescue the embryos.75 These studies showed that extremely high levels of RA are required
to reach a sufficient concentration of 9-cis-RA for RXR activation in vivo, and it is believed
that RXR activation by 9-cis-RA is a protective measure against RA-induced teratogenicity.76
1.3.3 Metabolism of retinoic acid
After RA binds and activates RARs, it returns from the nucleus to the cytoplasm, where it
is inactivated by members of the cytochrome P450 26 (Cyp26) family: Cyp26a1, Cyp26b1,
and Cyp26c1. Cyp26s oxidise RA into polar metabolites, which can then be conjugated and
excreted.63,67,70 Cyp26a1 is the primary degrading enzyme for inactivation of RA during
gastrulation.63 Exogenous RA induces Cyp26a1 activity in the hindbrain regions, however
depleting RA signalling does not eliminate Cyp26a1 expression, suggesting that Cyp26a1
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is expressed to prevent RA-induced teratogenicity after RA surpasses a certain threshold.
Once activated, Cyp26a1 does not require RA-RAR binding for ongoing expression.63,70
Shimozono et al., (2013) demontrated in mice treated with 4-(diethylamino)benzaldehyde
(DEAB) that RA is not required for the onset of Cyp26 enzymes in vivo, and Hernandez et
al., (2007) reported that Cyp26a1 can be upregulated by exogenous RA whereas Cyp26b1
and Cyp26c1 are not upregulated by exogenous RA.77,78 Another study demonstrated using
CD336, an RARα-selective agonist, that RARα activation upregulates Cyp26a1 and Cyp26b1,
but downregulates Cyp26c1.62 The above studies show that the effects of RA on Cyp26 are
not global, and that there are distinct effects of each Cyp26 enzyme on RA metabolism.
The resulting localised patterns of RA activation and inactivation may contribute to the
patterned differentiation of the neural tube.62 It is unclear whether a gradient of RA, or the
combined actions of Cyp26s and Raldh2, are responsible for patterned differentiation along
the neural tube. The effects of Cyp26 and Raldh activity on RA can be exploited in vitro to
investigate and identify the mechanisms of cell fate specification by RA. Global activation,
or inactivation, of both offers a novel strategy for controlling stem cell fate in vitro, and
identifying Cyp/Raldh activation and inactivation effects on cell fate.
1.3.4 Retinoic acid signalling is tightly regulated in vivo
Cyp26s and retinaldehyde dehydrogenases are expressed in complementary, non-overlapping
regions during gastrulation, and their interactions determine the availability of RA in vivo.64,66,79
RA upregulates Cyp26a1, and downregulates Raldh2, thus inducing its own metabolism and
inactivation in a negative feedback loop. The combined expression patterns of retinaldehyde
dehydrogenases and Cyp26 enzymes along the neural tube results in patterned inactivation
of RA signalling, and regulates RA-induced gene transcription.63,67,70 Depleting the expres-
sion of all Cyp26 enzymes induces hindbrain posteriorisation in zebrafish embryos.78 Sakai
et al., (2001)79 found that Cyp26-/- mutant mouse embryos exhibited abnormal hindbrain
and hindlimb development. They further estimated that Cyp26-/- mutation is fatal in two
thirds of embryos, and proposed that Cyp26 enzymes are crucial for preventing RA-induced
teratogenesis by metabolising RA. Another study showed consistent findings: Cyp26a1-/-
embryos without exogenous RA exhibited a greater level of abnormal development compared
to Cyp26a1-/- embryos treated with exogenous RA.78
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1.3.5 Retinoic acid-induced embryonic stem cell differentiation in vitro
RA can be used to induce mouse ESC differentiation to a neural fate in vitro. The first proto-
col for RA-induced ESC differentiation was reported in 1995, when mouse ESCs were induced
toward a neural fate using an EB suspension culture and exogenous RA.39 The resulting cell
population had greater numbers of β-III-tubulin positive cells and increased neurite extension
compared to EBs cultured without RA. In 2003, RA-induced EB differerentiation was used
to promote radial-glia-like cell fates from mouse ESCs.80 In 2014, EB culture was used to
differentiate mouse ESCs into functional, beating cardiomyocytes,55 and in the same year,
another study used RA to induce single mouse ESCs to differentiate to cell fates from the
three germ layers, and subsequently undergo self-organisation.81
RA-induced differentiation protocols have been used to generate in vitro analogues for
many in vivo cell types, however, there are limitations to in vitro RA differentiation methods.
The main limitation of these protocols is that exogenous RA is unstable in cell culture.82,83
RA is light-sensitive and isomerises rapidly when exposed to light, which can result in incon-
sistent concentrations of RA or its metabolites in the culture medium.83 One study showed
that 24h after RA was added to cell-free culture medium, only 69% and 27% of the RA was
recovered in serum-supplemented and serum-free medium, respectively82 - the experiments
were carried out under yellow light to minimise any light-induced degradation of RA, and
the results suggested that in less tightly controlled environments, and with cells present in
the culture conditions, the concentrations of RA at 24h would be substantially lower.82 The
instability of RA is a limiting step for fully understanding the effects of RA on cell devel-
opment using an in vitro system. To investigate the interactions between Raldh2, Cyp26a1
and RA in vitro, a durable, stable concentration of RA is required to ensure that any results
observed are not due to uncontrolled degradation and isomerisation of the RA.
Exogenous RA is used to induce neural differentiation in vitro, but some protocols use
supraphysiological concentrations of exogenous RA, which creates conditions in vitro that
do not normally occur in vivo.84 First, the metabolism of supraphysiological concentrations
of RA generates in vitro concentrations of 9-cis-RA that are not observed in the developing
embryo.75 It is proposed that dual ligand binding of RA and 9-cis-RA to RARs and RXRs
simultaneously, may activate downstream signalling pathways in vitro that are only activated
in vivo in response to teratogenic concentrations of RA.75 Experiments on RXR antagonism in
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mouse embryos demonstrated that 9-cis-RA is not required for embryogenesis, therefore, the
high concentrations of 9-cis-RA in vitro are likely activating off-target signalling pathways
that are not involved in cell development.75,76 Second, supplementing supraphysiological
concentrations of RA to the culture medium exposes all of the ESCs to high concentrations of
RA, whereas in vivo, the concentrations of RA are tightly regulated to prevent teratogenicity
and for the correct cell fate specification.84 One study compared mouse ESCs treated with
25 nanomolar (nM) or 1 micromolar (µM) RA in vitro, and showed that compared to a
concentration of 25nM of RA, supplementing 1µM of RA downregulated Fgf8, upregulated
Cdx1, and upregulated Wnt8a agonists. These genes are involved in neural plate patterning
and their altered expression in response to high concentrations of RA points to a mechanism
of forced neural differentiation in vitro, that may rely on off-target pathways not normally
activated during development.84
1.4 Specification of the dorso-ventral neuraxis
1.4.1 Retinoic acid in the ventral spinal cord
RA is essential for the specification of the dorso-ventral neuraxis.31 Hox genes are a di-
rect downstream target of RA signalling, and cross-repressive actions between Hox genes
are responsible for defining rhombomere boundaries, specifying progenitor domains and de-
termining cell fate specification.63,64,66,79 Within the ventral neural tube, there are five
progenitor domains (p0, p1, p2, pMN, p3) that generate the MNs and interneurons of the
ventral domains of the spinal cord (v0, v1, v2, sMN, v3). The identities of these progenitor
zones are defined by their expression of homeobox domain (HD) and basic-helix-loop-helix
(bHLH) proteins.31,85 Okada et al., (2004) reported that EBs treated with low levels of RA
express a midbrain-hindbrain HD protein profile, whereas EBs treated with high levels of RA
express a rostral spinal cord Hox profile.31 RA induces the expression of paired box protein
Pax 6 (Pax6), which subsequently interacts with homeobox protein Nkx6.1 to upregulate ex-
pression of Olig2, a marker of MN progenitor cells. The cross-repressive interactions between
HD proteins Pax6 (class I) and Nkx6.1 (class II) are required to establish the MN progenitor
domain, and subsequently for the generation of the diverse population of mature MNs.86
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1.4.2 Sonic hedgehog in the ventral spinal cord
Shh is a ventralising morphogen expressed from the notochord and floor plate, and is neces-
sary for the specification of dorso-ventral identity in the ventral spinal cord.87 Shh actions
are transduced via Smoothened, the signal transducing subunit of the Shh receptor. Shh
pathways regulate the expression of bHLH and HD proteins in ventral progenitor domains,
which in turn regulate patterned differentiation of the dorso-ventral axis.87,88 The differen-
tiation and specification of MNs during embryogenesis is induced by the interaction of the
neuralising effects of RA and the ventralising effects of Shh.12,47 RA works in combination
with the Shh to regulate expression of HD and bHLH proteins that define ventral progenitor
domain identity and the subsequent differentiation of spinal MNs.31,60
1.4.3 Establishing the progenitor domain boundaries during development
HD proteins can be divided into class I and class II transcription factors. The cross-repressive
interactions of these transcription factors establishes progenitor domain boundaries.60,89 The
combined actions of RA and Shh regulate ventralisation of the neural tube through their
actions on class I and II genes: RA signalling activates expression of class I genes and
inactivates expression of class II genes, Shh signalling activates expression of class II genes
and Shh is repressed by the actions of class I genes.31,87 As class I genes are repressed by
Shh signalling, this permits increased signalling of class II genes, which are further activated
by Shh signalling.31,87,90 This feedforward induction of HD proteins drives a gradient of Shh
signalling throughout the ventral spinal cord, such that the actions of Shh on class I and II
proteins defines the ventral and dorsal limits of progenitor domains (see Figure 1).
1.4.4 Subtypes of motor neurons in the central nervous system
The CNS is host to a diverse range of MNs with distinct identities that correspond to their
position along the spinal cord. MNs are a well characterised class of neurons, both molecularly
and functionally, thus are commonly studied in vitro as a paradigm for investigating nervous
system development and disease.72 The differentiation pathways for MNs are well-defined,
and in vitro protocols for MN differentiation are robust and reproducible. MNs are unique
in that their cell bodies remain with the CNS, but their axons project to targets in the
peripheral nervous system.91 All MNs arise from the pMN progenitor domain and become
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Figure 1: Formation of the Shh gradient in progenitor domains. Shh signalling from
the floor plate represses class I HD proteins, and activates class II HD proteins. Class I
and class II HD proteins repress each other, and this cross-repressive inhibition establishes
the progenitor domain boundaries in the ventral neural tube. Red arrow: cross repressive
interactions between class I and class II HD proteins; yellow gradient: class I transcription
factors; green gradient: class II transcription factors)
refined into subclasses according to the location of their cell body within the spinal column.87
The subclasses of MNs correspond to their columnar, divisional and motor pool identities,
which in turn are dependent on the target muscle of their axonal projections.60,72 Groups
of MNs sharing axonal projection targets cluster together to form five columnar identities,
spread along the rostro-caudal axis:
– Phrenic motor column (PMC)
– Preganglionic motor column (PGC)
– Hypaxial motor column (HMC)
– Medial motor column (MMC)
– Lateral motor column (LMC)
PMC MNs are located at the cervical level of the spinal cord and are required for in-
nervation of the diaphragm. PGC and HMC MNs are located at the thoracic spinal cord
level and innervate the sympathetic ganglia and the abdominal musculature, respectively.87,92
MMC neurons are generated along the length of the spinal column and innervate dorsal axial
musculature.85 LMC MNs, generated at brachial and lumbar levels, are responsible for limb
innervation and can be subdivided into divisional and pool identities, lateral LMC (LMCl)
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and medial LMC (LMCm), which innervate the dorsal and ventral muscles of the limb, re-
spectively. LMCl and LMCm are further divided into motor pool identities, according to
their specific target muscle within the limb, and a vertebrate LMC MN can belong to 1 of
∼50 distinct MN subgroups.93
1.4.5 Motor neuron subtype specification in vitro
ESCs have been successfully differentiated into MNs in vitro by supplementing combina-
tions of RA and Shh to the culture medium.24,50,94 Shh is commonly used to ventralise
differentiating ESCs into spinal motor neurons in vitro. Purmorphamine, HhAg1.3 (a Shh
agonist) and SAG (a Smoothened agonist) are cheaper substitutes for full Shh protein in
MN differentiation protocols.24,58,95,96 The standard in vitro MN differentiation protocol,
defined by Wichterle et al., (2002), adds exogenous RA and Shh (or Shh substitute) to the
culture medium to generate MNs of an MMC identity.47 The Wichterle and Peljto (2002)
protocol generates 30-50% homeobox protein B9 (HB9)+ post-mitotic MNs by EB suspension
culture.24 LMC neurons can be generated in vitro using RA and Shh (or Shh substitute)
and the Hox accessory factor forkhead box protein p1 (Foxp1).97,98 Foxp1 is expressed in
LMC and PGC neurons, but not in MMC and HMC neurons, thus the expression Foxp1
distinguishes between these MNs populations. High expression of Foxp1 is a marker of LMC
neurons, whereas low expression is a marker for PGC, thus allowing distinction between the
two Foxp1+ MN populations.12
Ectopic expression of Hox genes in vivo can induce MNs to an alternate motor pool iden-
tity, and alter the axonal projections of the newly programmed MNs.93 Depleting Raldh2
from the paraxial mesoderm induces a 50% decrease of RA in the spinal cord, leading to a
reduced number of LMCl neurons but only a small decrease in the total number of MNs.69
This indicates that in the absence of RA, LMCl MNs differentiate toward another MN sub-
class, either due to the lack of RA-induced transcription factor activity or the de-repression of
transcription factors usually inhibited by RA. Raldh2-/- mutants treated with exogenous RA
display disorganised brachial LMCs.65 Ricard et al., (2013) reported that MNs derived from
Cyp26a1-/- ESCs using the standard RA and Shh protocol were induced toward a PGC/LMC
columnar identity, rather than an MMC identity.85 These findings indicated that an increased
level of RA signalling induces a shift in Hox gene expression, which in turn affects the colum-
nar, divisional or pool identity of the cell. This offers a potential avenue for patterning ESC
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differentiation to generate a mixed population of LMC and MMC MNs in vitro.
These studies indicate a changing role for RA in cell fate specification during sequential
stages of development. In the early stages, RA is responsible for patterning the rostro-caudal
axis and in combination with Shh, establishing ventral progenitor domain boundaries.31,72
Later in development, RA is involved in the specification of the dorso-ventral axis - RA is
required for Pax6 activation, and indirectly for Olig2 expression in MN progenitors, and
subsequently influences the identities of the mature MNs generated by these Olig2+ progeni-
tors.50,90,99 By exploiting the effects of RA and Shh in vitro, the controlled exposure of ESCs
to both morphogens can pattern their differentiation towards a desired MN fate.
1.4.6 Lateral motor column motor neurons produce retinoic acid in vivo
LMCm MNs are identified by their expression of Raldh2, the major RA synthesising en-
zyme.100 During limb innervation, the Raldh2 in LMCm synthesises RA and this source of
retinoids determines cell fate specification of the later differentiating LMCl MNs.72 Early in
differentiation, all LMCs express Isl1 (a marker for LMCmMNs) and as LMCl MNs differenti-
ate, they are exposed to RA produced by LMCm MNs, at which point Isl1 is downregulated
and Lim1 is upregulated to specify an LMCl fate. RA also serves as an axonal guidance
signal for the LMCl MNs, which follow the axonal trajectories of the earlier differentiated
LMCm to innervate their target muscles.12,90,97 RA signalling in LMCl MNs activates a
cross-repressive interaction between Isl1 and Lim1 in both LMCl and LMCm MNs, which
subsequently determines the medial position of LMCm and lateral position of LMCl MNs in
the spinal cord.72 The LMC MN-derived RA signal is independent of the earlier RA produced
by the paraxial mesoderm: Raldh2 is first expressed at E7.5 and is maintained up to E10.5,
at which point, Raldh2 is downregulated until it reappears at E12.5, during differentiation
of limb-innervating LMC MNs.100–102
1.4.7 3D cell culture - a paradigm shift
Since mouse ESCs were first isolated, they have provided researchers with a rapid method
to investigate cell development in vitro.16 ESCs and ESC-derived cell lines are useful tools
for probing new areas of research or testing theories of development.15,16 Despite the ad-
vances that have been made using ESC lines and available differentiation protocols, there is
still a limited understanding of the mechanisms and processes involved in cell development
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and differentiation.103,104 A major barrier to our understanding of nervous system devel-
opment is the reduction of the intricate in vivo process of development into the simplified
two-dimensional (2D) paradigms used in vitro. 2D cell culture removes many physiological
components of the cell niche, including the cell-matrix interaction, ability to migrate into
multiple planes, and formation of long-range signalling gradients.1,2 This over-simplification
inhibits the potential to recreate cell processes in vitro that precisely mimic their in vivo coun-
terparts, including migration into multiple planes, responding to gradients of soluble factors
and cell-matrix interaction.3,105 Our lack of knowledge drives the need for novel, adaptable
and more complex in vitro platforms that we can use to investigate cell differentiation, the
pathophysiology of disease and the mechanisms of tissue regeneration.106,107
In 2006, a landmark study by Engler et al., demonstrated that human mesenchymal stem
cells (MSCs) responded to the substrate stiffness of the biomaterials that they were cultured
on. In their experiment, they cultured human MSCs on inert polyacrylamide scaffolds with a
substrate stiffness of 0.1-1 kilopascals (kPa), or a substrate stiffness of 34kPa. Their results
showed that the MSC/cytoskeletal interaction was important for determining cell fate.6 The
mechanosensitivity demonstrated by the Engler study represented a turning point for inves-
tigating the processes of cell development in vitro and posed some important questions for
tissue culture research. If tissue culture plastics have a substrate stiffness in the gigapascal
range,2,35 this raises the question of how suitable the cell microenvironment provided by
tissue culture plastics is for recreating the in vivo microenvironment?108
3D cell culture aims to address these questions, and the limitations associated with tra-
ditional 2D cell culture, by combining in vitro cell culture protocols with 3D biomaterial
scaffolds.109 In doing so, 3D cell cultures can generate novel platforms for investigating cell
behaviours in vitro that more closely resemble and recapitulate the conditions cells experience
in vivo. These approaches hold the potential to improve our understanding of the temoporal
and spatial processes involved in creating the vast diversity of cell types in the body.110 The
cell microenvironment or cell niche is comprised of ECM, a complex structural architecture
of fibrous proteins, proteoglycans, glycosaminoglycans and soluble factors.44,105,111,112 In
their physiological microenvironment, all cells are surrounded by ECM, which informs the
cell about its environment.113 Cell-ECM interactions are involved in a range of cell processes
including gene transcription, cell migration, patterned differentiation, and cellular regenera-
tion.6 3D cell culture platforms aim to recreate some, if not all, of the complexities of the cell
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niche by providing culture conditions that recapitulate the substrate stiffness, binding sites,
and signalling cues present in cells physiological microenvironment.86,105,106 For each of the
cell types in the body, the cell niche and available signalling factors vary both temporally and
spatially, thus creating these environments in the dish is difficult to achieve.3,114 The chal-
lenge for 3D cell cultures is to tightly control the in vitro environment, by providing culture
conditions that mimic the in vivo cell niche, whilst also limiting the number of uncontrolled
factors present in the experimental paradigm, so that we can gain high quality information
from the results.
1.5 3D cell culture for investigating cell development
1.5.1 Biomaterials as a platform for recreating the extracellular matrix
Each cell type has a specific ECM and the interaction between the cell and the cell-specific
ECM is responsible for directing cell fate specification.111 The chemical, structural and me-
chanical composition of an ECM interact to provide the essential cell microenvironment to
induce the desired cell fate, at the correct temporal and spatial point in development.115 The
three components are interlinked, with the chemical and structural composition influencing
the specific substrate stiffness (i.e. mechanical strength), and the chemical composition defin-
ing the porosity and topography of the ECM. ECM provides a structure for cell anchorage,
supports cell-cell interaction and cell migration, and provides guidance cues to stem cells
through the precise release of sequestered signalling morphogens.3,44,105
The ECM influences cell fate specification by temporally or spatially controlling the ac-
tivation and inactivation of signalling pathways.44 Tight regulation over the morphogenic
cues, cell adhesion factors, signalling gradients, and cross-repressive interactions between
soluble factors that are available to cells within a given cell niche, are ultimately respon-
sible for generating the diverse cell populations in the body.44,103,112 Understanding the
integration of chemical, structural, and mechanical signals provided by the ECM, and their
influence on cell fate specification canl inform researchers about the processes involved in
cell development.17,116 2D and EB suspension protocols have provided valuable insight into
the mechanisms of cell development, but a dynamic and complex 3D platform that can re-
capitulate the ECM will generate more physiologically relevant information.29,117 These 3D
systems should be capable of providing cell-cell and cell-matrix interactions, and of support-
ing long-term cell culture such that the influence of the cell niche over long periods can be
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investigated in vitro.118
1.5.2 Using 3D biomaterials for stem cell culture
A biomaterial’s chemical and mechanical composition are important characteristics to con-
sider when developing a 3D platform.115 The substrate stiffness is strongly linked with cell
fate specification, therefore to provide an in vitro system for examining physiological cell
behaviours, the culture conditions must first provide a substrate stiffness to mimic the ECM.
Tissue culture plastic is the most frequently used material for in vitro culture, but is a subop-
timal material for recreating the native ECM.103 As mentioned earlier, tissue culture plastic
has an elastic modulus in the gigapascal range, which is similar to the in vivo stiffness of
bone but much higher than the stiffness of the ECM and basement membrane.2,35 The Engler
study demonstrated substrate stiffness is a critical factor in cell development, thus recreating
the complex in vivo mechanisms of cell development in a dish requires a new approach.
A biomaterials approach concentrates on building 3D platforms from natural, synthetic or
ECM biomaterials to mimic the in vivo microenvironment and promote cell behaviours typical
of the physiological environment.9,14,110,117 A secondary aim of these platforms is that the
3D scaffolds provide the optimal microenvironment for the mature cell population, thus as the
ESCs differentiate, the mature populations experience a microenvironment similar to their
in vivo counterparts.11 Each biomaterial has advantages and limitations, and the specific
application for which a biomaterial can be used for depends on the biomaterial composition
and the aims of the experiment.3 Naturally derived biomaterials are inherently biocompatible,
whereas synthetic biomaterials allow greater control of the batch-to-batch consistency and
over the composition of the scaffold.2,3, 119 More recently, hybrid biomaterials have been
formed from combinations of natural and synthetic biomaterials to exploit the advantages of
both and create highly-tuned 3D microenvironments for in vitro research.
1.5.3 Naturally-derived biomaterials
Many studies have used natually-derived or ECM-based proteins as biomaterial scaffolds,
including laminin, fibronectin, collagen, fibrin, and hyaluronic acid.4,117,120 ECM-based pro-
teins are used in 2D cultures to support cell attachment to glass coverslips or tissue culture
plastics, however they can also be be layered to form 3D scaffolds or used to functionalise
biomaterials that do not contain inherent cell binding sites, to support cell-matrix interac-
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tions in those scaffolds.4,105 These materials are derived from animal or plant tissues and
are inherently biocompatible, making them an ideal substrate for cell encapsulation and 3D
cell culture.3,111 Naturally-derived scaffolds are inherently biocompatible and easy to pro-
duce but they often have batch-to-batch variability, in animal-derived materials due to the
gender, age or health status of the originating animal-, or in plant-derived materials due to
the species and methods of processing or isolation.3,121 These variations can be problematic
for reproducing experimental protocols, and have implications for controlling the outcomes
between experiments and between research labs.
Animal-derived biomaterials
Animal-derived scaffolds including collagen, fibronectin, fibrin, and hyaluronic acid can be
used to create 3D cell culture platforms in vitro105,122 or used to functionalise non-adhesive
scaffolds to allow cell attachment.4,111 Kothapalli and Kamm (2013) investigated the effects
of different naturally-derived biomaterials on the differentiation of mouse ESCs into neuronal
and glial lineages in 3D culture compared to 2D culture. Their results showed that collagen-I,
laminin, Matrigel and gelatin promoted significantly higher neural differentiation and signif-
icantly higher neurite outgrowth of mouse ESC-derived EBs relative to EBs differentiated
by suspension culture.9 Another study showed that collagen/Matrigel scaffolds were suitable
for ESC-derived EB differentiation to cardiac cells, and showed that the 3D culture of EBs
was capable of inducing cell migration out of the EBs and into the surrounding scaffold.30
Matrigel is composed of laminin, collagen and growth factors, and is commonly used for cell
culture however it is a poorly defined biomaterial that suffers from batch-to-batch variability,
that contributes to variations in the concentrations of growth factors within the biomaterial,
and this in turn limits the ability to determine which signals are involved in the cellular
responses observed and reduces the ability to replicate those effects across experiments.2,4
Of interest, decellularised EBs have been used to investigate 3D cell behaviours and the re-
sults showed that the EB-derived scaffolds supported mouse ESC proliferation and earlier
differentiation of the seeded ESCs relative to standard EBs.123
Plant-derived biomaterials
Plant-based biomaterials such as alginate, agarose, cellulose and silk are used for 3D cell
culture, and can be combined with ECM-based proteins to promote cell attachment and
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cell-matrix interactions.3,105,124,125 The advantages of plant-based materials over animal-
derived materials are that plant-based materials are more well defined. Some animal-derived
materials, such as Matrigel, are not fully defined and can have uncontrolled or unknown
effects on the behaviour of the encapsulated cells.116 Given that 3D cultures will induce
novel cell behaviours due to cell-matrix interactions, the ability to limit uncontrolled effects
by using plant-based materials offers a distinct advantage over animal-derived counterparts.
Cellulose is the most abundant naturally occuring glucose-based polymer and can be derived
from natural fibers. As it is plant-based, cellulose is naturally cytocompatible, and an added
advantage of cellulose scaffolds is their capacity to be enzymatically degraded in vitro or
naturally biodegraded in vivo without damaging the encapsulated cells.126 Muller et al.
(2006) demonstrated that cellulose hydrogels provided a suitable scaffold for cartilage tissue
engineering using chondrocytes.124 Stenberg et al., (2011) demonstrated that an agarose
scaffold could increase EB formation efficiency by 10% and promote a 3-fold increase in
the size of EBs formed from human ESCs.127 Bozza et al., (2014) demonstrated that 1%
weight per volume (w/v) alginate hydrogels conjugated with fibronectin or hyaluronic acid
had significantly fewer cells positive for markers of pluripotency, and significantly more cells
positive for β-III-tubulin+ compared to their EB counterparts.117 These studies provide
evidence that plant-derived biomaterials can support 3D cell culture and can be adapted
to promote enhanced cell differentiation efficiency compared to the standard EB suspension
protocol.
1.5.4 Synthetic biomaterials
Synthetic polymer biomaterials
As an alternative to both animal- and plant-derived scaffolds, synthetic biomaterials provide
3D ECM biomimetics that offer increased control over the composition, internal structure
and cell-binding sites available within a synthetic scaffold.4,105,128 Synthetic biomaterials are
commonly formed from poly-ethylene-glycol (PEG), poly-lactic-glycolic-acid (PLGA), poly-
dimethyl-siloxane (PDMS), or combinations of polymers.3,4, 129 Synthetic biomaterials do not
contain any inherent cell binding sites, and this absence of binding sites is both an advantage
and a limitation. Although they require addition of cell binding sites to support 3D cell
culture, synthetic scaffolds are a ‘blank slate’ on which the complex cell niche required for
a given paradigm can be created. As with plant-based scaffolds, the synthetic scaffolds can
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be functionalised with animal-derived proteins including collagen and laminin, to provide
integrin binding sites and support cell-matrix interactions.94 A layered hybrid silk:ECM
scaffold functionalised with poly-L-lysine (PLL) was used to produce a model for investigating
cell migration across the boundaries between scaffolds.130 The study also showed that hybrid
scaffolds were superior to hydrogel-only scaffolds, as the hydrogel-only scaffolds collapsed over
the course of cell culture and reduced the transport of nutrients, oxygen and waste products
through the scaffold compared to the hybrid scaffolds.
Biosynthetic self-assembling peptide biomaterials
Self-assembling peptides are a new form of biomaterial scaffold that are used for in vitro cell
culture.131 Self-assembling peptides are formed from chains of hydrophilic and hydrophobic
natural amino acids, that spontaneously self-assemble to create nano-fibrous scaffolds for cell
culture.2,131 Self-assembling peptides are typically high purity, which limits the variability
in composition that exists in animal- and plant-derived scaffolds.131 They are function-
alised with ECM-derived attachment factors to increase cell-matrix interactions, and can be
designed to provide cell-matrix interaction sites at precise locations along the chains thus
allowing enhanced control over cell-matrix interactions that cannot be achieved using either
animal- or plant-derived scaffolds.2,116,132 Cheng et al., (2013) created an injectable self-
assembling peptide that was capable of supporting neural stem cell differentiation, and after
injecting the scaffolds into the host spinal cord, they observed migration of the neural stem
cells into the host spinal cord and the reduced formation of the glial scar at the location of
the injection site.10 In another study, a self-assembling scaffold increased the formation of
EBs from mouse ESCs, and enhanced the subsequent differentiation of the EBs to a neuronal
fate.133 When the scaffold was functionalised with the laminin-derived epitope isoleucine-
lysine-valine-alanine-valine (IKVAV), the functionalised scaffold further enhanced neuronal
differentiation of the EBs, compared to unfunctionalised scaffold.
1.5.5 Hybrid biomaterial platforms
The ability to combine the robust reproducibility of synthetic biomaterials with the inher-
ent integrin binding sites and mechanical properties of a naturally-derived biomaterial are
attractive characteristics of a hybrid scaffold.121 For example, ceramic and alginate hybrid
platforms have been created to induce bone and cartilgate regeneration.134 The synthetic
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ceramic provides the substrate stiffness and mechanical composition to support bone devel-
opment, whereas the alginate top layer provides the softer substrate required for cartilage
development. The platforms tested that did not contain the combined hybrid ceramic-alginate
environment did not generate cartilage, demonstrating that the cell-scaffold interaction was
essential for generating cartilage.134 A hybrid alginate:carbon nanotube scaffold was created
to control the uneven crosslinking structure observed in alginate scaffolds used to culture.135
The results showed that HeLa cells cultured on the hybrid scaffold had significantly higher cell
proliferation compared to on alginate alone. Guillaume et al., (2015) reported similar results,
with alginate:collagen hybrid scaffolds having enhanced proliferation and ECM deposition by
encapsulated MSCs compared to cells cultured on alginate alone.
1.5.6 3D platforms are valuable tools for in vitro research
Many studies have used 3D culture methods to investigate the interaction between 3D bio-
materials and cell behaviours. For example, one study generated a nanocomposite syn-
thetic scaffold that recreated the native microenvironment and substrate stiffness of mature
cartilage, and showed that encapsulated human chondrocytes cultured on the scaffold pro-
duced cartilage that mimicked in vivo cartilage.136 Another study created synthetic RGD-
functionalised PEG hydrogels with substrate density gradients on the hydrogel surface, and
demonstrated that cell infiltration into the scaffold was dependent on the underlying surface
gradients.137 Yang et al., (2015) introduced an IKVAV gradient into a PEG hydrogel, and
reported that neural differentiation efficiency significantly increased with increasing IKVAV
concentration.138 Of interest, they observed that mouse ESCs had a temporary decrease in
proliferation when switched from tissue culture plastic to the PEG hydrogels, but recovered
after 3 days. Similar results were reported by Ali et al., (2015) who showed that mouse ESC
behaviour in response to changing substrate stiffness was stage dependent: pluripotent stem
cells were capable of recovering and adapting to the new environment but non-pluripotent
cells were unable to adapt to 3D culture.139 These two studies suggest that the stage of
differentiation at the time of encapsulation is important for predicting cell fate specification,
and this may be an important factor to consider when designing 3D cell culture experiments
and interpreting the results.
A limitation of 2D cell culture is the inability to introduce concentration gradients of
soluble factors. 3D platforms address this issue by providing gradients to cells in vitro using
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biomaterials platforms: biomaterials with incorporated soluble factors, such as growth factors
and morphogens, can be used to create concentrations gradients of signalling factors in the
scaffold and examine the effects on cell fate.140–142 Wang et al., (2009) used silk-based scaf-
folds loaded with concentration gradients of BMP and/or insulin-like growth factor (IGF) to
promote differentiation of encapsulated MSCs. They showed that the MSCs had preferential
differentiation to osteogenic cell fates in response to high concentration BMPs, and chondro-
genic differentiation in response to low concentration BMPs. They also showed that joint
IGF:BMP gradients promoted even higher osteogenic differentiation compared to BMP gra-
dients alone.143 Wang and Irvine (2011) generated chemokine-loaded alginate microspheres
and incorporated these microspheres into cell-containing collagen scaffolds. They investigated
the chemoattractive effects on the encapsulated cells and demonstrated that cells migrate to-
wards and made physical contact with the chemokine-loaded microspheres from distances
of up to 200 micrometre (µm).144 These results highlight the benefits of using biomaterial
scaffolds for investigating cellular respones to localised signalling factor gradients.
Unfortunately, the current techniques to incorporate growth factors and morphogens into
biomaterial platforms either create a homogenous distribution of soluble factors within the
scaffold, without any control over the spatial or temporal pattern of releases, or cannot main-
tain constant concentrations of soluble factors within the biomaterial for extended periods
of time. Despite the positive results by Wang et al., (2009) discussed above, microsphere
loading efficiency was only 41% and 14% for BMP and IGF, respectively. In addition, they
reported a burst release of 40% of the IGF over the first 48 hours (h) of cell culture (there
was no burst release of BMP).143 Wang and Irvine (2011) reported that 15-20% of the loaded
chemokines were burst-released from the microspheres within 4-5h in cell culture.144 Another
study loaded RA into PCL microspheres and then introduced the RA-loaded microspheres
into human EB suspension cultures to investigate the effect of localised RA release on the
EB differentiation.145 They reported a burst release of RA at approximately 15% over the
first 48h of cell culture, and a cumulative release of 50% of the RA over 28 days in culture,
although the remaining RA was sufficient to induce EB differentiation.
Improved systems for incorporating soluble factors within biomaterial platforms are be-
ing developed to create stable concentrations and/or gradients of signalling factors. Novel
heparin-based delivery systems can incorporate growth factors directly into the biomaterial
and maintain stable concentrations over long periods of time. One research group has devel-
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oped a heparin-based delivery system to incorporate neurotrophin 3 (NT3), platelet-derived
growth factor (PDGF) and glial-derived neurotrophic factor (GDNF) into fibrin based scaf-
folds, maintaining stable concentrations over long periods of time.41,50 An alternative method
uses either photoimmobilisation, or click chemistry, to incorporate growth factors into bioma-
terials.146 McKinnon et al., (2013) created a PEG hydrogel functionalised with ECM-derived
peptides using click chemistry, and showed that their scaffold promoted neurite outgrowth of
the encapsulated ESC-derived MNs.94 Click chemistry can use covalent binding techniques
to incorportate the growth factors or integrin binding sites into a biomaterial, and synthetic
and natural biomaterials can both be modified using click chemistry, making this an easy to
adopt protocol regardless of the biomaterial used for cell encapsulation.147,148
1.6 Alginate hydrogels for stem cell differentiation
Alginate is a plant-derived biomaterial isolated from the ECM of brown algae.149 Alginate
hydrogels are cytocompatible, tunable and degradable biomaterials that are commonly used
as in vitro 3D platforms.43,117,150 To create an alginate hydrogel, alginic acid is dissolved at
the desired weight per volume (w/v) to produce an alginate solution, which is then immersed
into a polymerisation buffer containing divalent ions, allowing the solution to crosslink and
form an alginate hydrogel.149 Alginates have a wide range of compositions and structures
depending on the plant species from which the alginic acid is isolated, and the properties of
a specific alginate affect the type of biomaterial scaffold produced.151
1.6.1 Properties of alginate
Alginate is a linear polysaccharide composed of (1→4) linked chains of β-D-mannuronic acid
(M-residues) and α-L-guluronic acid (G-residues). Each chain contains a combination of
homopolymer G- and M-residues, and copolymer G-M residues (see Figure 2).149,152 The
proportion of G-, M- and G-M residues and the G:M ratio determine the characteristics of
the resulting hydrogel.151 The factors affected include the viscosity and molecular weight of
the alginate solution, the internal porosity, mechanical strength, substrate stiffness, and rate
of degradation of an alginate hydrogel.5,153,154
Unmodified alginate hydrogels do not support cell attachment or proliferation, and must
be functionalised with ECM proteins such as collagen, gelatin, fibronectin, or laminin.149,155
Functionalisation of alginate hydrogels allows cell attachment to the scaffold, promoting cell-
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Figure 2: Chemical structure of alginate.152 Diagram shows the structure of a homopoly-
mer G-residue, homopolymer M-residue, and a copolymer G-M residue of an alginic acid.
matrix interactions, and allowing cell migration, proliferation and/or differentiation of cells
either encapsulated inside, or cultured on the alginate hydrogels.109,117 Alginate can also
be functionalised by adding integrin receptor binding sites within the hydrogels, using ‘click’
chemistry, to guide cytoskeletal organisation and influence gene transcription downstream of
integrin receptors, and thus influence cell fate specification.4,117,150
Although alginate hydrogels are versatile and easy to use, their limitations include batch-
to-batch variability of the alginic acid powders, instability in cell culture medium over time,
and variations in the internal consistency of the resulting alginate hydrogels according to the
type of gelation used, the concentration of calcium chloride and the G:M ratio of the alginic
acid.149,156,157 The gelation process itself requires submerging the alginate/cell solution in
a bath of high concentration calcium chloride (1-1.%) for several minutes.153 The pore size
of the alginate hydrogels can limit the diffusion of larger molecules through the hydrogel,
and reduce their interaction with the encapsulated cells. In addition, the negatively charged
alginate may prevent positively charged molecules from diffusing through the scaffold.120
This is of particular importance for experimental paradigms using an alginate hydrogel for
drug delivery/growth factor delivery after scaffold implantation.158 The following sections
outline the interaction of the G:M ratio of an alginic acid on alginate hydrogel characteristics.
1.6.2 Influence of alginate composition on hydrogel characteristics
The molecular weight of an alginate depends on the length and number of the G- and M-
residues in the alginic acid, and the viscosity of the alginate solution increases as a function
of the molecular weight.122,158 The greater the proportion of homopolymer G-residues, the
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greater the viscosity of the alginate solution, and the higher the elastic modulus of the
resulting hydrogel.5,151 The G-residues in the alginate contain the binding sites for ionic
crosslinking and contribute to the stiffness and porosity of the hydrogel, whereas the M-
residues do not form crosslinks, thus the elastic modulus of an alginate hydrogel increases as
a function of the fraction of G-residues.5,149,156 Alginate hydrogels are formed by polymeris-
ing the alginate solution in a crosslinking buffer containing divalent ions, such as calcium
chloride (CaCl2), magnesium chloride (MgCl2) or barium chloride.156 During polymerisation
the divalent ions crosslink adjacent G-residues between homopolymer G-G residues and/or
copolymer G-M residues. This leads to the formation of a gel network and alginate hydrogels
with a higher proportion of G-residues will have a higher elastic modulus and smaller pores,
due to the increased number of crosslinks forming between G-residues in the solution.5,151,156
The increased number of crosslinks results in a higher subtrate stiffness in high-G alginates
relative to high-M alginates which can affect cell behaviour. For example, Kandalam et al.,
(2012) showed that umbilical cord derived MSCs encapsulated in G-rich alginate hydrogels
had significantly lower viability compared to M-rich alginate hydrogels.157
The concentration of the crosslinking solution also influences the stiffness of the resulting
hydrogel, and even when holding the alginate concentration constant, increasing or decreas-
ing the crosslinking concentration can affect the cell viability of encapsulated cells.149,151,157
The greater the proportion of divalent ions available to crosslink, the more G-residues form
crosslinks and become saturated, thus increasing the elastic modulus of the resulting alginate
hydrogel.149,153 The elastic modulus of alginate hydrogels is also increased by increasing
the concentration (w/v) of an alginate solution, as there are more G-residues present for
crosslinking. Li et al., (2011) reported the elastic modulus of 0.5%, 1.1% and 2.2% alginate
as 3.7kPa, 7.35kPa and 13.13kPa respectively.159 Increasing the concentration of the alginate
w/v also increases the viscosity of the solution and affects cell viability.149 At higher vis-
cosities, alginate hydrogels reduce the viability of encapsulated cells due to the shear forces
exerted on the cells during mixing with the viscous alginate solution. This can be overcome
by combining low and high molecular weight solutions to form alginate solutions with good
structural stability but at a lower viscosity that does not affect cell viability during mixing.149
The influence of the G:M ratio, molecular weight and viscosity of the alginate solution are
thus important factors to consider when choosing an alginic acid, and producing alginate
hydrogels for cell encapsulation applications.149,151
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Alginate’s molecular weight can be reduced by γ-irradiation to break down the G-, M-
and G-M residues: this creates shorter alginate chains that have reduced interactions in
solution but can still form crosslinks during polymerisation to support the hydrogel structure.
The γ-irradiation reduces the molecular weight of the alginic acid and the viscosity of the
alginate solution, without affecting the mechanical stability of the resulting hydrogel.149,158
The less viscous alginate solution reduces the shear forces on the cells and is therefore more
suitable for cell encapsulation. The ability to control the mechanical properties of an alginate
hydrogel independently of viscosity is thus an important characteristic of this biomaterial and
represents an advantage of using alginate hydrogels for producing 3D platforms.154,158 Given
the importance of tuning the ECM composition and stiffness to promote differentiation to
a desired cell fate, the ability to control many factors of alginate hydrogels makes them an
attractive biomaterial for 3D cell culture applications.
1.6.3 Importance of controlling alginate hydrogel porosity
The porosity of a biomaterial scaffold must be sufficient to allow diffusion of oxygen, nutrients
and waste throughout the scaffold, whilst simultaneously surrounding the encapsulated cells
to provide support and cell-matrix interactions.160 A study in collagen-glycoaminoglycan
scaffolds demonstrated that the porosity of the scaffold influenced osteoblast behaviour, with
osteoblasts showing higher infiltration into a scaffold with larger porosity.161 A study in
polycaprolactone scaffolds showed that larger pore sizes support chondrocyte and osteoblast
growth, but smaller pore sizes supported fibroblast growth.162
The porous nature of alginate allows both the diffusion of medium throughout the scaffold
and the release of waste products back into the medium. Wang et al., (2009) and Horiguchi
et al., (2014) investigated the penetration of soluble factors into alginate hydrogel beads of
varying compositions, and both reported that penetration of a soluble factor into the alginate
beads decreased as a function of molecular weight.150,163 Wang et al., (2009) demonstrated
that alginate porosity decreases with increasing w/v of the alginate solution, with pore sizes
of 10.9µm, 5µm and 3.4µm in alginate beads of 0.5%, 1% and 2%, respectively.150 Horiguchi
et al., (2014) investigated the diffusion of molecules of increasing molecular weight into algi-
nate capsules of different composition (uncoated, hollow-liquid core, and PLL coated alginate
beads). Their results showed that regardless of the alginate composition, the rate of pen-
etration of molecules into the beads decreased with the increasing molecular weight of the
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molecule, and that at a molecular weight of 40kDa or more, only 50% of the molecules would
diffuse through the alginate beads after 24h.163
This property of alginate hydrogel beads represents both a limitation and a technical
advantage for cell encapsulation. The inability to use soluble factors of high molecular weight
can limit the use of alginate for some differentiation protocols. For example, full length Shh
typically used for MN differentiation protocols is approximately 19.8kDa, and based on the
results from Horiguchi et al., (2014), less than 75% of this would penetrate alginate beads of
1% w/v at 24h.163 On the other hand, given that a major limitation of 2D cell cultures is that
cells are exposed to a homogenous concentration of soluble factors in the culture medium,
using alginate hydrogels represents an opportunity to introduce gradients of soluble factors
by controlling the hydrogel porosity and manipulating the size of the soluble factors.
In knowing that the size of a soluble factor will affect the time taken to penetrate the
alginate hydrogel, and that the porosity of the scaffold further influences this diffusion rate,
we can manipulate the composition of alginate hydrogels to create gradients of soluble factors.
Exploiting these properties may permit spatial and/or temporal exposure of the encapsulated
cells to developmental cues, which more closely recreates the in vivo environment. For 3D
cell culture, the ability to alter many variables of alginate hydrogels means that platforms
can be adapted for many cell types and applications. By creating growth factor gradients
in 3D, we can closely examine the cell-matrix-gradient, or cell-cell-gradient interactions to
identify any effects that the gradient has on cell fate at different points along the gradient or
different stages of differentiation.
1.6.4 ESC differentiation in 3D alginate platforms
Alginate hydrogels have been used to promote ESC differentiation into a range of cell types.
Studies have differentiated encapsulated ESCs in alginate hydrogels into neurons,117,159 hep-
atocytes,7 motor neurons,164 and pancreatic Islet-like cells.36 Alginate platforms have been
used to develop ESC aggregates in vitro, and the results showed that alginate hydrogels
prevent the agglomeration of encapsulated aggregates, thus preventing the formation of a
necrotic core.165,166 EB agglomeration is a limiting factor for EB suspension cultures as the
increased size of agglomerated EBs creates a necrotic core and also reduces the differentiation
efficiency of the protocol.22,41–43
Some studies have developed cell-laden alginate platforms for in vivo applications. When
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alginate hydrogels are implanted, they protect encapsulated cells from from antibodies and
antigens within the host tissue.150,159,167 Qian et al., (2014) used an alginate hydrogel loaded
with gelatin microspheres to demonstrate that the platform could be used as a soluble factor
delivery system in vivo.168 Their alginate:gelatin hybrid platform reduced the burst release
of growth factors observed in previous platforms. Burst release at 2h was reduced from 30%
to 5%, and cumulative release at 1 week was reduced from 95% to 50% in the hybrid al-
ginate:gelatin platform versus the alginate only platform.168 Another study differentiated
encapsulated mouse ESCs into insulin-producing cells that efficiently responded to glucose
challenge, demonstrating that the cells behaved in a similar way compared to their in vivo
counterparts.150 The cell-laden scaffold could be implanted to provide a source of insulin for
diabetic patients that behaves similarly to endogenous insulin. Alginate typically degrades
slowly in vivo however one study developed an alginate model with incorporated alginate
lyase-loaded PLGA microspheres in the scaffold, which provided a controlled method for de-
grading the scaffold after implantation to the host tissue.155 The above studies demonstrated
that cell-laden alginate scaffolds can be adapted for in vivo applications.
1.7 Focus of the current research
The evidence from the literature points to a need for further development of 3D culture
platforms to generate more complex systems for investigating the mechanisms of ESC differ-
entiation in vitro. For example, the in vivo process of development relies on 3D gradients of
RA to correctly specify cell fates and progenitor boundary domains, to promote axonal mi-
gration and to prevent RA-induced teratogenicity. 2D cell culture protocols cannot recreate
these 3D gradients, and cells in monolayer are exposed to uniform concentrations of soluble
factors in the medium. The previously described 3D platforms have generate 3D signalling
gradients, but their limited control over the concentration of soluble factors, or the use of
exogenous RA to induce ESC differentiation, represent limitations of the existing 3D systems.
The primary goal of this PhD project was to develop a novel 3D platform for investigating
the patterned differentiation of mouse ESCs to cell fates from the three germ layers using
alginate hydrogels. The platform aimed to address the limitations of previous 3D systems
by introducing a cell-derived source of RA into the novel 3D platform, thereby providing
encapsulated ESCs with a stable concentration of RA that was not prone to degradation or
burst release. In the current project, a cell density gradient plus a consequent gradient of
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cell-derived RA were incorporated into the 3D platform. The ability to introduce gradients
into the scaffold was an important feature of the system as it created a more versatile 3D
platform could be adapted for future experiments.
3D cell cultures are important platforms for recapitulating the in vivo environment when
investigating the mechanisms of cell development in vitro.4,106 Altering the concentration of
an alginate solution, or the concentration of the crosslinking buffer changes the properties
of alginate hydrogels, thus these factors can be easily manipulated to design finely-tuned
scaffolds for 3D cell culture. However, the G:M ratio of a specific alginate will impact how
changes to the alginate or crosslinking concentrations affect the viscosity, internal porosity,
elastic modulus and mechanical stability of an alginate hydrogel.169 Despite the influence of
the G:M ratio on the scaffold architecture, no study has conducted a side-by-side comparison
of the effects of using alginates of different G:M ratios on the differentiation efficiency of the
alginate hydrogels. As a direct consequence of this, there is currently no evidence to support
using one type of alginate over another for ESC differentiation.
The present thesis aimed to address this question by investigating the impact of two types
of alginate (high G-residue versus high M-residue) on ESC encapsulation and differentiation
in 3D hydrogels. The ability to select an optimal alginate subtype for ESC differentiation
will contribute to developing more efficienct, finely-tuned 3D platforms for investigating cell
development. An ongoing challenge in using alginate for 3D cell cultures is that some studies
using alginate hydrogels do not report the G:M ratio of the alginate used. Without knowing
what type of alginate was used in a given experiment, the ability to reproduce experiments
between labs is limited but there are no published studies that demonstrate the importance
of reporting the G:M ratio. The experiments described in this thesis aimed to generate strong
evidence to support the use of either high-G or high-M alginates when recreating 3D platforms
for ESC differentiation. By demonstrating that ESCs encapsulated in alginate hydrogels of
different G:M ratio, molecular weight and viscosity are viable, capable of forming aggregates,
and by showing that both types of alginate hydrogel remain intact over the course of cell
culture, the experiments demonstrate that the G:M composition may not exert significant
effects on ESCs. Alternatively, if one (or both) compositions of alginate has a negative impact
on viability, does not support aggregation, or does not maintain hydrogel structure during cell
culture, this shows that the choice of alginate must be carefully considered before designing
a 3D platform for ESC encapsulation.
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Previous studies in alginate demonstrated that ESCs can be encapsulated and differenti-
ated in 3D platforms, however, no study to date has investigated if the ESC aggregates formed
within alginate hydrogels are EBs containing cells from each of the three primary germ layers.
Two studies using alginate hydrogels have investigated ESC differentiation towards the germ
layers where the cells were cultured on layers of alginate after the hydrogels were polymerised,
but no study has examined the effects of pre-encapsulation of the ESCs on germ layer differ-
entiation within the aggregates.165,166 As the foundation for 3D cell culture is the knowledge
that cell-matrix interaction significantly affects cell fate, it was possible that the encapsulated
ESCs did not differentiate in the same way as ESCs seeded onto pre-polymerised alginate
scaffolds. Thus it was important to demonstrate that germ layer differentiation occurred
when ESCs were encapsulated, and then differentiated within alginate hydrogels.
This thesis describes experiments to investigate the whether the encapsulated ESC-derived
aggregates were canonical EBs. The aim of these experiments was to bridge the gap in the
available literature by demonstrating that alginate beads are capable of supporting differ-
entiation of canonical EBs, containing cells from the three germ layers. Providing evidence
of germ layer differentiation within the alginate hydrogels would increase the utility of the
platform to include studies of embryogenesis, germ layer self organisation, ESC differentia-
tion to cell derivatives from each germ layer, or the outcomes of long-term EB culture within
alginate beads. In demonstrating the ability to generate cell types from all three germ layers,
the experiments show that alginate hydrogels are suitable for experiments differentiating any
cell type derived from any germ layer, but conversely, by demonstrating that the encapsu-
lated ESCs will only differentiate one or two of the germ layers, the results provide evidence
that this 3D culture method is not suitable for investigating ESC differentiation towards cells
fates from the unsupported germ layers. In that instance, the previously described methods
of seeding the ESCs onto pre-polymerised scaffolds are optimum for generating cell fates from
germ layers not present within aggregates encapsulated within alginate.
1.7.1 Objectives of the experimental chapters
– Chapter 3 aimed to demonstrate that alginate hydrogels are suitable biomaterials for ESC
encapsulation and 3D cell culture, and build the foundation for experiments investigat-
ing ESC differentiation within the alginate hydrogels.
– Chapter 4 outlines experiments to demonstrate that alginate hydrogels support ESC differ-
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entiation to cell fates from the three primary germ layers, and experiments to determine
whether high-G or high-M residue alginate hydrogels are optimum for ESC neuronal
differentiation, relative to standard EBs.
– Chapter 5 describes experiments to validate a cell-derived source of endogenous RA from
HGF11-derived LMC MNs, which can provide a stable concentration of RA in vitro
over several days.
– Chapter 6 describes the development of a novel 3D alginate platform, for investigating
patterned ESC differentiation in vitro, generated by incorporating the platform com-
ponents outlined in Chapters 3-5 using an adapted gradient maker protocol.
1.7.2 Hypotheses
– Hypothesis 1: Alginate hydrogels are a suitable biomaterial scaffold for culturing and
differentiating encapsulated ESCs, as demonstrated by the presence of viable cells and
markers of embryoid body germ layers within the scaffolds.
– Hypothesis 2: There will be an influence of alginate molecular weight/G:M content on
the relative differentiation of encapsulated ESCs towards the ectodermal germ layer as
examined using relative gene expression by quantitative PCR.
– Hypothesis 3: Lateral motor column, motor neurons differentiated from the HGF11 ESC
line will produce a source of endogenously produced retinoic acid.
– Hypothesis 4: An alginate hydrogel tube containing a gradient of retinoic acid producing
cells will induce varying levels of ESC differentiation along the retinoic acid gradient.
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Chapter 2. Methods
2.1 Cell Culture
2.1.1 Aseptic cell culture
All cell culture work was carried out using aseptic techniques. Alginate, CaCl2, forceps,
and spatulas were autoclaved. The gradient maker and tubing were decontaminated with
70% ethanol. Cells were cultured in a humidified incubator at 37oC, 5% CO2. A full list of
reagents used is listed in Appendix 1, p.138.
2.1.2 Preparation of tissue culture plates
Mouse embryonic fibroblasts (MEFs) and ESCs were cultured on gelatin-coated tissue culture
flasks: 0.1% gelatin solution in Dulbecco’s phosphate buffered saline (dPBS) was added to
each flask at a sufficient volume to coat the base of the flask. The flasks were incubated for
2h at 37oC, or overnight at 4oC, and washed once in dPBS before seeding cells.
2.1.3 Culture of feeder-free mouse embryonic stem cells
CGR8 mouse ESCs from passage 10-20 were used for alginate characterisation and co-culture
experiments. CGR8 are feeder-free mouse ESCs derived from the inner cell mass of a pre-
implantation, 3.5 day male mouse (Mus musculus, strain 129).170 CGR8 maintain their
pluripotency in the absence of feeder layers with the addition of a high concentration of
LIF to the culture medium. CGR8 were cultured in ESC medium composed of Dulbecco’s
modified eagle medium (DMEM)-high glucose, 10% ES-qualified fetal bovine serum (FBS; Lot
No. FB-1001H), 100 units/millilitre (mL) penicillin, 100 microgram (µg)/mL streptomycin,
2 millimolar (mM) L-glutamine, 100µM beta-mercaptoethanol (β-ME), and 1000 units of
LIF/mL. Medium was changed daily to maintain pluripotency and ESCs were passaged at a
ratio of 1:8 at 80% confluence (∼every 2 days).
2.1.4 Passaging cell populations by trypsinisation
To passage the cells, the culture medium was aspirated, the cells were washed once in dPBS,
and 3mL or 6mL of 0.25% trypsin:ethylene-diamine-tetraacetic-acid (EDTA; 1X) was added
to the T25 or T75, respectively, for 2-5 minutes (min) until the cells detached from the flask.
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Trypsin was quenched using an equal volume of culture medium (3mL or 6mL) and the cell
suspension was pelleted by centrifugation (5min, 200 relative centrifugal force (rcf)). The
supernatant was aspirated, the cell pellet was resuspended in fresh medium, and the cells
were seeded at the required ratio into a new gelatin-coated flask.
2.1.5 Culture of mouse embryonic fibroblast feeder layers
MEFs (Mus musculus, strain CF1) were cultured as feeder layers for the HGF11 ESC. MEF
medium was composed of DMEM-high glucose, 10% FBS, 100 units/mL penicillin, 100µg/mL
streptomycin, and 2mM L-glutamine. Cells were passaged at a ratio of 1:2 at 80% confluence
(∼every 3 days). At passage 6, confluent flasks of MEFs were inactivated with 10µg/mL
Mitomycin-C treatment for 2h. After inactivation, the cells were washed 3 times with dPBS,
and cultured in MEF medium for up to 10 days, with medium changes every 2 days. MEF
medium was replaced with ESC medium 30min before seeding with HGF11 ESCs.
2.1.6 Culture of feeder-dependent mouse embryonic stem cells
The HGF11 feeder-dependent mouse ESC line was a gift from Professor Bennett Novitch, Uni-
versity of California, Los Angeles. HGF11 are a transgenic cell line derived from HB9::Foxp1
transgenic mice. When HGF11 are differentiated to MN fate, the ESCs express green fluores-
cent protein (GFP) and Foxp1 under control of the HB9 promoter and can be induced toward
GFP+/Foxp1+ LMC MN fate.12 HGF11 were cultured on MEF feeder layers in DMEM-high
glucose, 10% FBS, 100 units/mL penicillin, 100µg/mL streptomycin, 2mM L-glutamine, 1X
non-essential amino acids, 100µM β-ME, and 1000 units of LIF/mL. Medium was changed
daily to maintain pluripotency and HGF11 ESCs were passaged at a ratio of 1:8 at 80%
confluence (∼every 2 days).
2.1.7 Separation of embryonic stem cells from feeder layers
The presence of feeder cells in EB suspension cultures reduces differentiation efficiency,104
so MEFs were separated from HGF11 ESCs before seeding the ESCs for EB culture. After
trypsinisation, the MEF-HGF11 cell suspension was pelleted by centrifugation (5min, 200rcf),
and resuspended in 5mL ADFNK medium: Advanced DMEM-F12:Neurobasal medium
(1:1), 10% Knockout serum replacement, 100 units/mL penicillin, 100µg/mL streptomycin,
2mM L-glutamine and 100µM β-ME. This cell suspension was plated onto a gelatin-coated
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100mm dish (0.1% gelatin). After 45min, MEFS had adhered to the dish and ESCs remained
in suspension. The ESC suspension was aspirated, cells were counted using trypan blue
exclusion and used for differentiation experiments.
2.1.8 Embryonic stem cell neuronal differentiation by suspension culture
ESCs differentiated using the EB suspension culture method served as control conditions for
alginate bead experiments. ESCs were reseeded at 5x104 cells/mL in ADFNK, and the cell
suspension was plated onto 100mm suspension dishes and cultured for 6 days, with 1µM RA
added on days 2 and 4. To change the medium, the dishes were swirled gently to gather the
EBs in the centre of the dish, and the EBs and medium were aspirated into a 15mL falcon
tube. The EBs were centrifuged to pellet (3min, 200rcf) and resuspended in 10mL ADFNK
supplemented with 1µM RA.
2.1.9 Preparation of laminin-coated coverslips
To prepare laminin-coated coverslips for immunocytochemistry (ICC) and enzyme-linked
immunosorbent assay (ELISA) experiments, glass coverslips were added to each well of 12-
well plates, and sterilised by ultraviolet irradiation for 2h. Laminin at 2µg/centimetre (cm)2
in dPBS was added to each well, the plates were placed on a rocker for 15min at room
temperature, then incubated at 37oC overnight. Prepared plates were used immediately, or
sealed with Parafilm and stored at 4oC for up to 2 weeks. The wells were washed twice with
dPBS before seeding cells.
2.1.10 EB dissociation and monolayer culture for immunostaining
On day 6 of differentiation, EBs were collected and dissociated to form a single cell suspension.
The EB suspension was centrifuged (3min, 200rcf) to form a pellet, resuspended in dPBS,
re-centrifuged (3min, 200rcf) and the pellet was resuspended in 5mL of 0.25% trypsin-EDTA
(1X). The EBs were placed on a rocker for 5-10min at room temperature, then 5mL of
ADFNK was added to the suspension to dilute and reduce the activity of the trypsin-EDTA.
The cell suspension was recentrifuged (5min, 200rcf) to form a pellet, resuspended in 5mL
of ADFNK, and passed through a 70µm cell strainer. Cells were counted using trypan blue
exclusion, replated at the required cell density onto laminin-coated coverslips and cultured
for 2 days in ADFNK supplemented with 5 nanograms (ng)/mL GDNF. After 24h, the cells
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adhered to the coverslip and extended neurite processess. On day 8 (48h after replating),
cells were fixed for 20min in 3.7% paraformaldehyde (PFA), washed once in dPBS, and the
plates were sealed with Parafilm and stored at 4oC until immunostaining.
2.2 Characterisation of HGF11-derived lateral motor column motor neu-
rons
2.2.1 Differentiation of motor neurons from HGF11 embryonic stem cells
HGF11 ESCs were differentiated using the Wichterle and Peljto EB differentiation protocol:24
mouse ESCs were differentiated toward a MN lineage by EB suspension culture, adding
1µM RA and 1.5µM purmorphamine on days 2 and 4; this protocol generates 30-50% MN
populations by day 6 of differentiation. On day 6, the EBs were collected, dissociated by
trypsinisation, counted via trypan blue exclusion and replated onto laminin-coated coverslips
at 1x105 cells/cm2 for ICC, or at 17.5x105 cells/cm2 for ELISA experiments (see subsection
2.2.2, p.35). For ICC, cells were cultured for 2 additional days in ADFNK supplemented with
10ng/mL GDNF, then fixed and stored for immunostaining. Control conditions were HGF11
ESCs differentiated with 1µM RA only or CGR8 wildtype ESCs differentiated to MNs using
the Wichterle and Peljto protocol.
2.2.2 Quantification of endogenous retinoid concentrations
Competitive ELISAs were used to confirm that HGF11-derived MNs can produce endogenous
RA and Raldh2, and to quantify the concentration of RA and Raldh2 released by these MNs
into the culture medium. HGF11 ESCs were differentiated as above, and replated at 1x105
cells/cm2 onto laminin-coated coverslips. The cells were cultured for 6 days after replating
(12 days of differentiation) in ADFNK supplemented with 5ng/mL GDNF to enhance the
maturation and survival of MNs.24 Half of the medium was changed every 2 days, allowing
48h build up of RA and Raldh2 in the medium before samples were collected for ELISA. Cells
were tested on days 8 through 12 to confirm the presence of RA and Raldh2 in the medium
at each timepoint.
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2.3 Viability Assays
2.3.1 Live/dead assay for alginate beads
Cell viability inside alginate beads was tested using fluorescein diacetate (FDA)/propidium
iodide (PI) or thiazole orange (TO)/PI. ESCs were encapsulated in alginate beads and cul-
tured for 6 days. On day 6, the beads were incubated in live/dead buffer for 5-10min in the
dark. Live/dead buffer was either 30µM FDA and 20µM PI (in early optimisation exper-
iments) or 100nM TO and 10µM PI (in all subsequent experiments). After incubating for
5-10min, the live/dead buffer was aspirated and the beads were washed once in dPBS. Beads
were imaged using a Zeiss Axiovert A1 inverted microscope and Axiovision software (v4.0).
2.3.2 Validation of live/dead assay by flow cytometry
ESCs were used to set up a live/dead assay template for flow cytometry analysis. To validate
the assay, 100nM TO and 10µM PI were tested on single population of (i) live cells (positive
control for TO, negative control for PI) and (ii) dead cells (negative control for TO, positive
control for PI). CGR8 were passaged, counted using trypan blue exclusion, and aliquoted at
1x106 cells/mL in dPBS. For dead cell populations, the cells were pelleted and resuspended in
100% ethanol for 15min at room temperature. Live and dead cell aliquots were single labelled
with either 100nM TO or 10µM PI, and the samples were incubated for 10-20min at room
temperature. Cells were analysed using a BD Accuri C6 flow cytometer and C-Flow Sampler
software (v1.0). Cell populations were thresholded at 200,000, flow rate was 14 microlitre
(µL)/min, and 10,000 events were collected per condition. Populations were gated for debris
using forward and side scatter (FSC vs SSC), and single stained controls were used to gate
live/dead populations on FL1 vs FL3.
2.4 Immunofluorescence methods
2.4.1 Cryosectioning embryoid bodies and alginate beads
Alginate beads and EBs were fixed at day 6 of differentiation for 1h in 3.7% PFA, cryopro-
tected for 4-6h in 30% sucrose solution, embedded in optimum cutting temperature compound
(OCT) and stored at -80oC. Samples were sectioned at 15-30µM, collected on gelatin-coated
microscope slides, dried overnight at 37oC and stored at 4oC. Microscope slides were coated
to prevent the negatively charged alginate sections from washing off the slides during im-
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munostaining. To apply the coating, standard microscope slides were washed in a 0.2%
gelatin:0.02% chromium potassium sulfate dodecahydrate solution; slides were dipped into
the solution 5 times for 5s, then air-dried for 1min; this was repeated 5 times. The slides
were dried overnight at room temperature. All sections were outlined with an ImmEdge wax
pen for immunostaining.
2.4.2 Immunocytochemistry
To prepare cells for ICC all samples were blocked and permeabilised in 20% normal goat
serum (NGS) in 0.05% Triton-X-100 for 1.5h at room temperature. Primary antibodies
were applied for 1.5h at room temperature or overnight at 4oC. Samples were washed in
dPBS (2x10min). Secondary antibodies were applied for 2h at room temperature, and then
washed once in dPBS. Nuclei were counterstained with Hoechst 1:25,000 for 10min at room
temperature. A full list of antibodies and concentrations used is listed in Table 1. Samples
were washed in dPBS (2x10min), double distilled water (ddH2O) (1x5min), and mounted
using Vectashield mounting medium. Samples were imaged using a Zeiss Axioimager A1
fluorescent microscope and Axiovisionsoftware (v4.0). Immunofluorescence negative controls
were fixed and and stained under the same conditions as experimental samples. Negative
control tissues used for immunofluorescent analysis were as follows:
– Negative controls for alginate beads: CGR8 were encapsulated in alginate beads and
cultured for 6 days in ESC medium with LIF to prevent differentiation.
– HGF11-derived MN characterisation: HGF11 ESCs were cultured on gelatin-coated
coverslips in ESC medium until confluent.
– HGF11-derived MN GFP/FoxP1 validation: HGF11 ESCs were differentiated using
1µM RA only. CGR8 ESCs were differentiated with 1µM RA and 1.5µM purmor-
phamine toward a MN lineage.
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Table 1: Details of antibodies used for immunocytochemistry experiments
Primary Antibody Supplier Code Host Conc.
α-fetoprotein Thermo Fisher PA5-21004 Rabbit IgG 1:200
α-smooth muscle actin Abcam ab7817 Mouse IgG2a 1:300
α-smooth muscle actin Abcam ab5694 Rabbit IgG 1:300
β-III-tubulin Abcam ab41489 Chicken IgY 1:300
β-III-tubulin Abcam ab18207 Rabbit IgG 1:300
Foxp1 Thermo Fisher PA5-52006 Rabbit IgG 1:100
HB9 Santa Cruz sc515769 Mouse IgG2a 1:200
HB9 Thermo Fisher PA5-23407 Rabbit IgG 1:150
Nestin Santa Cruz sc101541 Rat IgG 1:250
Secondary Antibody Supplier Code Host Conc.
anti-chicken Alexa Fluor 647 Abcam ab150171 Goat IgY 1:500
anti-chicken IgY fluorescein Aves Labs F1005 Goat IgY 1:500
anti-mouse Alexa Fluor 488 Life Tech A11001 Goat IgG 1:500
anti-mouse Alexa Fluor 568 Life Tech A11004 Goat IgG 1:500
anti-rabbit Alexa Fluor 488 Life Tech A27034 Goat IgG 1:500
anti-rabbit Alexa Fluor 568 Life Tech A11011 Goat IgG 1:500
anti-rabbit Alexa Fluor 647 Life Tech A21245 Goat IgG 1:500
anti-rat Alexa Fluor 594 Life Tech A11007 Goat IgG 1:500
Hoechst 33342, 10mg/ml Life Tech H3570 n/a 1:25,000
Abbreviations: Conc, concentration; HB9, homeobox protein B9
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2.5 Alginate hydrogels for cell culture
2.5.1 Formation of cell-encapsulating alginate hydrogels
CGR8 were resuspended in 1% w/v alginate:0.1% gelatin at a cell density of 3x106 cells/mL
alginate. Two molecular weights of alginate were tested: low molecular weight, low viscosity
alginate with a high G:M ratio (hereafter referred to as LMW) and high molecular weight, high
viscosity alginate with a low G:M ratio (hereafter referred to as HMW). Alginate beads were
formed by manually extruding the alginate-cell suspension from a syringe with a 21 gauge (G)
needle, into a bath of 100mM CaCl2/10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (Hepes) (see Figure 3, p.40). The alginate beads were polymerised for 5min at room
temperature, washed once with ADFNK, and cultured for 6 days in ADFNK with 1µM RA
added on days 2 and 4. Cell density per bead was calculated by dividing the volume of
alginate by the number of beads: LMW beads, ∼6x104 cells/bead; HMW beads, ∼5x1040
cells/bead. On day 6, beads and EBs (used as control conditions) were collected and used
for depolymerisation experiments, or prepared for cryosectioning (see subsection 2.4.1, p.36).
2.5.2 Depolymerisation of alginate beads
On day 6 of differentiation, alginate beads were collected for depolymerisation to harvest the
encapsulated cells. To harvest the cells, scaffolds were depolymerised using a depolymerisa-
tion buffer to chelate the CaCl2 crosslinks inside the beads, allowing the alginate to return to
a liquid state. To determine the optimum conditions for depolymerising and harvesting cells,
the number of cells and the cell viability for each condition were recorded. Cell viability was
tested using trypan blue exclusion or live/dead assay via flow cytometry.
2.5.3 Live/dead viability counts by flow cytometry
The viability of cells harvested from alginate beads was assessed by live/dead assay and flow
cytometry. To harvest the cells, the beads were collected using a spatula, washed once in
dPBS, and the depolymerisation buffer was added for the required length of time. Once the
encapsulated aggregates were released, the depolymerisation buffer was diluted using dPBS,
the cell suspension was centrifuged (5min, 200rcf) and resuspended in 1mL dPBS. Cells were
double stained using TO and PI, incubated for 10-20min at room temperature and analysed
via flow cytometry using a BD Accuri flow cytometer and C Flow Sampler software (v1.0).
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Figure 3: Images of alginate beads with encapsulated ESCs on day 0. The images show
alginate beads containing encapsulated ESCs immediately after polymerisation: (a) beads
formed from 1mL of alginate:cell suspension by manual extrusion from a 21G needle; (b)
low magnification brightfield images of beads after polymerisation; (c) high magnification
brightfield images of beads after polymerisation. Scale Bar: (b) 1mm; (c) 400µm
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Figure 4: Diagram of the Boyden chamber setup for alginate co-culture experiments.
To test the activity of endogenously produced RA, alginate beads were co-cultured with
differentiated, RA producing, HGF11-derived MNs. This setup allowed the alginate beads
to be cultured in the same medium as the RA without having the beads in close proximity
to the mature MNs. The Boyden chamber also allowed easy medium changes every 2 days
and easy collection of the beads at the end of the culture period.
2.6 Alginate co-culture
2.6.1 Boyden chamber co-culture
To test the ability of the endogenously produced RA from HGF11-derived MNs to differentiate
ESCs toward a neuronal lineage, alginate beads containing CGR8 were co-cultured with
HGF11-derived MNs (see Figure 4, p.41). To prepare the co-culture, HGF11 ESCs were
differentiated to day 6 as above (see subsection 2.2.1, p.35), and replated onto laminin-
coated coverslips in 12-well plates. On the day that the HGF11-derived MNs were replated,
alginate beads were prepared (day 0 of alginate differentiation) and transferred into Boyden
chambers (8-10 beads per chamber). After 48h (day 2 of alginate differentiation), half of
the medium on the HGF11-derived MNs was replaced and each Boyden chamber containing
alginate beads was transferred into a well containing HGF11-derived MNs. After 2 days (day
4 of alginate differentiation), half of the medium was changed, and on day 6 (day 6 of alginate
differentiation), the beads were fixed, cryopreserved and immunostained for markers of the
three germ layers (see subsection 2.4, p.36).
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2.6.2 Formation of alginate tubes for co-culture
To investigate the potential for endogenous RA to induce patterned differentiation of ESCs at
increasing concentrations, mature HGF11-derived MNs were co-cultured with CGR8 ESCs
inside an alginate tube. The tube was created with a standard gradient maker using the
setup shown in Figure 5. A simplified colour-coded diagram of the system and a description
of the process involved in creating alginate tubes is presented in Figure 6. To create the
alginate tubes containing gradients of two cell types, the alginate cell suspensions are loaded
into each chamber of the gradient maker (A & B). When the pump was switched on, a
volume of alginate from chamber B was drawn into the tubing to form the Leading Edge (L).
This simultaneously draws an equal volume of cell suspension from chamber A into chamber
B, which was then mixed with the cell suspension in chamber B. In this manner, the cell
suspension from chamber A was continuously drawn into and mixed with the suspension in
chamber B.
Whilst the tube was formed through the action of the peristaltic pump, the cell suspension
in chamber B was diluted with a the cell suspension drawn in from chamber A, such that the
Trailing Edge (T) contains a low concentration of cell suspension B and a high concentration
of cell suspension A. For this experiment, both chambers had cell suspensions containing equal
cell densities of CGR8, and chamber B also contained HGF11-derived MNs. This results in
an alginate tube with a consistent cell density of CGR8, and an decreasing cell density of
RA-producing MNs along the length of the tube (see Figure 6, p. 44).
2.7 Quantitative polymerase chain reaction
2.7.1 RNA extraction and DNA synthesis
Quantitative polymerase chain reaction (PCR) was used to assess the gene expression of
markers for the three germ layers in EBs and in cells encapsulated in alginate beads. Alginate
beads were cultured for 6 days (see subsection 2.5.1, p.39), and on day 6, the cells were
harvested using 50mM EDTA, 120mM sodium chloride (NaCl) and 10mM Hepes (pH 7.4)
for 5min at room temperature. The aggregate suspension and EBs were centrifuged (3min,
200rcf) to pellet, and ribonucleic acid (RNA) was extracted using a Qiagen RNeasy kit,
according to the manufacturers instructions. In brief, the cell pellet was resuspended in
200µl RLT buffer and vortexed for 30s to lyse the cells and eliminate ribonucleases (RNase).
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Figure 5: Diagram of a gradient maker and the equipment required to make alginate
tubes. The gradient maker was used to form alginate tubes, to test the effect of localised
RA concentrations on ESC differentiation: (a) the gradient maker setup and equipment
for making the alginate tubes, (b) a close-up image of the gradient maker showing the two
chambers containing alginate-cell suspension solutions for forming alginate tubes.
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Figure 6: Diagram of gradient formation in the tubes. The gradient was formed from
two alginate:cell solutions: (A) alginate containing CGR8 only, and (B) alginate containing
CGR8+HGF11-derived MNs. An equal volume of alginate solutions A and B are added to
chamber A and B, respectively. The peristaltic pump is switched on and draws a volume of
alginate B from chamber B into the tubing forming the Leading Edge (L) of the hydrogel,
which has a high concentration of alginate B, and low concentration of alginate A. This
simultaneously draws an equal volume of alginate A from chamber A into chamber B,
which is then mixed with the alginate B in chamber B by the stir bar (red star). As this
process continues, alginate A from chamber A is continuously drawn into and mixed with
alginate B in chamber B, and the alginate in chamber B is drawn into the tubing and
towards the CaCl2 where it crosslinks to form a hydrogel tube. The alginate solution in
chamber B is continuously diluted with the solution from chamber A such that the Trailing
Edge (T) contains a low concentration of alginate B and a high concentration of alginate A.
This results in a hydrogel tube containing a cell density gradient similar to that depicted
by the blue and red coloured gradients in the diagram. MN: HGF11-derived MNs, CGR8:
wildtype ESCs, Red star: location of stir bar.
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200µl of 70% ethanol was added to the sample, and mixed gently. This suspension was
transferred to an RNeasy mini spin column, and centrifuged (15s, 8000g) to bind the RNA
to the column membrane. The supernatant was discarded, and the column was washed once
with 700µl, and then twice with 500µl of RPE buffer. The mini spin column was transferred
to a fresh 1.5mL eppendorf and 30µl of nuclease free water was added to the column. The
column was centrifuged for 1min at full speed to elute the RNA into the collection tube. RNA
concentration was measured using a Thermo Scientific Nanodrop 2000 spectrophotometer.
RNA samples were stored at -80oC.
Some RNA samples harvested from LMW beads were concentrated using the Qiagen
RNeasy MinElute Cleanup kit. In brief, the sample was adjusted to a starting volume of
100µl with nuclease free water. 350µl RLT buffer was added to the sample, and then 250µl
of 100% ethanol was added and mixed gently. The suspension was transferred to an RNeasy
MinElute spin column, centrifuged (15s, 8000g) to bind the RNA to the column membrane,
and the supernatant was discarded. The membrane was washed once with RPE buffer, once
with 80% ethanol, and then the column was dried by centrifugation (5min, full speed). The
column was transfered to a fresh 1.5mL eppendorf, 12µl of nuclease free water was added to
the centre of the membrane, and the column was centrifuged for 1min at full speed to elute
the RNA into the collection tube.
The Qiagen Quantinova Reverse Transcription kit was used for complementary DNA
(cDNA) synthesis and genomic DNA (gDNA) elimination. For gDNA elimination, 500ng
of template RNA and 2µl of gDNA removal mix (containing RNase inhibitors) were added
to a 200µl eppendorf. The sample was mixed and incubated for 2min at 45oC. For cDNA
synthesis, 1µl of Quantinova reverse transcription enzyme and 4µl of Quantinova reverse
transcription mix (containing deoxyribonucleotide triphosphates and Mg2+) were added to
the template/gDNA reaction. The samples were incubated in a PCR thermal cycler for 3min
at 25oC, 10min at 45oC, and 5min at 85oC to inactivate the reverse transcriptase enzyme.
To prepare the no reverse transcription controls, the reactions were set up as above but the
reverse transcription enzyme was omitted.
2.7.2 Primer validation and efficiency
The primers for POU class 5 homeobox 1 (Pou5f1), Nestin (Nes), Pax6 and β-actin (Actb)
were tested in-house using a five point standard curve (see Table 2). The positive control
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sample was combined cDNA from EBs and cells harvested from alginate beads (4 EB, 4
HMW, and 3 LMW samples). ESC cDNA was used as the negative control. The quantitative
PCR was run using the Qiagen Quantinova SYBR green kit, according to the manufacturer
instructions. In brief, 0.75µl of cDNA template, 10µl of SYBR Green PCR master mix, 2µl
of QN ROX reference dye, and 1µl each of forward and reverse primer (final concentratrion
0.7µM) were added to each reaction, and the volume was adjusted to 20µl with nuclease free
water. The plates were sealed with a PCR plate seal, mixed for 5min on a plate mixer, and
spun with a plate spinner for 30 seconds (s). The thermal cycler conditions were: 2min at
95oC, followed by 40 cycles of 5s at 95oC and 10s at 60oC. Data were collected using an
Applied Biosystems StepOnePlus Real-Time PCR system and StepOne Software (v2.3).
Table 2: Primer efficiencies for real time PCR. Primer efficiencies were measured using a
5pt standard curve, on combined cDNA from EBs and Beads. The slopes and efficiencies
were calculated using the StepOne Software.
Primer Slope r2 Efficiency
Pou5f1 -3.168 0.98 106%
Nestin -3.126 0.99 108%
Pax6 -3.30 0.99 100%
β-actin -3.11 0.99 109%
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Chapter 3. Characterisation of alginate hydrogels as a suitable
scaffold for encapsulating mouse embryonic stem cells
3.1 Introduction
Alginate hydrogels are a commonly used biomaterial for 3D cell culture,43,105,117 and have
previously been used to encapsulate ESCs and induce cell differentiation to GABAergic
neurons,43 insulin-producing cells,150 and hepatocytes.7 Alginate is inherently biocompat-
ible, scalable for high-throughput applications, and allows easy modulation of characteris-
tics such as porosity, elastic modulus, cell adhesion factors and the size/shape of the scaf-
fold.43,105,171,172 EBs are used for in vitro cell culture experiments to mimic early embryoge-
nesis as they can induce ESC differentiation toward cell fates from the three embryonic germ
layers (endoderm, mesoderm and ectoderm).19,38,173 EB suspension culture generates high
numbers of differentiated cells, however there is limited control over the size of the EBs, the
diffusion of signalling morphogens into the EBs, and the efficiency of cell differentiation.
Biomaterials such as alginate offer increased control over the size of EBs and can promote
increased differentiation efficiency of encapsulated ESCs.43,174,175 Alginate beads have been
used to differentiate encapsulated mouse ESCs using RA and studies using these protocols
reported that ESCs encapsulated in alginate beads formed cell aggregates, had high viability
at the end of the culture period and produced a higher proportion of neurons relative to EB
controls.43,150,159 To date, no study has demonstrated that the aggregates within alginate
beads are canonical EBs comprised of cells from the three germ layers; this topic will be
addressed in chapter 4 and to avoid confusion, this chapter refers to the cell aggregates in
alginate beads as aggregates, and to cell aggregates formed by suspension culture as EBs.
This chapter outlines experiments to validate and characterise alginate beads of 1%
w/v, crosslinked in 100mM CaCl2 as a suitable biomaterial for mouse ESC culture. These
alginate/CaCl2 concentrations were selected based on the results from previous studies that
demonstrated successful ESC encapsulation in alginate hydrogels formed using these condi-
tions.43,117,142 Alginate hydrogel beads of different composition and size, and a range of cell
densities were tested to identify the optimum conditions for ESC encapsulation and subse-
quent aggregate formation. The conditions tested in these experiments are listed in Table 3.
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Table 3: Alginate conditions tested for optimisation of ESC encapsulation
Variation Conditions Tested
Alginate Base Solution DMEM ddH2O
Alginate Molecular Weight Low High
Needle Gauge 21G 30G
Gelatin Concentration 0% 0.1% 0.5%
Cell Density (cells/mL alginate) 2x106 3x106 5x106
These experiments optimised the conditions for cell encapsulation, assessed whether ESCs
within the alginate beads formed cell aggregates, and determined if those aggregates were
comparable in size and shape to EBs differentiated by suspension culture.17,176 The formation
of aggregates inside the beads was assessed by brightfield microscopy, and cell viability was
investigated using a live/dead assay. Initial experiments used HMW alginate for cell encap-
sulation, however following high variations in cell viability in early experiments, a literature
review on cell viability in alginate hydrogels was conducted. The review found that alginate
molecular weight and viscosity significantly affected cell viability and cell-matrix interac-
tions. Alginates of higher molecular weight produce alginate solutions with higher viscosity
and expose cells to shear forces during encapsulation which reduces cell viability.154,171,177
All subsequent experiments compared the effects of LMW and HMW alginate for cell encap-
sulation to assess differences in viability or cell fate between the two compositions.
3.2 Optimising alginate beads for embryonic stem cell encapsulation
3.2.1 Identifying a suitable base for alginate hydrogel solutions
Methods
HMW alginate was dissolved at 1% w/v in (i) DMEM-high glucose, or (ii) ddH2O, and gelatin
was added to each solution at a final concentration of 0.1% v/v. CGR8 were passaged by
trypsinisation, pelleted by centrifugation (5min, 200g) and resuspended at a cell density of
5x106 cells/mL in (i) alginate:DMEM or (ii) alginate:ddH2O. The solution was extruded from
a syringe with a (i) 21G or (ii) 30G needle into a bath of 100mM CaCl2, and polymerised
for 5min at room temperature. Beads were washed once in dPBS and cultured for 8 days in
ADFNK. 1µM RA was added to the medium on days 4 and 6 to induce neural differentiation.
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Results
Alginate:DMEM was optimum for embryonic stem cell encapsulation
The formation of cell aggregates inside the alginate beads was compared on day 8 of dif-
ferentiation. Brightfield images showed that ESCs encapsulated using an alginate:DMEM
solution produced large numbers of aggregates in beads formed using both a 21G needle (see
Figure 7a) and a 30G needle (see Figure 7b). Cells encapsulated in an alginate:ddH2O so-
lution formed a small number of aggregates in beads formed using a 21G needle (see Figure
7c) and zero aggregates in beads formed using a 30G needle (see Figure 7d). These results
showed that an alginate:DMEM solution was optimum for ESC encapsulation and that an
alginate:ddH2O solution was not a suitable composition.
Figure 7: Representative images of aggregate formation by encapsulated ESCs in four
alginate bead conditions. Alginate:DMEM beads contain high numbers of aggregates in
21G beads (a) and 30G beads (b). Alginate:H2O beads contain small numbers of aggre-
gates in 21G beads (c), and no aggregates in 30G beads (d). n=1, 3 beads per condition.
Arrowheads: black - encapsulated aggregates; red - escaping aggregates. Scale Bar: 1mm
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Encapsulated aggregates migrate out of alginate beads
At day 8 of differentiation, there were cell aggregates floating in the cell culture medium of
the 21G and 30G alginate:DMEM conditions, that had migrated out of the alginate beads
(see Figure 8a and b). These aggregates were similar in size and shape to EBs formed by
suspension culture (see Figure 8c versus d), and were visually indistinguishable from the EBs
(8b versus d). The encapsulated aggregates were visible at the edges of the beads and there
were striation marks in the direction that the aggregate had migrated from the interior of
the beads into the medium. This indicated that the encapsulated aggregates were interacting
with the alginate matrix and was evidence that the cell aggregates observed floating in the
cell culture medium had migrated out of the beads as whole aggregates, and were not formed
from single ESCs that had aggregated within the medium (see Figure 8e).
Conclusion
The aggregate formation observed in this experiment was consistent with previously re-
ported results for ESCs encapsulated in alginate beads.43,117 The results indicated that
alginate:ddH2O hydrogels were suboptimal for supporting aggregate formation, compared
with alginate:DMEM beads. Previous research reported that alginate solutions formed from
H2O had a 2-fold higher elastic modulus compared to alginate solutions formed in α-minimum
essential medium.171 If this was true for alginate:DMEM versus alginate:ddH2O, the increased
elastic modulus may have inhibited ESC aggregation by restricting cell-matrix interactions.
The 21G-DMEM condition had a smaller number of escaped aggregates versus 30G-DMEM
beads, indicating that they were more suitable for maintaining cell encapsulation during cell
culture. The following experiment builds on these results to further optimise the alginate
encapsulation conditions by examining the effect of reduced cell density and increased gelatin
concentration on aggregate migration from the beads.
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Figure 8: Brightfield images of escaped cell aggregates, EBs and an aggregate migrating
from a bead. Canonical EBs (a) were similar in size and shape to cell aggregates that escaped
from alginate:DMEM beads (c). Magnified images showed that EBs formed by suspension
culture (b) were visually indistinguishable from the free floating aggregates (d). The escaped
aggregates migrated out of the beads as whole aggregates, and appear to interact with the
alginate matrix, forming striations in the bead (e, blue arrowheads). Arrowheads: red -
escaping aggregate; blue - striation marks. Scale Bars: white - 500µm; black - 200µm
.
– 51 –
Characterisation of alginate hydrogels 3.2 Optimising alginate beads
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.2.2 Optimising the seeding cell density and differentiation duration
This experiment aimed to reduce the number of aggregates escaping from the 21G-DMEM
beads by manipulating the seeding cell density and gelatin concentrations of the alginate
beads. The cell density was reduced from 5x106 cells/mL to 2x106 cells/mL alginate, based
on results from a previous study that reported a cell density of 2x106 cells/mL is optimum for
maintaining high viability of cells encapsulated in alginate.150 Alginate does not contain cell
adhesion sites and must be functionalised to allow cell attachment and to provide a suitable
environment for anchorage-dependent cells.105,178 The previous experiment used 0.1% v/v
gelatin to support cell adhesion to the alginate. This experiment tested low gelatin (0.1%)
and high gelatin (0.5%) concentrations to examine whether increased gelatin concentration
could enhance aggregate formation or limit migration of the aggregates into the medium. The
previous experiment used an 8 day neural differentiation protocol176 however Montgomery et
al., (2015) reported that a 6 day protocol adding 1µM RA at days 2 and 4 was as efficient
as the 8 day protocol for neural differentiation.17 This experiment tested whether this 6 day
protocol was sufficient for aggregate formation by ESCs encapsulated in alginate beads.
Methods
HMW alginate was dissolved at 1% w/v in DMEM-high glucose and gelatin was added at a
final concentration of 0.1% v/v or 0.5% v/v. CGR8 were passaged by trypsinisation, pelleted
by centrifugation (5min, 200g) and resuspended at a cell density of 2x106 cells/mL. The
solution was extruded from a syringe with a (i) 21G or (ii) 30G needle into a bath of 100mM
CaCl2, and polymerised for 5min at room temperature. Beads were washed once in dPBS and
cultured for 6 days in ADFNK. 1µM RA was added to the medium on days 2 and 4 to induce
neural differentiation. The formation of aggregates was assessed by brightfield microscopy.
Data were collected for n=1-2 experiments with 2-3 beads imaged per condition.
Results
Embryonic stem cells formed aggregates at a reduced cell density
ESCs encapsulated in alginate at a reduced cell density of 2x106 cells/mL successfully formed
aggregates by day 6 of differentiation (see Figure 9). The aggregates were a mixture of cir-
cular and tubular shapes, but no aggregates were observed migrating across the edges of
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Figure 9: Brightfield images of encapsulated and escaped aggregates at a reduced cell
density. ESCs encapsulated at a cell density of 2x106 cells/mL formed aggregates by day 6
in 21G (a) and 30G (b) beads. The encapsulated aggregates were circular (red arrowheads),
or elongated in shape (yellow arrowheads). There were fewer escaped aggregates at this cell
density (c) relative to the higher cell density of 5x106 cells/mL (d). Scale Bar 500µm
.
the beads. The number of aggregates migrating from the beads was reduced and very few
aggregates were observed in the medium at day 6 (compare Figure 9c and d). This indicated
that a lower cell density was optimal for maintaining the cells inside the scaffold compared
with the higher cell density of 5x106 cells/mL.
Gelatin concentration did not affect aggregate formation
Brightfield images of alginate beads (HMW plus 0.1% or 0.5% gelatin) across 6 days of
differentiation showed that aggregate formation was visually comparable between low-gelatin
and high-gelatin conditions (see Figure 10). Some beads with low-gelatin conditions appeared
to have more aggregates in the scaffold (see Figure 10, D4, 0.1% versus 0.5%), but this was
not observed for all beads per gelatin condition. The low-gelatin condition generated beads
with rounder aggregates whereas the high-gelatin condition generated more elongated/tube
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Figure 10: Brightfield images of aggregate formation from ESCs for high and low gelatin
concentrations. Aggregate formation was similar across both conditions, with aggregates
visible from day 4 of differentiation. Some low-gelatin beads produced higher numbers of
round aggregates compared to high-gelatin beads, but this was not consistent across all
beads. n=2, 2-3 beads per condition. Scale Bar: 500µm
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shaped aggregates. This difference could be due a change in the porosity of the alginate at
the higher gelatin concentration or may represent a different ability of the encapsulated cells
to interact with the alginate matrix and form rounded aggregates.
Conclusion
These results showed that a cell density of 2x106 cells/mL and a 6 day differentiation protocol
were suitable for ESC differentiation within alginate beads. There were no differences in
the formation of aggregates between the low- and high-gelatin conditions, thus subsequent
experiments used 0.1% v/v gelatin. The encapsulated ESCs successfully formed aggregates by
day 6 of culture in all conditions tested, and there were very few aggregates free floating in the
medium, indicating that these conditions were more suitable for maintaining the encapsulated
cells within the scaffold compared to the conditions in the previous experiments.
3.3 Assessing the viability of encapsulated embryonic stem cells
In the previous experiments, there were some alginate beads that did not contain any ag-
gregates after 6 days of cell culture. This result indicated that there was variability within
the beads which affected ESC aggregation. It was possible that an inconsistent cell-alginate
suspension resulted in some beads having a cell density below the minimum threshold for cell
viabiltiy (2x106 cells/mL alginate), thus the encapsulated cells did not form aggregates in
some beads. Increased mixing of the cell-solution would improve homogeneity, however ex-
tended mixing would expose the cells to high shear forces and also reduce viability.169,171 As
an alternative, in the present experiments the cell density was increased from 2x106 cells/mL
to 3x106 cells/mL alginate. This cell density was chosen to increase the individual bead cell
density to maintain cell viability, whilst keeping the cell density low enough to limit aggregate
migration out of the beads.
Methods
CGR8 were encapsulated in HMW alginate of 1% w/v in DMEM:0.1% v/v gelatin at a cell
density of 2x106 cells/mL alginate. Beads were cultured for 6 days in ADFNK and 1µM RA
was added on days 2 and 4 to induce neural differentiation. Viability was tested on days 2,
4, and 6. At each timepoint, beads were incubated in 2mL of live/dead buffer (20µM FDA;
30µM PI). The assay was also carried out using 100nM TO and 10µM PI with similar results.
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Data were collected for n=2 experiments, 2-3 beads per experiment. Beads were imaged
using a Zeiss A1 Inverted Epifluorescent Microscope using Axiovision software (v4.0).
Results
Cell viability was high in alginate beads
Live/dead assay showed that encapsulated cells contained viable cells over 6 days of culture
(see Figure 11). On day 6, larger aggregates contained live cells (green labelled cells) but
smaller aggregates contained dead cells (red labelled cells). The cell death in single cells
was expected as aggregation is required for cell survival in alginate hydrogels.172 There was
variable aggregation and some beads did not form any aggregates by day 6. The encapsu-
lated aggregates varied in shape from circular to elongated/tubular (see Figure 9). Round
aggregates contained dead cells clustered in the center, and elongated aggregates contained
dead cells at the tips of the aggregates. These findings were consistent with Wilson et al.,
(2014), who observed dead cells at the tips of elongated aggregates within alginate beads.179
Conclusion
ESCs encapsulated in alginate remain viable over 6 days in culture. The viability of aggre-
gates within the beads may be influenced by internal porosity, elastic modulus or alginate
molecular weight, thus to examine the effects of alginate molecular weight on cell viability,
the following experiments compared aggregate formation by encapsulated ESCs in alginate
hydrogels formed from two different types of alginate.
3.4 Embryonic stem cell aggregate formation and viability in LMW versus
HMW beads
This experiment examined the effects of two types of alginate on the viability and extent
of aggegate formation. The two alginates tested were low molecular weight, low viscosity
alginate with a high G:M ratio (60:40), and high molecular weight, high viscosity alginate
with a low G:M ratio (40:60). The alginate G-residues contain ionic binding sites, thus a
higher G-residue content alginate has a stiffer elastic modulus relative to a low G-residue
content alginate due to the increased number of crosslinks present within the structure. The
higher number of crosslinks creates alginate hydrogels with a smaller pore size relative to low
G-residue content hydrogels.149,156,177
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Figure 11: Live/dead assay showed that alginate beads contained viable cells across 6 days
of culture. By day 2, there were live and dead single cells within the beads; by day 4, the
cells formed aggregates inside the beads; by day 6, there were large numbers of aggregates,
containing both live and dead cells (yellow arrowheads). n=2 with 2-3 beads per condition.
Scale Bar: 1mm
.
Methods
To investigate the effect of alginate molecular weight on ESC aggregation, LMW and HMW
alginate solutions were prepared at 1% w/v in DMEM-high glucose, 0.1% v/v gelatin. Details
for the alginates used are listed in Table 4. CGR8 were resuspended in each alginate solution
at a cell density of 3x106 cells/mL alginate, polymerised and cultured in ADFNK. 1µM RA
was added on days 2 and 4 to induce neural differentiation. The formation of aggregates was
assessed by brightfield microscopy on day 0, 2, 4 and 6 of differentiation. Live/dead assay
was used to examine differences in viability between aggregates in the LMW and HMW
beads, and to assess the cell viability at the increased cell density of 3x106/mL. On day 6 of
differentiation, beads were transferred to a 12-well plate, and incubated in live/dead buffer
(100nM TO; 20µM PI) for 5-10min at room temperature. Beads were imaged on a Zeiss A1
Inverted Epifluorescent Microscope using Axiovision software (v4.0).
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Live/dead images were quantified in ImageJ. Live and dead images were analysed si-
multaneously: for each live/dead image pair, the background was subtracted, images were
thresholded and particle analysis was carried out to count the number of aggregates per con-
dition containing live and dead cells. The number of aggregates containing live and dead cells
was converted to a percentage of total aggregates counted in Image J and the results were
analysed using a t-test in GraphPad Prism (v7.0).
Table 4: Product details for LMW and HMW alginate solutions
Product Details LMW HMW
Supplier Sigma #71238 Acros Organics #17777
Viscosity (at 1% w/v) 100-200 mPas 350-550 mPas
Molecular weight 100,000-200,000g/mol 450,000-550,000g/mol
G:M content 65-75%:35-25% 40%:60%
Results
Alginate composition affects aggregate formation within beads
The formation of aggregates by the encapsulated cells was assessed by brightfield microscopy
at day 6 of differentiation (see Figure 12). Both the LMW and HMW beads had aggregate
formation within the scaffold, and aggregates were observed within the beads by day 4 of
differentiation. As was observed in the previous experiments (at cell densities of 2x106/mL
and 5x106/mL), when ESCs were encapsulated at 3x106 cells/mL alginate, the encapsulated
cells form aggregates of both a rounded/circular and elongated/tubular shape. This effect
was observed in alginate beads formed from low and high molecular weight alginate.
Aggregate shape varies across the depth of the beads
LMW and HMW alginate beads contained both circular and elongated aggregates (see Figure
13). Brightfield images across different planes of the beads showed that circular aggregates
were confined to the centre of the bead (see Figure 13a and b), and elongated aggregates
formed near the edges (see Figure 13c and d). These results further support the theory that
the internal topography and porosity of the alginate beads influences aggregate formation.
The porosity of the scaffold affects the diffusion of oxygen, waste and nutrients;180 as the
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Figure 12: Brightfield images of aggregate formation in beads of two alginate molecular
weights. There was aggregate formation in both LMW and HMW alginate beads, with
rounded aggregates visible from day 4 (red arrowheads). Although some aggregates in
LMW were very large (∼300µM), these were infrequent, and the majority of beads contained
smaller circular and tubular aggregates. Scale Bar: 500µm
.
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Figure 13: Brightfield images of aggregate formation at day 6, showing aggregates at the
the centre and exterior of alginate beads. There were changes in aggregate shape according
to their location within the beads. Aggregates near the edges/exterior of the beads were
elongated in shape, and those in the central mass of the beads were more circular and
compact. Scale Bar: 400µm
.
cells proliferate/aggregate within the beads, competition for nutrients or space may result
in the aggregates migrating toward the culture medium. Alternatively, it was possible that
the elongated aggregates were migrating out of the bead; matrix-dependent cell behaviour
has been observed in mouse ESCs encapsulated in gelatin-glutaraldehyde scaffolds, with cells
displaying varied affinities for the matrix at different stages of differentiation.139 In the
present experiments, aggregate migration could indicate that as differentiation progresses
the differentiated aggregates migrate towards the culture medium, or away from the alginate
scaffold due to a change in preference/compatability with the alginate scaffold.
Molecular weight of alginate did not affect viability
The live/dead assay showed that both HMW and LMW alginate beads contained viable
encapsulated cells at day 6 of differentiation (see Figure 14, p. 62). These results were
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similar to those from the 2x106 cells/mL cell density experiment (see Figure 11, p. 57).
The majority of live cells (green) were observed within cell aggregates, dead cells (red) were
observed as single cells or within smaller aggregates, and the elongated aggregates contained
dead cells at the tips of the aggregates (see Figure 11, p. 57, white arrowheads).
The proportion of aggregates containing live/dead cells was counted for each alginate con-
dition (see Figure 15). The results of a two-tailed t-test showed that there was no significant
difference between LMW and HMW beads in the number of aggregates containing live or
dead cells (t(1)=5, p=0.1257).
Conclusion
Both LMW and HMW beads showed aggregate formation by the encapsulated ESCs, and
there were no observable differences in the cell viability or the shape and size of the encap-
sulated aggregates. There were aggregates of different shape and size at the exterior and the
interior of the beads but this was true for both LMW and HMW beads. Based on the liter-
ature the G:M ratio and molecular weight of the alginates was LMW and HMW beads were
expected to have a significant effect on cell behaviours, thus these results were unexpected.
As these experiments could not definitively identify which alginate type was more suitable
for ESC encapsulation, all subsequent experiments used alginate hydrogels of both subtypes.
The following chapters will encapsulate ESCs in alginate hydrogels of LMW and HMW to
determine whether the encapsulated aggregates are differentiating to a neuronal fate, and
investigate if the G:M ratio of the alginate significantly affects the cell types generated by
differentiatiing the encapsulated ESCs.
3.5 Discussion
This chapter outlined the experiments carried out to identify the optimum alginate hydrogel
conditions for the encapsulation on mouse ESCs. The experiments aimed to demonstrated
that alginate biomaterials could maintain high cell viability of the encapsulated cells during
cell culture, and that the alginate beads supported ESC aggregate formation. The alginate
composition variables that were examined are listed in Table 3, p.48.
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Figure 14: Cell viability of encapsulated ESCs in LMW and HMW beads. Alginate
beads of LMW and HMW contained both live cells (green labelled cells) and dead cells (red
labelled cells) on day 6 of differentiation. The merged images demonstrated that aggregates
contained a mixture of live and dead cells, with the dead cells localised to the tips of
tube/lens shaped aggregates (white arrowheads). BF: brightfield; Scale Bar: 500µm
.
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Figure 15: Quantification of cell viability in LMW and HMW beads. The percentage
of aggregates containing live and dead cells was quantified using ImageJ, however a two-
tailed t-test observed no significant difference between alginate conditions (p=0.1257). n=2
technical replicates for 2 independent experiments. Data are presented as mean and SEM.
.
3.5.1 Understanding alginate composition is critical for 3D culture applications
An initial experiment showed that alginate:DMEM hydrogels were superior to alginate:ddH2O
hydrogels for supporting ESC aggregation inside the scaffold. The aggregates inside the
alginate:DMEM beads were observed mgirating out of the scaffolds, with a high rate of
migration in the beads formed using smaller 30G needles. The extent of aggregates escaping
from the 30G beads restricts their utility cell encapsulation, as the cell viability in alginate is
dependent on cell density.150 Retaining more cells inside the scaffold is necessary to predict
higher cell viability, thus uncontrolled migration from the beads should be minimised. Addae
et al., (2012) reported increased neuronal differentiation observed in their study due to the
higher number of cells available within the scaffolds to be differentiated , and not due to
an increased percentage of cells differentiating.43 Their results support the choice of a 21G
needle to create larger beads for subsequent experiments, as the lower number of escaped
aggregates can retain a larger number of cells within the scaffold to be differentiated.
Alginate hydrogels require divalent ions to bind the structure together, and the hydro-
gels lose their mechanical integrity in the presence of monovalent ions, as the monovalent
ions in the medium compete with divalent calcium ions for binding sites on the alginate G-
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residues.120,169,180–182 In cell culture, the negatively charged alginate polymerises with the
positively charged salts in the culture medium,183,184 and over the course of differentiation,
this slow crosslinking contributes to the degradation of the beads. This effect may have con-
tributed to aggregates near the exterior of the beads being released into the medium. One
explanation for the larger number of aggregates escaping from the 30G beads was that the
beads produced using a 30G needle were smaller in diameter, thus a larger proportion of these
beads disintegrated relative to their size during cell culture and permitted a higher number
of aggregates to migrate out of the beads. Alternatively, the levels of aggregate migration out
of the beads may also have reduced the mechanical strength of the beads as the aggregates
burst through the exterior of the beads, which would result in a cumulatively larger number
of cell aggregates to migrate out of the beads.169,185
This slow degradation of alginate hydrogels was both an advantage and a limitation of
using alginate as a cell culture scaffold. as the alginate degradation results in a change in
the elastic modulus of the scaffold over time, the behaviour of the encapsulated cells should
be monitored to ensure that the degradation of the scaffold does not have an uncontrolled
effect on the cell fate or behaviour.174,186 For the purposes of these experiments, this was a
limitation of using alginate, as stem cell spreading,187 and differentiation6 are closely inter-
linked with the elastic modulus of a biomaterial scaffold. Conversely, for alginate hydrogel
in vivo applications, as the alginate was unstable in a physiological environment, carefully
controlling the rates of degradation offers a technical advantage over other hydrogels, and
could provide a method of controlled degradation of an implanted alginate cell scaffold.184
This controlled disintegration could be used for sequential or time-controlled release of dif-
ferent cell types/growth factors from the scaffold into the implantation site, or to ensure the
scaffold remains in place for a sufficient period of time to exert the desired effects on the
implantation site, before being degraded and excreted.
3.5.2 Examining the relationship between alginate internal structure and em-
bryonic stem cell behaviours
The viscosity of alginate solutions is dependent on the molecular weight of the alginate, which
is in turn dependent on the number, length, and ratio of the G-residues to M-residues in that
specific alginate.149,156 The G-residues crosslink with the divalent ions in the crosslinking
buffer (in this case, CaCl2), but the M-residues do not contain ionic binding sites, thus a
– 64 –
3.5 Discussion Characterisation of alginate hydrogels
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
higher M content within the alginate solution predicts a larger porosity within the scaffolds.5
The porosity of the hydrogel is linked to the mechanical stability, and diffusion of nutrients,
oxygen and waste through the scaffold.180 Alginate salts with a high G:M ratio form hydrogels
with a smaller pore size but a more mechanically stable hydrogel, whereas a high M:G ratio
results in larger pore size and less mechanical stability.5,148 These factors were independent of
the molecular weight of alginate, as HMW alginate can be irradiated to reduce the molecular
weight whilst keeping the G:M ratio constant.171 The alginate used for the above experiments
was HMW, high viscosity with a high M:G ratio (60%:40%), and may have resulted in reduced
cell viability by shear stress on cells during mixing due to the high viscosity.169
This internal variability in elastic modulus (reducing cell spreading) and internal porosity
(affecting cell proliferation) may have contributed to the failed cell aggregation inside the
empty beads observed in these experiments, and in previous studies.178,179,187 The specific
localisation of viable cells between circular and tubular aggregates may support this theory:
the cell-matrix interaction is elastic modulus dependent such that variations in the internal
topography/stiffness of the beads produced aggregates of different shapes/sizes. Wilson et al.,
(2014)179 proposed that the shape of the aggregates was dependent on localised weaknesses
of the bead porous structure. As the alginate used in this experiment had a high M:G ratio,
the pores would have been larger but with weak stability, and as the aggregates increased in
size, they may have outgrown the pore space and broken down the internal structure of the
beads. The prevalence of dead cells within the circular aggregates suggested they reached a
restrictive boundary in this localised weakness, where a higher proportion of G-residues were
located next to each other, and without room to expand the cells experienced cell death.
Contrastingly, the elongated aggregates may have formed along a larger weak fissure within
the bead, and the dead cells at the tips of these elongated aggregates might indicate the point
at which those aggregates met a high concentration of crosslinked G-residues which created
a restrictive boundary in the beads.179
3.5.3 Alginate composition influences cell-matrix interactions
The results from experiments comparing alginate beads of LMW and HMW beads were un-
expected. Based on the literature, it was predicted that there would be observable differences
in the level of cell aggregation in the scaffolds due to the differences in G:M ratios and sub-
sequently porosity of the alginate solutions.105,120,171 The G-residue content of the LMW
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alginate was higher than the G-residue content of the HMW alginate (60 versus 40%, re-
spectively), and as the G-residues are responsible for crosslinking with CaCl2, this predicted
that LMW beads would have a higher elastic modulus, more stable internal structure and
and smaller pore size compared to HMW beads.120,148,154 These variations were expected to
produce changes in the size or shape of the encapsulated aggregates in the LMW and HMW
alginate beads but that effect was not observed. The HMW alginate was thus expected to
have a negative effect on cell viability due to the higher shear forces on the cells during
mixing, but this result was also not observed here - both LMW and HMW beads contained
viable aggregates of circular and elongated shape. The similar results between the two algi-
nate subtypes may mean that the differences in G:M ratio and porosity are exerting different
effects on the cells, but not affecting viability or aggregation.
One explanation is that cell proliferation rates may have differed between the two algi-
nate types. Previous experiments showed that molecular weight affects the initial cell viability
(immediately after encapsulation) but not the proliferation rates,163,169 whereas alternative
studies have shown that the properties of alginate beads can affect proliferation and migration
depending on the ability of the cells to interact with the matrix.188 The rates of proliferation
within the beads was not tested for this thesis, but as the cell viability and proliferation were
expected to change according to the internal characteristics of the beads, future experiments
to assess the proliferation profiles of in both alginate types might identify whether different
proliferation rates resulted in similar sized aggregates between LMW and HMW beads. Poh
et al.,(2014)81 reported that single ESCs plated onto a fibrin scaffold were capable of prolifer-
ating to form an aggregate which contained organised germ layers. Single ESCs encapsulated
in alginate were expected to undergo cell death,150 however given the wide variability in cell
behaviour depending on the alginate characteristics, it was possible that some single cells
proliferated here and formed aggregates which would have affected the number and size of
the aggregates observed in brightfield images.
Alternatively, the internal composition may have affected the ability of the cells to interact
with the matrix, but not with each other, thus they maintained viability through cell-cell
interactions despite the G:M variation between alginates. The images in Figure 13 showed
that aggregate shape changed across different planes of the beads, with circular aggregates
in the central mass of the bead, and elongated aggregates at the exterior. The cause of this
localised variation might depend on substrate stiffness, crosslinking buffer, and the stage of
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cell differentiation. Ali et al., (2015) showed that encapsulated ESCs have changing affinities
for a scaffold according to the stage of cell differentiation.139 Their study showed that prior to
the expression of β-tubulin, ESCs were capable of adapting to the elastic modulus of a scaffold,
but after β-tubulin expression, the cells lost this ability and were strongly influenced by the
scaffold stiffness. In the present study, the elongated aggregates may therefore indicate that
the cells were migrating out of the scaffold after they differentiate as the hydrogel properties
were no longer suitable for those cells.
The change in aggregate shape between the centre and edge of the beads could indicate
there was a non-uniform substrate stiffness within the beads, due to one of two changes in the
alginate: (i) inhomogeneous crosslinking, or (ii) uncontrolled degradation in culture. Alginate
polymerisation with CaCl2 is gentle for cells, but is difficult to control due to the fast rate of
gelation and typically generates hydrogels with a non-uniform structure.154,189 This creates
inconsistency between the beads and across experiments, in terms of internal porosity and the
stiffness gradient from the exterior to interior of the bead. This represents an uncontrolled
factor in these experiments and could explain why some beads failed to form any aggregates,
when others had aggregates of varied size/shape, and also provides an explanation for the
varied aggregate shape across different planes of the beads.
As mentioned above, alginate beads degrade slowly in medium due to the divalent cal-
cium ions of the structure competing for binding sites with the monovalent ions in the culture
medium.169 The exterior of the beads was in direct contact with the medium, causing degra-
dation of the scaffold and changes the elastic modulus of the beads. Based on the findings
of Ali et al., discussed above, if the encapsulated ESCs experienced a change in stiffness as
the exterior of the beads degraded, this would have lesser effect on the aggregates at day 4
relative to day 6. This may also explain the change from circular aggregates at day 4 to a
mixture of circular/elongated aggregates at day 6, where the differentiated cells have started
to change their formation and migrate out of the beads. Future experiments to investigate
this effect could quantify the elastic modulus of the beads at different timepoints to assess
any significant differences in aggregate behaviour according to elastic modulus. Another set
of experiments could incorporate CaCl2 washes between medium changes to re-polymerise
the beads and return the elastic modulus to the original state.
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3.6 Chapter summary
The results from chapter 3 showed that ESCs encapsulated at a cell density of 3x106 cells/mL,
in alginate beads of 1% alginate:DMEM with 0.1% gelatin, and extruded using a 21G needle
provide suitable conditions for ESC encapsulation and aggregate formation. Beads formed
under these conditions formed aggregates over 6 days of differentiation, contained viable
cells after 6 days in culture and had low levels of aggregate migration from the beads. The
results did not show any observable differences between beads formed from LMW and HMW
alginate, thus both alginate types will be used for subsequent experiments.
Chapter 4 will investigate whether mouse ESCs encapsulated in alginate beads form
EBs, as defined by the presence of cells from all three germ layers within the aggregates.
EBs recapitulate early embryogenesis in vitro and generate cells from all three germ layers,
endoderm, mesoderm, and ectoderm. The experiments will assess the neural differentiation
of encapsulated ESCs, and to what extent this compares with cells differentiated using an
EB suspension protocol. The presence or absence of the three germ layers will be tested by
ICC, and the results from LMW and HMW beads will be compared against control EBs. The
aim of these experiments was to verify that alginate scaffolds are suitable for inducing neural
differentiation of ESCs, and the expression of neural markers Nestin and Pax6 will be tested
by quantitative PCR to verify whether LMW or HMW beads are optimum for promoting a
neural cell fate.
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Chapter 4. Optimising alginate hydrogels for mouse embryonic
stem cell neural differentiation
4.1 Introduction
The results from Chapter 3 identified the optimum conditions in LMW and HMW alginate
beads for ESC encapsulation and aggregation. An advantage of using alginate hydrogels
for 3D culture is the tunability of the biomaterial: small changes to the molecular weight,
viscosity, or concentration of crosslinking buffer can generate an alginate hydrogel of the
desired porosity and elastic modulus.109,140,150,159 ESCs encapsulated in alginate beads have
previously been differentiated to neurons, insulin-producing cells, and hepatocytes.7,43,150
Several studies have reported the formation of aggregates from murine stem cells encapsulated
within alginate beads7,150,159,163 but to date, no study has investigated if these aggregates
are canonical EBs, as defined by the presence of cells from the three germ layers (endoderm,
mesoderm, ectoderm). Gerecht-Nir et al.(2004)165 reported that human ESCs cultured on
alginate hydrogels aggregated to form canonical EBs, expressing cells from the three germ
layers, however the ESCs were seeded onto a pre-gelled hydrogel, whereas the present study
introduced the cells into the alginate before polymerisation. Using biomaterials to control
the ESC/EB microenvironment offers new paradigms for investigating and controlling stem
cell fate,44 and creates novel avenues for using cell-laden or growth factor-loaded biomaterials
to investigate cell differentiation, proliferation and migration.143,144,190
This chapter investigates the ability to generate canonical EBs from mouse ESCs encap-
sulated in alginate beads. The encapsulated ESC-derived aggregates and EBs were compared
by examining the presence of cells positive for markers of the three germ layers by ICC: endo-
derm (α-fetoprotein, AFP), mesoderm (α-smooth muscle actin, SMA), and ectoderm (Nestin,
β-III-tubulin). As the main purpose of this thesis was to develop a novel platform for ESC
differentiation, the experiments aimed to determine which alginate composition (LMW or
HMW) was optimal for ESC differentiation by comparing cell viability, aggregation and the
presence of cells from the three germ layers between the two alginates.The gene expression
of neural progenitor marker Nestin and immature neuronal marker β-III-tubulin was com-
pared to determine whether alginate beads supported similar levels of neural differentiation
to standard EBs.
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4.2 Methods
4.2.1 Differentiation of encapsulated embryonic stem cells to neuronal fate
LMW beads, HMW beads and EBs were cultured for 6 days in ADFNK with 1µM RA added
on days 2 and 4 to induce neuronal differentiation. On day 6, EBs and beads were collected,
fixed and cryosectioned (see subsection 2.4). Samples were immunostained for markers of
each germ layer: endoderm (AFP), mesoderm (SMA), and ectoderm (Nestin, β-III-tubulin).
To identify any spatial differences in differentiation toward each germ layer, the EBs and
beads were serially sectioned at 15µm and 20µm, respectively, and samples were imaged on
3 planes, each separated from the next by 150µm to 200µm (see Figure 16). All of the EBs
and beads from each experiments were cryopreserved in one embedding mould. Primary
antibodies were rabbit anti-AFP, mouse anti-SMA, rabbit anti-β-III-tubulin, and rat anti-
Nestin. Alexafluor secondary antibodies were goat anti-rat 594, goat anti-rabbit 488, goat
anti-rabbit 568, and goat anti-mouse 488 (see Table 1, p.38). Images were collected for
n=3 experiments, 3 technical replicates per sample (EBs and beads), and 2-3 beads/EBs
were imaged per technical replicate. Samples were imaged using a Zeiss Axioimager A1
fluorescence microscope and Axiovision software (v4.0).
4.2.2 Pixel quantification of immunofluorescent images
Serially sectioned beads and EBs were imaged and semi-quantitative analysis was carried out
by pixel counting using ImageJ. To prepare the images for pixel counting, images for each
condition (AFP, SMA, Nestin, β-III-tubulin, Hoechst) were stacked, scaled and thresholded.
Particle analysis was set to include object areas of 500µm2 - infinity and a circularity of
0.00-1.00. Images were analysed and data was exported to Microsoft Excel. For each image,
the area of germ layer marker was divided by the area of Hoechst; this ratio was used to
control for the higher number of cells in EBs versus alginate beads. Pixel counting was used
to measure any difference in the markers of germ layer present across serial sections per
sample (A, B and C; see Figure 16). Data were tested for outliers using the robust regression
and outlier removal (ROUT) method at 10%, and for normality using Shapiro Wilk. Cleaned
data were analysed by two-way analysis of variance (ANOVA) and multiple comparisons were
carried out with Tukeys post-hoc analysis in GraphPad Prism (v7.0).
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4.2.3 Depolymerisation and viability of harvested cells
Three depolymerisation buffers were used to dissolve the alginate beads and harvest the
aggregates. Depolymerisation buffers were prepared in ddH2O and buffered to pH 7.4:
– 100mM Sodium Citrate
– 50mM EDTA + 95mM NaCl + 20mM Hepes
– 50mM Sodium Citrate + 10mM Hepes
The alginate beads were collected on day 6 of differentiation, washed once in dPBS and
incubated in 5mL of buffer until the beads were fully dissolved (3-5min for LMW; 8-10min for
HMW). During depolymerisation, alginate crosslinks are disrupted and the solution becomes
more viscous; 5mL of dPBS was added after depolymerisation to dilute the buffer and reduce
the viscosity before centrifuging to protect the cells from shear stress. The aggregates were
pelleted by centrifugation (3min, 200g), and resuspended in trypsin-EDTA 0.25% (5min,
room temperature) to dissociate the aggregates into single cells. The cell suspension was
recentrifuged (5min, 200g) to pellet, and resuspended in 1mL of live/dead buffer consisting
of 100nM TO and 10µM PI for 5-10min (see subsection 2.3, p.36). The percentage of live and
not viable cells (injured + dead) was counted by flow cytometry; 10,000 events were collected
per sample using a BD Accuri Flow Cytometer and C Flow Sampler software. Statistical
analysis was carried out in GraphPad Prism (v7.0). Data were tested for outliers using the
ROUT method at 10%, the cleaned data were tested for normality by Skapiro-Wilk, and
analysed using a two-tailed t-test or two-way ANOVA.
4.2.4 Gene expression analysis
The relative expression of neural genes Nestin and Pax6, and pluripotency gene Pou5f1
were compared between EBs, LMW beads and HMW beads by quantitative PCR. RNA
was extracted using a Qiagen RNeasy kit, and cDNA synthesis was carried out using the
Qiagen Quantinova kit; quantitative PCR was run using a Qiagen Quantinova SYBR green
kit (see subsection 2.7, p.42 for detail). The primers are listed in Table 5. Samples were run
in triplicate for 3 independent experiments. Data were tested for outliers using the ROUT
method at 10%, tested for normality using the Shapiro-Wilk test. The expression of neural
genes was analysed by two-way ANOVA using GraphPad Prism (v7.0).
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Table 5: Details of primers used for quantitative PCR
Name Sequence (5’ - 3’) bp Tm GC (%)
Fwd Pou5f1 GAAGCCGACAACAATGAGAA 20 62.8 45
Rev Pou5f1 TCTCCAGACTCCACCTCACA 20 63.7 55
Fwd Pax6 CGGAGGGAGTAAGCCAAGAG 20 65.0 60
Rev Pax6 TCTGTCTCGGATTTCCCAAG 20 64.1 50
Fwd Nestin TTGCAGACACCTGGAAGAAG 20 63.1 50
Rev Nestin TCAAGGGTATTAGGCAAGGG 20 62.7 50
Fwd β-actin AGAGGGAAATCGTGCGTGAC 20 66.5 55
Rev β-actin CAATAGTGATGACCTGGCCGT 21 66.0 52
Figure 16: Cryosection slicing plan for alginate beads. ICC was carried out on serial
sections of alginate beads to identify spatial effects on cell differentiation. For each condition,
all of the beads were embedded in OCT embedding medium and cryopreserved in one brain
mould (1), samples were serially sectioned at 20µm for beads, and 15µm for EBs (2), serial
sections were separated so slice A to B, and slice B to C were 200µm apart for beads, and
150µm apart for EBs (3), and multiple beads per slice per condition were imaged (4).
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4.3 Results
4.3.1 Encapsulated aggregates in alginate were canonical embryoid bodies
The presence of cells from the three germ layers within EBs and alginate beads was inves-
tigated using immunofluorescent staining. The results demonstrated that EBs, LMW and
HMW beads contained cells positive for endoderm (AFP), mesoderm (SMA), and ectoderm
(nestin, β-III-tubulin) indicating the presence of cells from each of the three germ layers (see
Figure 17). The images showed that aggregates contained cells positive for each germ layer,
for each differentiation condition. The presence of the cells from all three germ layers within
all three conditions indicated that these protocols were suitable for generating cell types from
each of the three germ layers. These results also demonstrated that alginate beads of LMW
and HMW were suitable hydrogels for neural differentiation, as determined by the presence
of neuroectoderm markers nestin and β-III-tubulin. This result was consistent with previous
studies using RA to induce neural differentiation in alginate hydrogels.117,150,159,191 This
novel result provides the first evidence that mouse ESCs encapsulated in LMW and HMW
alginate beads form canonical EBs, comparable to control EBs formed by suspension culture.
4.3.2 Germ layer presence may vary spatially between culture conditions
Alginate beads and EBs were serially sectioned and immunostained to investigate if there
were spatial variations in germ layer differentiation across sequential sections of the samples
(see Figure 16). Immunofluorescent images showed that there were aggregates positive for
the three germ layers across all sections imaged in all three culture conditions (LMW, HMW,
EBs). Cross-sections of the images indicated that the number of aggregates containing cells
positive for each germ layer marker may vary across different planes of the samples. For
EBs and aggregates encapsulated in HMW beads there appeared to be higher numbers of
aggregates that contained β-III-tubulin+ cells (see Figure 18) and AFP+ cells (see Figure 19).
Contrastingly, LMW beads appeared to contain higher numbers of encapsulated aggregates
that contained Nestin+ cells (see Figure 18) and SMA+ cells (see Figure 19).
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Figure 17: Immunofluorescent staining showed that beads and EBs were suitable for
inducing ESC differntiation towards all three germ layers. Encapsulated aggregates in EBs,
LMW and HMW beads cultured within the same cell culture population were positive for
β-III-tubulin (green; top row), Nestin (red; 2nd row), AFP (green; 3rd row) and SMA (red;
bottom row) indicating the presence of the three germ layers. Scale Bar: 50µm.
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Figure 18: Spatial variations in β-III-tubulin and Nestin. Images showed variations in
ectoderm markers in sequential sections of EBs and beads. There appeared to be more
Nestin+ aggregates in LMW beads, and more β-III-tubulin+ aggregates in EBs and HMW
beads. Scale Bars: 50µm.
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Figure 19: Spatial variation in AFP and SMA. Images showed variations in endo-
derm/mesoderm markers at sequential sections of EBs and beads. There appeared to be
more AFP+ aggregates in EBs and HMW beads, and more SMA+ aggregates in LMW
beads. Scale Bar: 50µm.
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To further investigate whether the spatial variation in germ layer presence observed in
immunofluoresecent images were significant, pixel counting was used to quantify the area
of fluorescence in all images. As there were low levels of proliferation in alginate beads,
the HMW and LMW beads were expected to contain fewer aggregates compared with cells
cultured as EBs.150 To control for the lower number of cells in alginate beads relative to
EBs, the pixel values for each image was converted to a ratio by dividing the area of the
fluorescent signal for each germ layer marker (AFP, SMA, Nestin and β-III-tubulin) by the
area of fluorescent signal for the cell nuclei marker (Hoechst). Figure 20 shows a plot of
the ratio values for germ layer marker to nuclear staining, for each differentiation condition.
For each germ layer marker, the images were analysed by two-way ANOVA to compare the
differentiation condition (EBs, HMW beads, LMW beads) with germ layer presence or with
slice position (A, B or C).
Figure 20: Pixel counting data for ratios of germ layer marker to nuclear stain. Data from
the pixel counting quantification of germ layer markers relative to nuclear stain, for each
differentiation condition (EB, HMW, LMW). The ratio values indicated that there may
be a higher proportion of cells positive for Nestin, AFP and SMA in HMW beads relative
to EBs and LMW beads. Data are presented as mean and SEM. * indicates significance
versus LMW and HMW beads. † indicates signficance versus LMW beads. See Table 6 for
p values.
Pixel counting was used to assess the total area of fluorescence for β-III-tubulin, Nestin,
AFP and SMA relative to Hoechst between LMW beads, HMW beads and EBs (irrespective
of slice position). The ratio data from all images per group (EBs, LMW, HMW) per germ
layer marker (β-III-tubulin, Nestin, AFP, SMA) were combined and tested using a two-way
– 77 –
Neural differentiation in alginate beads 4.3 Results
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ANOVA to compare the differentiation condition with germ layer presence. The results from
pixel counting supported the theory that there were fewer cells in beads relative to EBs:
the total area covered by Hoechst across all images for EBs (124,883µm2) was more than
2-fold greater than in HMW beads (54,157µm2) and LMW beads (41,794µm2). The results
showed a significant interaction between differentiation condition and germ layer presence
(F(6,308)=4.4, p<0.001, df=6), which indicated that manipulating the differentiation con-
dition for ESCs could be a useful tool to control the cell fate. Tukey’s post-hoc analysis
determined that there was significantly more AFP and SMA in LMW and HMW beads rela-
tive to EBs, and significantly more AFP in HMW beads relative to LMW beads; there were
no significant differences between any of the groups for the presence of β-III-tubulin or Nestin
(see Table 6). These results showed that the alginate conditions (LMW and HMW) were suf-
ficient to differentiate cells to an ectoderm cell fate at equivalent levels to EBs formed by
suspension culture. The results further suggested that for protocols aiming to induce differ-
entiation to an endoderm or mesoderm fate, alginate hydrogels might offer improved culture
conditions compared to the standard EB suspension culture: based on the current results,
HMW beads were predicted to promote higher levels of AFP differentiation relative to LMW
beads. Although the results did not show any significant differences in the presence of neural
markers Nestin and β-III-tubulin, there was a 2-fold greater proportion of Hoechst in the EB
conditions indicating a greater number of cells in this condition. This result was consistent
with previous reports that alginate limits cell proliferation, and therefore the use of an EB
suspension protocol is optimal where large scale differentiation to neural cells is required.
Table 6: Significance values for pixel counting experiment. All significance values are
adjusted p values for multiple comparisons
AFP SMA β-III-tubulin Nestin
p MD p MD p MD p MD
EB vs. HMW <.001 -0.69 .001 -1.1 .978 0.024 .372 -0.16
EB vs. LMW .033 -0.31 .020 -0.83 .459 0.14 >.99 -0.003
HMW vs. LMW .004 0.38 .404 0.25 .547 0.12 .366 0.16
MD, mean difference.
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4.3.3 Spatial variability in the presence of cells from the three germ layers
To identify any spatial variations in cells from each germ layer across different planes of EBs,
HMW or LMW beads, the images from serial sections were analysed by pixel counting to
assess any interaction between differentiation condition (EBs, HMW, LMW) and slice position
(A, B or C). The results from pixel counting indicated that there was no interaction between
differentiation condition and slice position for β-III-tubulin (F(4,57)=0.31, p=0.87) or Nestin
(F(4,55)=0.54, p=0.7). There was a significant interaction between differentiation condition
and slice position for AFP (F(4,89)=2.7, p=0.035, df=4). Tukey’s post-hoc analysis found a
significantly higher proportion of AFP in Slice B relative to Slice A for EBs (p=0.036). Slice
B was located 150µm from Slice A in the sample, indicating that different cell types might
be present on different planes of EBs.
There was a significant interaction between differentiation condition and slice position for
SMA (F(4,86)=3.3, p=0.016, df=4). Tukey’s post-hoc analysis found a significantly higher
level of SMA in Slice B relative to Slice A for aggregates in HMW beads (p=0.007). Slice
B was located 200µm from Slice A in the sample, indicating that different cell types may be
present at different planes of the beads. These results were consistent with previous results
showing a bi-lateral change in endoderm presence in EBs, with one side of the EB having
a greater proportion of AFP.55 Although the analysis showed significant differences in germ
layer presence across slice position, the results should be interpreted with caution. Each
alginate bead contained multiple cell aggregates of different sizes throughout the bead, thus
as the beads were serially sectioned from top to bottom, subsequent sections (Slice A, B,
or C) may have originated from the same aggregate or from two (or more) aggregates lying
close together. Significant differences were only observed in 1/89 comparisons for AFP, and
1/86 comparisons for SMA which suggested that the observed differences perhaps do not
represent a spatial variation in germ layer presence in the aggregates, but rather a difference
in the proportions of AFP and SMA between two different aggregates within 150-200µm of
each other during sectioning. Future experiments can identify any spatial distribution of cells
from the three germ layers by sectioniong an individual EB or bead and immunostaining all
of the sections for the germ layer markers. In this way, a 3D reconstruction of the images
would provide definitive results on the spatial location of cells from each of the germ layers
across the whole EB or bead.
– 79 –
Neural differentiation in alginate beads 4.3 Results
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.3.4 Alginate hydrogel depolymerisation reduces cell viability
Previous research reported that cells cultured in biomaterials were more functionally active
(measured by electrophysiology) and displayed markers of mature cells earlier in cell culture
(measured using immunocytochemistry) relative to their 2D/monolayer counterparts.27,192,193
The current experiments attempted to harvest viable aggregates from the LMW and HMW
beads so that the differentiated cells could be replated to investigate the stage of differen-
tiation of the cells compared to standard EBs, or to test using electrophysiology if the cells
differentiated in 3D were more or less functionally active relative to their EB counterparts.
Three depolymerisation buffers were used to harvest the cell aggregates from alginate beads,
and the viability of the harvested cells was tested by live/dead assay using flow cytometry.
The average cell counts within the gated regions used for flow cytometry were consistent
across EBs, LMW beads and HMW beads, and for cell densities of 2x106 and 3x106 cells/mL
alginate (see Table 7). The average results from all depolymerisation experiments (see Table
7) demonstrated that alginate depolymerisation had a negative effect on cell viability. The
highest average percentage of viable cells (36%) was harvested from LMW alginate beads,
with an initial ESC encapsulation density of 2x106/mL alginate and depolymerised using
100mM sodium citrate (see Table 7, Column 1). The average viability of cells harvested from
alginate ranged from 16-36%, with a combined average viability of 25% for all depolymeri-
sation experiments. These viability ranges were between 1.9-fold and 4.3-fold lower than the
average viability of 68% for EBs. Given the limitations in retrieving the cells from the beads,
these results showed that alginate was less suitable for experimental protocols that require
the cells to be harvested from the hydrogel for downstream applications.
The data for viability counts from depolymerisation were highly variable between exper-
iments (see Table 8). No depolymerisation protocol was consistently capable of harvesting
live cells from the beads. In initial experiements at the lower cell density of 2x106/mL, the
percentage of viable cells only exceeded 50% in one experiment (see Table 8, Exp 1). The
depolymerisation/cell harvesting using the EDTA buffer was more variable than with sodium
citrate buffers, and in 2 of 5 experiments there was a very small cell pellet with fewer than
10,000 events counted by flow cytometry so these data were excluded from analysis (see Table
8, red font). The variability was thought to be due to an inhomogenous distribution of cells
within the beads due to insufficiently mixing the alginate-cell suspension, resulting in the cell
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Table 7: Average viable cell counts for depolymerisation experiments. Cell viability for EBs
was higher than for cells harvested from alginate: at a lower cell density, cells harvested from
LMW alginate have higher viability than HMW but at a higher cell density, this difference
was eliminated. +100mM sodium citrate; ++50mM sodium citrate+10mM Hepes; #50mM
EDTA+95mM NaCl+20mM Hepes. n=5 for SC/EBs; n=3 for EDTA
SC+ SC++ EDTA# EBs
Cell Density 2x106/mL 3x106/mL 3x106/mL 5x104/mL
Alginate mW LMW HMW LMW HMW LMW HMW n/a
Gated Cells 8818 8780 9668 9625 9656 9600 9064
Live Cells 3138 1402 3017 2574 2376 2165 6200
% Viable 36% 16% 24% 27% 25% 23% 68%
density for some beads falling below the minimum threshold of 2x106/mL alginate required
to maintain cell viability.150 Although increased mixing would homogenise the alginate-cell
suspension, this was not a suitable option as the extended mixing would place extensive shear
stress on the cells thus reducing viability. To counter this, the cell density was increased but
even at the higher cell density there was large variability in the percentage of viable cells,
with a maximum viability of 46% achieved in one of five experiments (see Table 8, Exp 5).
Although the between-experiment viability was inconsistent, the within-experiment viability
was consistent at both the lower and higher cell densities; this result was unexpected and
suggested that the effects on cell viability were caused by an uncontrolled factor either during
cell encapsulation or cell harvesting (see Figure 21). In experiments using a cell density of
2x106 cells/mL there was a downward trend in percentage viability over five experiments (see
Figure 21a); at the higher cell density of 3x106 cells/mL, there was no clear trend, with the
percentage of viable cells increasing and decreasing between experiments (see Figure 21b).
A two-tailed t-test found that at the lower cell density there was significantly higher via-
bility in cells harvested from LMW beads compared to HMW beads (t(18)=4.49, p<0.001).
At this cell density, there were many beads that did not contain aggregates after differentia-
tion, consistent with previous results by Wilson et al.(2014).179 This effect was attributed to
an inhomogenous cell-alginate solution resulting in the initial cell density of the beads falling
below the minimum threshold of 2x106/mL alginate. To address this issue, the cell density
was increased to 3x106 cells/mL alginate for subsequent experiments (see subsection 3.3 for
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Table 8: Individual replicates for the percentage of viable cells harvested per experiment.
There was high variability in the percentage of live cells harvested for each depolymerisation
buffer and at both cell densities. Cell densities are per mL/alginate. Data were collected for
n=5 experiments, 2 technical replicates per experiment. Values in red were excluded from
statistical analysis as the samples contained fewer than 10,000 events. +100mM sodium cit-
rate; ++50mM sodium citrate+10mM Hepes; #50mM EDTA+95mM NaCl+20mM Hepes.
Buffer: SC+ SC ++ EDTA#
Cell Density: 2x106 3x106 3x106
Exp,Rep LMW HMW LMW HMW LMW HMW
1,1 60 67 12 20 15 14
1,2 64 43 13 13 11 9
2,1 38 7 43 42 40 41
2,2 32 7 43 44 43 41
3,1 45 8 18 21 19 17
3,2 42 11 13 15 21 14
4,1 37 7 10 13 24 0
4,2 34 16 6 13 0 33
5,1 22 2 45 42 4 2
5,2 13 1 33 46 3 0
Average 35 16 24 27 25 23
full details). At this higher cell density, two alternative depolymerisation buffers were used
to try and increase the percentage of viable cells harvested: (i) 50mM sodium citrate+10mM
Hepes, and (ii) 50mM EDTA+95mM NaCl+20mM Hepes. A two-way ANOVA found no sig-
nificant effect of the alginate molcular weight or the depolymerisation buffer on the viability
of harvested cells (F(1,36)=0.16, p=0.691, df=1). The result showed that an increase in the
seeding cell density eliminated any significant difference in viability due to molecular weight,
but in absolute values, the new conditions decreased the percentage of viable cells harvested
from LMW beads, and increased the percentage of viable cells harvested from HMW beads.
This suggested that alginate hydrogels of different G:M ratio might require a specific depoly-
merisation buffer to successfully harvest viable cells. The depolymerisation buffer competes
with the CaCl2 for binding sites on the G monomers and disrupts the hydrogel crosslinks,
thus the proportion of G residues in the alginic acid influences the rate at which alginate
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Figure 21: The within-experiment variability across depolymerisation experiments. The
percentage of viable cells harvested from alginate beads over each condition followed a similar
trend within experiments, but had high variability between experiments. SC: sodium citrate;
n=5, except EDTA n=3.
hydrogels were degraded to release the encapsulated cells.169,181 Alginate hydrogels with
higher proportions of G residues would take longer to depolymerise relative to hydrogels with
a higher proportion of non-crosslinking M residues due to the greater number of crosslinks
present in a high-G alginate.
4.3.5 Neural gene expression was comparable in beads and embryoid bodies
The expression of neural (Nestin, Pax6) and pluripotency (Pou5f1) markers was assessed by
quantitative PCR to determine which alginate condition (LMW or HMW) was more suitable
for differentiation of mouse ESCs to a neural fate, and to examine the differences in gene
expression between ESCs differentiated as EBs and ESCs differentiated in alginate beads. A
two-way ANOVA did not show an interaction between the differentiation conditions (LMW,
HMW, EBs) and the expression of Pou5f1, Nestin or Pax6 (F(4,21)=1.4, p=0.260, df=4).
Tukey’s post-hoc analysis showed that there was a significantly higher expression of Pou5f1 in
both HMW beads (p=0.047) and in LMW beads (p=0.047) compared to EBs. The presence
of Pou5f1 was expected as alginate beads have previously been shown to maintain stem cell
pluripotency over long periods of time and EBs are known to maintain some ESCs at their
core during differentiation.194,195
There was no significant difference in the expression of Pou5f1 between HMW and LMW
beads (p=0.982) and there were no significant differences in the expression of Nestin or Pax6
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in any differentiation condition (p>0.999 for all comparisons). This result demonstrated that
alginate beads of HMW and LMW were capable of supporting neural differentiation, and that
there was no significant difference in the expression of Nestin/Pax6 by cells differentiated in
alginate beads relative to cells differentiated as EBs (see Figure 22). This was an unexpected
finding, as ased on the literature, the softer HMW hydrogels were expected to support higher
levels of neuronal cell differentiation compared to the stiffer LMW beads. The current ex-
periment did not investigate the presence of astrocytes markers in the differentiated cells,
however, astrocytes typically differentiate on stiffer substrates compared to neurons.196–198
As astrocytes also express Pax6, the gene expression levels in LMW and HMW beads might
represent a mixed neuron and astrocyte population, and additional experiments to quantify
the gene expression of astrocyte marker glial fibrillary acidic protein (GFAP) could determine
if there is a significant difference in the proportion of neurons and astrocytes (if present) be-
tween the beads or EBs. This may help to determine whether one alginate composition was
optimal to support neuronal differentiation of the encapsulated ESCs.
Figure 22: Gene expression for neural and pluripotency markers in beads and EBs. There
was no significant difference between the expression of Nestin and Pax6 between beads and
EBs (a), however beads had significantly higher expression of pluripotency marker Pou5f1
relative to EBs, but significantly lower expression relative to ESCs (b). *p<0.05 versus EBs,
triplicate values for n=3-4. Data are presented as mean and SEM. HMW and LMW data
were normalised to EBs = 1.
This finding supports the use of alginate hydrogels as a platform for neural differentia-
tion. There was no significant difference in the levels of gene expression for markers of neural
differentiation between the EBs and cells encapsulated in LMW or HMW beads. There was
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a high level of expression of the pluripotency marker Pou5f1 in the alginate beads which
indicated that there were residual ESCs in the alginate hydrogels that had not been differen-
tiated. Within the present protocol, this was a limitation of the cell culture paradigm however
previous research by Addae et al., (2012) used alginate hydrogels for differentiation and the
authors reported that the increased differentiation efficiency observed in their experiments
was the result of the increased availability of ESCs in the beads for differentiation.43 Their
results indicated that under the right conditions, the alginate conditions presented here could
produce a higher efficiency of neural differentiation relative to the EB condition resulting in
a higher percentage of differentiated cells but a lower total number of cells compared to EB
suspension culture. Further investigation into the mechanisms of ESC differentiation in algi-
nate might provide avenues for expanding the neuronal differentiation efficiency in alginate
hydrogels. Given the large proportion of cells that did not differentiate, this indicated that
there may be insufficient RA supplemented to the culture medium to induce differentiation of
all ESCs, or there may be microenvironmental factors at play which inhibit the change from
a pluripotent to a differentiating state. For the purpose of the experiments in this thesis,
the comparable levels of neuronal gene expression in beads and EBs indicated that these
hydrogels were suitable for the development of the novel 3D differentiation platform outlined
in Chapter 6.
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4.4 Discussion
4.4.1 Alginate beads present a suitable platform for investigating embryogenesis
The results from this chapter demonstrated that alginate beads were capable of supporting
differentiation of ESCs into cells from the three germ layers, and that the relative gene ex-
pression of neural markers by the encapsulated EBs was comparable with EBs formed by
suspension culture. The results from depolymerisation were inconsistent and cell harvesting
produced variable percentages of live cells, suggesting that alginate is more suitable for ex-
periments were cell harvest is not required. The results found no difference between LMW
and HMW alginate beads in neural gene expression or the germ layer presence; this was an
unexpected result as the previously published results indicated that molecular weight would
affect cell differentiation. These novel results expand the range of protocols for which algi-
nate hydrogels can be adapted to include in vitro studies of embryogenesis in biomaterials,
and 3D in vitro models for investigating the interaction or development of multiple tissues
encapsulated within a hydrogel.
Previous studies on EBs in alginate hydrogels have seeded the cells onto the pre-gelled
hydrogels to investigate germ layer presence,165 or examined the effect of altering substrate
stiffness during the cell culture period on ESC differentiation toward the three germ layers.166
However, there was previously no evidence that aggregates formed by ESCs encapsulated in
alginate hydrogels before polymerisation were EBs. Given that cell culture in biomaterials
exerts significant effects on cell fate,6 stem cell spreading,187 proliferation150 and cell-matrix
interactions,199 the aggregates formed from ESCs encapsulated in alginate before polymeri-
sation might not have been EBs. Alginate beads were previously used to maintain ESC
pluripotency over long periods of time,194 so the formation of aggregates inside the alginate
could prevent downstream fate commitment and instead maintain the ESCs in a pluripotent
state, resulting in aggregates of ESCs and not EBs. The results from the present experi-
ments indicated that the aggregates formed in the alginate beads were canonical EBs, and
by verifying that the three germ layers were present in both LMW and HMW alginate beads,
this chapter has contributed to novel avenues for investigating cell differentiation in alginate,
specifically for investigating the process of embryogenesis using EB-alginate cultures. The
ability to differentiate EBs within alginate hydrogels provides several technical advantages for
in vitro cell culture. A current limitation of EB suspension culture is the inability to restrict
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the size of the EBs and prevent agglomeration of EBs or the attachment of EBs to the culture
dish; this limits control over cell differentiation and results in high heterogeneity of the differ-
entiated cell population.44,173 Larger EBs and agglomerated EBs have limited soluble factor
delivery to cells at the centre of the EB, and this creates a necrotic core.44,127,200 These
limitations can be successfully countered using the hanging drop method22 or bioreactor sys-
tems201 to limit the size of the EBs, however these methods are more labour intensive and not
easily scalable.44 EB-alginate culture can be used as an alternative to these methods, as it is
a scalable platform that can limit the size of the EBs and prevent agglomeration.150,173,194
EB-alginate culture offers an additional advantage over hanging-drop or bioreactors, as in
addition to controlling EB size, the alginate hydrogel properties can be adapted to mimic the
microenvironment of the desired cell fate, or investigate the interaction between the microen-
vironment and cell differentiation.44,159,165,200 A limitation of EB-alginate culture is the low
quantity of EBs forming inside the hydrogels compared to EB suspension cultures, due to
the limited ESC proliferation inside the alginate. A second limitation of the alginate-EB cell
cultures is the inability to harvest viable cells from the hydrogels for downstream applica-
tions such as electrophysiology, or comparisons between the 3D encapsulated cell culture and
2D counterparts. These were clear disadvantages for protocols that require large quantities
of cells for additional assays, however where the experimental aim is to investigate cell be-
haviour, control cell fate or aid tissue regeneration within a 3D environment, the results from
the current experiments demonstrated that alginate hydrogels provide a suitable platform for
these applications.
4.4.2 The influence of alginate G:M composition on differentiation
A critical feature of biomaterial cell culture is the ability to investigate how modulating
biomaterial properties such as substrate stiffness or porosity can influence cell fate and cell
behaviour. In mouse ESCs, the temporo-spatial effects of increasing substrate stiffness on
primary germ layer expression has been investigated using alginate hydrogels.166 Dixon et al.,
(2014) demonstrated using an alginate-collagen biomaterial that a temporo-spatial change in
substrate stiffness could induce cell-state switching from a pluripotent self-renewing state
to differentiation,202 and the interaction between stem cell stage of differentiation and cell-
matrix attachment has been examined using a gelatin-glutaraldehyde biomaterial.139 The two
alginate salts used in these experiments varied in molecular weight/viscosity and G:M ratio:
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(i) HMW, high viscosity, low G:M ratio, and (ii) LMW, low viscosty, high G:M ratio. The
effects of molecular weight, viscosity, and G:M ratios on alginate hydrogel properties are in-
terdependent, and their combined influence affects the behaviours of encapsulated cells.149,156
The low G:M ratio of the HMW alginate reduces its crosslinking potential with the divalent
CaCl2, resulting in a soft hydrogel with a low elastic modulus; contrastingly, the high G:M
ratio of the LMW alginate contains a larger proportion of G chains that crosslink with the
CaCl2, resulting in a stiffer and more stable hydrogel.109,148,154
Based on previous studies that used alginate salts of the same composition as the alginates
used for these experiments, the beads in the present study were estimated to have an elastic
modulus of approximately 7.3kPa for LMW beads,159 and 1-5kPa for HMW beads.5,177,203
The in vivo substrate stiffnesses for neural cell fates are 0.1-1kPa for neurons, >7kPa for
oligodendrocytes, and 9-10kPa for astrocytes, and the LMW and HMW hydrogels span these
ranges however the LMW modulus is also close to the in vivo substrate stiffness for myogenic
cell fates (8-10kPa).196–198,204 Based on the evidence from the literature, the differences
in the composition of the LMW and HMW alginates were predicted to have a significant
effect on hydrogel porosity and substrate stiffness, which subsequently were expected to
significantly influence cell differentiation toward the primary germ layers.6,169,187 In contrast
to the literature, the results from these experiments demonstrated that both LMW and HMW
alginate hydrogels contained cells from each of the three germ layers (see Figure 17, p.74),
and contained cells with comparable levels of gene expression of neural markers Nestin and
Pax6 (see Figure ??, p.??). These results indicated that the molecular weight, viscosity or
G:M ratio of alginate hydrogels may not have as significant an effect on cell differentiation
as previously reported.
The initial substrate stiffness was predicted to be 7.3kPa for LMW and 1-5kPa for HMW
beads, which falls into the in vivo range of tissue stiffnesses for neural tissues, but a de-
crease in the substrate stiffness would not inhibit neural differentiation as the in vivo elastic
modulus for neural tissues is very soft, ranging from 60Pa for notochord,205 85Pa in the neu-
ral tube,205 200Pa in the human spinal cord132,206 up to 3.4kPa in the early blastocyst.207
Ali et al., (2015) showed that neural differentiation was possible on gelatin-glutaraldehyde
biomaterial scaffolds up to 30kPa, but that the day of differentiation at the point of cell en-
capsulation was a greater predictor of the cell differentiation than the substrate stiffness.139
In their experiments, the greatest effects of substrate stiffness on cell differentiation occur on
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day 4 of differentiation at the onset of β-III-tubulin expression: cells encapsulated up to day
4 of differentiation were capable of cell-matrix interaction and successful generation of neural
precursors as prior to this point the encapsulated stem cells could adapt to their microen-
vironment.139,208 Candiello et al., (2013) reported similar results, with alginate hydrogels
of stiffnesses from 400-1400Pa showing similar levels of ectoderm expression at day 5 of dif-
ferentiation.166 The current experiments encapsulated pluripotent ESCs into the alginate
biomaterials, and based on the results from in the above studies, the early stage of encap-
sulation may mean that the ESC were more amenable to adapting to their specific alginate
environment and subsequently differentiated efficiently resulting in comparable levels of gene
expression for neural and pluripotency markers between cells in both alginate compositions.
In the current study, the encapsulated stem cells had aggregated into large numbers of
EBs by day 4 of differentiation, so it was possible that the substrate stiffness of the alginate
beads had reduced to an elastic modulus that was suitable to support EB differentiation at
this point in cell culture. Previous research showed that an alginate hydrogel elastic modulus
decreased by approximately 40% over the first 9 days of cell culture, which supports this the-
ory.183 However, EBs form their own microenvironment in suspension culture which exerts
biomechanical and chemical effects on the aggregated stem cells.44,209 This microenviron-
ment controls nutrient/waste diffusion, and can form signalling gradients with the EB, and
influences cell-cell interaction.22,44,200 Once the encapsulated ESCs in alginate have aggre-
gated to form EBs, it was possible that the influence of this localised EB microenvironment
may overcome the effect of the alginate hydrogel substrate stiffness. As the EBs provide a
localised microenvironment, the predicted differences between LMW and HMW beads based
on the previous research would not be observed, and subsequently, the localised EB microen-
vironment may have supported comparable levels of ESC differentiation, and consequently,
the comparable gene expression between the ESCs differentiated in LMW and HMW beads
relative to standard EBs.
4.4.3 Germ layer differentiation was not influenced by aggregate spatial location
Alginate beads in cell culture medium slowly degrade over the course of the culture period
due to the interaction between the monovalent ions in the medium with the guluronic acid
binding points in the alginate.169,180,208 Encapsulated aggregates escaped from the alginate
beads by day 4 of culture which indicated that they were capable of breaking the alginate
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structure, or that hte alginate had degraded sufficiently to release aggregates at the exterior
of the beads into the medium.169,179 In addition, alginate hydrogels crosslinked by extrusion
into CaCl2 have an inconsistent structure, in terms of both porosity and elastic modulus, due
to the rapid crosslinking of the divalent CaCl2 with the G-residues, which creates a stiffness
and porosity gradient from the exterior toward the interior of the beads.154,177 Cell fate
determination is significantly influenced by the porosity and substrate stiffness of alginate
hydrogels,6,178,179,187 so although the aggregates in LMW and HMW beads contained cells
positive for markers of the three germ layers, the beads were serially sectioned to examine if
there were any differences in the spatial distribution of cells from each germ layer markers
within the beads. A difference in the level of AFP at different levels of the beads and EBs was
expected based on previous research that showed EBs were non-uniform at day 6, and had an
increased density of endoderm at one end of the EBs versus the other.55 Spatial localisation
of AFP and β-III-tubulin positive cells was expected, with more AFP+ cells at the exterior
of the aggregates and more β-III-tubulin+ cells at the interior of the aggregates.195
Semi-quantitative analysis using pixel counting did not find a significant difference in
the presence of cells positive for the germ layer markers across sequential sections of the
beads. This suggested that the differences in G:M ratio between the two alginate hydrogels
did not exert the significant effect on cell differentiation that was expected based on the
literature. The G:M composition of the alginate hydrogels is known to create beads of differing
porosity and substrate stiffness, and consequently, the aggregation and differentiation of the
encapsulated ESCs may be expected to be significantly different between the LMW and
HMW beads.166,169 Consistent with the results from Fuchs et al., (2012),55 there was a
significant difference in the presence of AFP at different locations within EBs, however as
multiple EBs were embedded per block, serial sections may have originated from two or more
EBs lying close together and not from the same structure so further experiments are required
to validate these results. The bilateral difference in AFP expression was not observed in
any of the encapsulated aggregates, which indicated that either the encapsulated aggregates
were at a different stage of development compared to the standard EBs, or perhaps that ESC
encapsulation affected the distribution of cell differentiation within the beads. The inability
to successfully harvest the aggregates from the alginate beads was a major disadvantage,
as harvesting the cells at different timepoints to examine the influence of the cell-matrix
interaction on differentiation towards each of the germ layers would be a useful in vitro
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paradigm.
4.4.4 Alginate hydrogels do not support cell harvesting after experiments
Previous literature has reported that cells encapsulated in alginate can be harvested using
sodium citrate or EDTA based buffers that de-crosslink the hydrogels and release the en-
capsulated cells.43,159 This study attempted to harvest cells from alginate hydrogels using
three different buffers however the experiments were not successful. One technical replicate
from a total of ten experiments achieved the highest viability of 67%, and changes to the cell
density and the composition of the depolymerisation buffers did not increase the consistency
or percentage of viability achieved. Alginate hydrogels have previously been shown to gener-
ate neurons with greater functional maturity compared to their EB-generated counterparts
(measured by electrophysiology),43 and to generate mature dopaminergic neurons earlier in
cell culture compared to neurons generated using a 2D differentiation system (measured by
ICC).140 The ability to harvest viable cells from the hydrogels would be useful for designing
experiments to examine the effects of 3D culture on cell development over time, the differ-
ences between ESCs differentiated in biomaterials compared to their 2D counterparts, or for
using the harvested cells for downstream applications such as electrophysiology experiments.
A previous study showed that mouse embryos embedded into a biomaterial scaffolds in vitro
had significantly different levels of development when implanted into female mice, compared
to the mouse embryos cultured on tissue culture plastics.210 In a similar way, encapsulating
and harvesting the differentiating aggregates from alginate beads at different timepoints could
create platforms for analysing the temporo-spatial changes to differentiation in response to
changes in cell-matrix interaction at different stages of development.
Research by Ali et al., (2015)139 may hold an explanation for the wide variability in
viabilitly of harvested cells between experiments. Their results showed that stem cell-matrix
interaction was dependent on the stage of differentiation of stem cells at the time of seeding
them on the 3D scaffold: pluripotent cells had the greatest ability to adapt to being cultured
on a biomaterial, whereas once cells expressed β-III-tubulin they had the lowest ability to
adapt to 3D culture. If the ESC bank had any drift from pluripotency, and underwent
spontaneous differentiation between passages (and thus between alginate experiments), each
subsequent alginate experiment would have had a lower number of pluripotent stem cells
encapsulated, and a higher number of spontaneously differentiated cells. Given that the
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ability to adapt to the 3D environment changes with the level of pluripotency, any partially
differentiated cells would not have interacted in the same way as the ESCs with the alginate
matrix, and this may have had negative effects on cell viability. The pluripotency of the
stem cell populations was not verified before encapsulation, thus future experiments could
investigate if this variable was responsible for the variability between the experiments.
Although the experiment did not successfully harvest the encapsulated cells, they high-
lighted a potential benefit of using alginate hydrogels of different composition for 3D cell
culture. As mentioned above, alginate beads degrade over the course of the culture period
due to monovalent salts in the cell medium competing with CaCl2 at G monomer binding
sites.169 Alginate hydrogels with a high G:M ratio degrade at a faster rate than those with a
high M:G ratio, due to the larger proportion of G residue binding spots being de-crosslinked
in the hydrogel155,177 and LMW hydrogels degrade faster due to their shorter G and M chains
versus HMW alginates.155,165,177 This effect was observed during depolymerisation with the
LMW beads degrading and releasing their encapsulated aggregates faster than the HMW
beads. The G:M ratio and the length of the G or M chains of an alginic acid composition
are interlinked with the rate of degradation of the hydrogel and this factor provides the op-
portunity to tightly control the rate of degradation of an alginate hydrogel. If the alginate
hydrogels will be used for in vivo implantation for cell transplants or release of growth factors
for a paracrine effect, the ability to temporally control the degradation of the hydrogel offers a
technical advantage that can be exploited to allow slow release of incorporated growth factors
into the medium. Alternatively a controlled degradation of the beads in future experiments
could examine the effects of substrate stiffness on cell differentiation by encapsulated ESCs.
The stiffness of an alginate hydrogel has been observed to decrease rapidly during the first
week in cell culture183,186 and the rate of alginate degradation in vivo can be estimated based
on the concentration of potassium and NaCl in the localised area surrounding the implant
site.184 The ability of alginate to degrade in a physiological environment was therefore both
a limitation and a benefit of using these hydrogels, and the ability to use alginate as a bio-
material depends on the purpose of the platform, the required time in cell culture or in vivo,
the cell types encapsulated and the specific composition of the hydrogel being used for cell
encapsulation.
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4.4.5 Future research based on the current experiments
The current experiment investigated ESC differentiation toward the three germ layers and
investigated the spatial distribution of the germ layer markers in beads and EBs. In the
experiment, multiple beads and EBs were embedded in one block which limited the ability
to fully investigate the spatial location of cells positive for the germ layer markers. Future
experiments to serially section an individual bead and examine the germ layer distribution
within the beads will be useful for determining which bead composition is optimal for ESC
differentiation to a given germ layer. The results from the quantiative PCR indicated that
alginate beads might be superior to EBs for endoderm and mesoderm differentiation, and
serially sectioning an individual bead could verify if this is the case. Stem cells can be differ-
entiated toward neural fates on substrates with an elastic modulus <30kPa139 however the
specific neural subtype varies with substrate stiffness: neurons on softer substrates, oligo-
dendrocytes on medium substrates, and astrocytes on the stiffest substrates.196 Quantitative
PCR investigated the relative gene expression of neural markers, but not markers for the
three germ layers; additionally, Pax6 is expressed by neurons and astrocytes, thus using Pax6
to quantify the expression of neural genes in LMW and HMW beads could not distinguish
between the proportion of neurons and astrocytes in each alginate condition. Further in-
vestigations of the relative expression of markers of neurons, astrocytes and cells from the
germ layers may identify a signficiant difference according to alginate composition. A future
experiment to examine the relative gene expression of all three germ layers, and neuron and
astrocyte specific genes, will allow a more in-depth investigation of the specific cell types
present in the two alginate hydrogels.
4.5 Conclusion
The results from this chapter showed that HMW and LMW alginate beads were suitable
biomaterials for neural differentiation. EBs, HMW and LMW methods using a differentiation
protocol with 1µM RA were sufficient to derive cells from all three germ layers, expanding
the potential for the current work to include studies of embryogenesis. The results from
depolymerising were inconclusive and a consistently successful method for harvesting viable
cells from the alginate hydrogels is still required. The results from quantitative PCR showed
that the relative gene expression for neural markers was similar between EBs and both LMW
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and HMW alginate beads, indicating that alginate:EB culture is a suitable platform for
neural cell differentiation and can produce aggregates containing equivalent expression levels
of Nestin and Pax6 to ESCs differentiated using the EB suspension protocol.
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Chapter 5. Developing a novel tool for 3D ESC culture - LMC
MNs are a novel source of endogenous RA
5.1 Introduction
RA is a key signalling morphogen in neural differentiation and neuronal patterning in vivo31,64
and is required for successful vertebrate embryogenesis.211 RA is synthesised by Raldh2 in
the presomitic mesoderm65,67,212 and Raldh2 is responsible for all RA synthesis prior to
E8.5 in the mouse embryo.213 Loss of mesodermal RA or knockdown of Raldh2 is lethal
by E8.75.71,214 RA is first detected at E7.5 during the late primitive streak stage, and is
required for body axis extension,71 and patterning the rostrocaudal and dorsoventral axes of
the neural tube.64,211,213 The ability to stimulate stem cell differentiation in vitro using RA is
a valuable research tool for investigating embryogenesis and cell-fate specification.31,71,215,216
ESC differentiation protocols use RA concentrations from 1nM to 1µM to induce ESC differ-
entiation toward a neuronal lineage, which spans the in vivo concentration of 1nM to 300nM
for endogenous RA in the developing mouse embryo.86,217
Cell-laden biomaterial platforms hold potential for tissue engineering applications for
spinal cord injury or neurodegenerative conditions, as they can deliver cells directly to the
site of injury and/or initiate cell migration or regeneration of the host cells via a paracrine
effect.17,145,218 Previous experiments to induce patterned neuronal differentiation combined
3D biomaterials with RA to investigate the effects of RA signalling on ESC differentiation.
Binan et al., (2014) showed that a RA- and purmorphamine-loaded PLGA scaffold could
direct neural stem-like cells to a MN fate.11 Other experiments have shown that polymer
microspheres loaded with RA145,159,175 or nanospun fibres loaded with RA or growth fac-
tors NT3 and PDGF17,219 can successfully control morphogen release and induce neuronal
differentiation of encapsulated/seeded stem cells. These platforms demonstrated the poten-
tial for using combined biomaterial-cell culture platforms to generate novel paradigms for
investigating tissue regeneration.
A limitation of these platforms is the inability to control how much RA is released from
the scaffold over time, due to RA leaching or burst release from the scaffolds.11,145 Although
the decreasing concentration of RA over time is a technical limitation of the scaffolds, the
ability of RA to diffuse through the scaffolds/into the medium represents a distinct advantage
– 95 –
A novel source of retinoic acid for in vitro cell culture 5.2 Methods
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
of using biomaterial scaffolds over 2D cell culture protocols: in monolayer/2D cell culture,
signalling morphogens or growth factors can diffuse freely throughout the medium, whereas
3D biomaterials cell culture allows for concentration gradients of signalling or growth factors
to be created, more closely resembling the in vivo environment.4,44,200 RA signalling acts in
a paracrine manner in vivo and this paracrine effect can be recapitulated in 3D biomaterial
platforms by incorporating RA into the scaffold and allowing the RA to leach from the
biomaterial and into the medium or at close proximity to the encapsulated ESCs.64,71,201
This offers a useful in vitro platform for investigating the effect of RA gradients on ESC
differentiation.
The results from chapter 4 showed that encapsulated ESCs in alginate beads could be
differentiated toward cell types from the three germ layers using exogenous RA. Exogenous
RA is unstable in cell culture and is prone to light-induced degradation during medium
changes, which may result in a reduced concentration of RA present in the medium relative
to the concentration that was initially supplemented to the medium. Developing a source
of RA that can be incorporated into a biomaterial scaffold, without a decreased in RA
concentration over time, would present a major breakthrough for investigating embryogenesis
or patterned differentiation in vitro. This chapter outlines experiments to characterise a cell-
derived source of endogenous RA, which could be used as a stable source of RA for in vitro
research. To generate this source of RA, transgenic HGF11 ESCs (see subsection 2.1.6, p. 33)
will be differentiated to Raldh2+ LMC MNs. This MN-produced source of Raldh2 is known
to be physiologically active and capable of synthesising endogenous RA in vivo.85,220,221
The aim was to generate a source of RA that can be incorporated into 3D biomaterials
platforms, in order to overcome the limitations of the currently available RA-incorporated
platforms described above. To do so, this source of RA must be capable of generating a stable
concentration of RA in the culture medium for 4 days (a duration sufficient to induce ESC
differentiation) and must be be physiologically active (i.e. capable of differentiating mouse
ESCs).
5.2 Methods
5.2.1 Culture of feeder-dependent mouse embryonic stem cells
HGF11 ESCs were cultured on feeder layers (CF1 mouse embryonic fibroblasts) in mouse ESC
medium with LIF until confluent. The cells were passaged by trypsinisation (every 2 days),
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and split at a ratio of 1:8. For EB experiments, any carry-over of mouse embryonic fibroblasts
into the EB suspension can inhibit differentiation, so the feeder layers were separated before
replating the stem cells for EB culture: the flask of HGF11 was passaged as normal, pelleted
and resuspended in ADFNK. The cell suspension was plated into a gelatin-coated 100mm
petri dish for 30min at 37oC, 5% CO2. At this point, feeder cells had adhered to the surface of
the dish, and HGF11 ESCs remained in suspension. The stem cell suspension was aspirated,
cells were counted via trypan blue exclusion, and replated at the required cell densityfor EB
suspension culture.
5.2.2 Motor neuron differentiation via embryoid body suspension culture
HGF11 ESCs were differentiated to MNs using the EB suspension protocol describedWichterle
et al., (2002).47 After separation from the feeder layers, HGF11 ESCs were replated at 5x104
cells/mL ADFNK in an un-coated 100mm dish, and cultured for 6 days with 1µM RA and
1.5µM purmorphamine added on days 2 and 4 to induce MN differentiation. On day 6, the
EBs were collected, pelleted by centrifugation (3min, 200g), washed once in dPBS, and re-
suspended in 0.25% trypsin-EDTA. The cells were dissociated for 10min on a rocker to form
a single cell suspension, then the cell suspension was pelleted, and resuspended in ADFNK
supplemented with 5nM GDNF. Cells were plated at the required cell densities onto well
plates coated with laminin at 2µg/cm2. Half of the medium was changed every 2 days.
5.2.3 Characterisation of the HGF11-derived motor neurons
Immunofluorescent staining
After EB dissociation the HGF11-derived MNs were plated at a cell density of 1x106 cells/cm2
onto laminin-coated 12-well plates. The MNs were cultured for 2 additional days and then
fixed and immunostained (see subsection 2.4). To verify the presence of the transgene, which
drives GFP and Foxp1 under the control of HB9, the MNs were immunostained for GFP, HB9
and Foxp1 co-localisation. Primary antibodies were mouse anti-HB9 and rabbit anti-Foxp1;
GFP was expressed at a level that could be visualised without antibody staining so no GFP
antibody was required. Secondary antibodies were goat anti-mouse 568, goat anti-rabbit 568
and goat anti-rabbit 647.
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Flow cytometry cell counting
To determine the proportion of cells that differentiated into MNs (GFP+), the cells were
counted by flow cytometry using the GFP reporter. The MN differentiation protocol was
expected to generate 30-50% MNs.12,24 After EB dissociation, the single cell suspension was
counted by flow cytometry to quantify the proportion of MNs differentiated using this cell
line. The control condition was HGF11 ESCs differentiated using only 1µM RA without
purmorphamine. Purmorphamine is the ventralising morphogen required to produce MNs
and the control condition was expected to generate lower numbers of MNs compared to the
experimental condition (7% compared to 30-50%).12,104 For each sample, 10,000 events were
counted using a BD Accuri C6 flow cytometer and C-Flow Sampler software (v1.0).
5.2.4 Quantification of retinoic acid and Raldh2 produced by HGF11-derived
motor neurons
To determine whether the HGF11-derived MNs were producing Raldh2 and/or RA, the dis-
sociated EBs were replated at a cell density of 1.75x106 cells/cm2 and cultured in ADFNK
supplemented with 5nM/mL GDNF. The medium was collected and tested using competitive
ELISA to quantify the concentration of RA and Raldh2 produced by the MNs. To compare
the concentration of RA and Raldh2 present in the medium across several timepoints (day
8 to 12), freshly collected medium for all timepoints was tested simultaneously. In all sam-
ples, the medium was changed by 50% 48h before being collected for ELISA to allow the
RA/Raldh2 concentration to build up in the culture medium for 2 days. This duration was
selected to time match with the standard protocols, which replace the cell culture medium
and add fresh RA every 2 days. Statistical analysis was carried out in GraphPad Prism (v7.0).
Data were tested for outliers using the ROUT method at 10%, tested for normality using
the Skapiro-Wilk method, and analysed using a one-way ANOVA and multiple comparisons
were conducted using Tukey’s post-hoc analysis.
5.2.5 Investigating mouse embryonic stem cell differentiation using a novel source
of retinoic acid
A co-culture experiment was designed to assess whether the endogenous RA produced by the
HGF11-derived MNs was sufficient to induce neural differentiation. To set up the co-culture
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experiment, the HGF11 ESCs were first differentiated to MNs by EB suspension culture, and
then dissociated and replated onto laminin-coated well plates. On the same day, CGR8 ESCs
were encapsulated in alginate beads, of both LMW and HMW (see subsection 2.5.1) and the
beads were transferred into Boyden chambers (6-8 beads per chamber). This denoted day 0 for
alginate beads, and d6 for the HGF11-derived MNs. After 48h, the medium on the MNs was
changed by 50% and the Boyden chambers containing the alginate beads were transferred into
the wells containing the HGF11-derived MNs (see Figure 4) - this was day 2 of differentiation
for cells in the alginate beads and day 8 for the HGF11-derived MNs. After another 48h, there
were cells attached to the Boyden chambers in the wells containing alginate beads indicating
that some ESCs had escaped from the beads; on this day, the medium was changed again by
50%. After another 48h, which denoted day 6 of differentiation for the alginate beads, the
beads were fixed in the Boyden chamber for 1h in 3.7% PFA, then transferred into OCT in
brain-embedding moulds and prepared for cryosectioning (see subsection 16). Samples were
cryosectioned and immunostained for markers of the three germ layers.
5.3 Results
5.3.1 HGF11-derived motor neurons express the Foxp1 transgene
The HGF11 ESC line is derived from transgenic HB9::Foxp1 mice, which drives Foxp1 and
GFP expression under control of HB9. When the HGF11 ESCs are differentiated towards a
MN fate, the expression of Foxp1 in post-mitotic HB9+ MNs forces an LMC MN fate.12,97 To
verify that the differentiation was successful, the HGF11-derived MNs were immunostained
to demonstrate co-localisation of GFP, HB9 and Foxp1. The control conditions were wild
type CGR8-derived MNs differentiated using the same protocol, which do not express Foxp1,
thus differentiate to a medial motor column, MN fate: these MNs do not express Raldh2
and and do not synthesise RA. The results showed that HGF11-derived MNs were positive
for GFP, HB9 and Foxp1 (see Figure 23), and the wild type CGR8-derived MNs did not
contain any GFP+ cells, indicating that HB9 promoter for GFP and Foxp1 was specific to
the HGF11 ESCs (see Figure 25). There were some GFP-, HB9+, Foxp1+ cells in the CGR8-
derived condition; this was expected as spontaneous differentiation to a LMC fate occurs in
approximately 0.5% of EB-differentiated cells.12,104
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Figure 23: HGF11-derived MNs were GFP+, HB9+ and Foxp1+. (a) HGF11-derived MNs
were positive for Hoechst (blue), GFP (green), HB9 (red) and Foxp1 (yellow), with some
GFP+ neurites present (white arrowheads). n=3 independent experiments, 5 images per
condition. Scale Bar: 20µm
5.3.2 HGF11-derived motor neurons have a lateral motor column identity
To determine the proportion of cells that were GFP+ LMC MNs, the differentiated HGF11-
EBs were dissociated and the single cell suspension was counted by flow cytometry. The
results showed that approximately 30% of the cells were GFP+, which was consistent with
the previous reports of 30% by Wichterle et al., (2008)24 and 40% by Adams et al., (2014)97
(see Figure 26). The cells in the control condition generated 7% GFP+ cells which was
consistent with the expected levels of spontaneous differentiation to a MN fate.12,104 The
control condition was generated by differentiating HGF11 ESCs using 1µM RA without pur-
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Figure 24: Magnified images (40X) showed that not all of the GFP+ (green) cells were
HB9+ (red) and/or Foxp1+ (yellow) indicating a mixed population. Scale Bar: 20µm
morphamine. Purmorphamine is the ventralising morphogen required to drive a MN fate,
and ESCs differentiated using RA only are expected spontaneously generate low numbers of
HB9+ MNs - the presence of GFP in the control conditions was due to GFP driven under
control of the HB9 promoter in spontaneously differentiating MNs.
5.3.3 HGF11-derived motor neurons produced Raldh2 and retinoic acid
To measure the concentration of Raldh2 and RA produced by HGF11-derived MNs, the cul-
ture medium from monolayer HGF11-MN cultures was tested by competitive ELISA. The
results from the ELISA analysis of Raldh2 concentrations showed that the MNs produced
Raldh2 throughout the day 8 to day 12 period. The average concentration of Raldh2 pro-
duced by HGF11-derived MNs ranged from 6.63ng/mL to 7.55ng/mL (see Table 9), but the
concentrations were highly variable between experiments and the r2 value was low. This may
be due to the experimental design whereby each technical replicate was taken from a sepa-
rate well; this method was chosen to capture any variation in the concentration of Raldh2
or RA being produced between wells in an individual experiment. A one-way ANOVA did
not detect a statistically significant difference in the concentration of Raldh2 across the five
timepoints F(4,12)=0.19, p=0.939, df=4 (see Figure 27a).
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Figure 25: CGR8-derived MNs were HB9+ and GFP-, demonstrating that the GFP ex-
pression under the control of HB9 was specific to the transgenic HGF11 cell line. The
control condition contained GFP-, HB9+, Foxp1+ cells (arrowheads) which was expected
due to spontaneous differentiation to an LMC lineage. Scale Bar: 20µm
Figure 26: MN differentiation from HGF11-ESCs. (a) HGF11 ESCs differentiated to a
MN fate contained approximately 30% GFP+ MNs. (b) HGF11 ESCs differentiated with
RA and without purmorphamine contain approximately 7% spontaneously differentiating
MNs. n=2 experiments, 10,000 events per condition
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Table 9: HGF11-derived MNs produced Raldh2. There was between-experiment variability
in the Raldh2 concentration produced by the cells throughout day 8 to day 12, but the
within-experiment concentrations were consistent. Text in red indicates outliers that were
excluded from statistical analysis. n=4 experiments, 2-3 technical replicates per experiment.
Concentration (ng/mL) Mean
D8 0.00 5.95 13.05 3.37 7.45
D9 2.41 10.73 16.06 3.94 7.47
D10 2.30 5.50 15.36 3.37 6.63
D11 3.67 5.12 15.62 4.06 7.12
D12 2.45 9.22 15.32 3.20 7.55
r 0.86 0.86 0.88 1
ELISA analysis of RA concentrations showed that the cells were producing RA through-
out the day 8 to day 12 period, with the average concentration range of RA from 65pg/mL to
105pg/mL or 214-291pM (see Table 10). The concentration of RA produced by the HGF11-
derived MNs was much lower than the in vivo concentration of 122nM RA previously reported
for the E9.5 neural tube.217 Although the concentration was low, it remained consistent over
the five day period tested. As the standard neural differentiation protocol adds RA on days
2 and 4 of differentiation, the five day time period observed here was sufficient to test ESC
differentiation using this novel endogenous source of RA. A one-way ANOVA did not de-
tect a statistically significant difference in the concentration of RA in the culture medium
across the five timepoints F(4,9)=1.53, p=0.274, df=4. The individual concentrations of RA
produced ranged from 49.31ng/mL to 96.09ng/mL across day 8 to day 12; mean concentra-
tions increased from 64.98ng/mL at day 8 to 87.53ng/mL at day 12 but this effect was not
significant (see Figure 27b).
Raldh2 is responsible for the RA synthesis by the HGF11-derived MNs and to determine
if there was any correlation between the concentration of Raldh2 and RA in the culture
medium, data were analysed using a two-tailed Pearsons correlation coefficient. The results
showed that there was no correlation between the concentration of Raldh2 and RA across the
five timepoints r(4)=-0.55, p=0.337 (see Figure 27c). This result was difficult to interpret
based on the limited data from these experiments. Raldh2 is the sole enzyme responsible
for synthesising RA in these cells, however high concentrations of RA downregulate Raldh2
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Table 10: HGF11-derived MNs produce RA. The concentrations of RA produced across
the five timepoints were not significantly different. The mean concentration ranged from
214-291pM. Text in red indicates outliers which were excluded from statistical analysis. n=3
experiments, 2-3 technical replicates per experiment.
Concentration (ng/mL) Mean pM
D8 53.59 65.90 75.47 64.98 216
D9 49.31 65.85 77.81 64.32 214
D10 59.24 68.69 92.17 73.36 244
D11 68.32 168.88 79.21 73.76 246
D12 96.09 92.10 74.41 87.53 291
r2 0.93 0.9 0.98
in vivo to protect the cells from RA-induced teratogenicity during embryogenesis.212,222 If
the cells from these experiments behave in the same way as their in vivo counterparts, using
these cells as an in vitro tool requires a detailed understanding of the timescale of RA-induced
Raldh2 inhibition.
5.4 Discussion
5.4.1 HGF11-derived motor neurons produced a stable source of retinoic acid
The HB9::Foxp1 transgenic HGF11 ESC line was differentiated toward a MN lineage. The
differentiated cells were positive for GFP, HB9 and Foxp1 indicating that they were LMC
MNs. Adams et al., (2014) demonstrated that these HGF11-derived MNs were de facto LMC
MNs, capable of innervating muscle explants in vitro and migrating to the correct positional
location in the neural tube when injected into chick embryos.12,97 These LMCs produce a
source of RA responsible for limb innervation during embryogenesis: earlier differentiating
medial LMC MNs express Raldh2, which synthesises the RA responsible for both differenti-
ating and providing axonal guidance to the later differentiating, lateral LMC MNs.12,90,223
Although these cells were identified by their expression of Raldh2, which is known to
produce physiologically active RA in vivo, no previous study has investigated the potential
for using these MNs to create an in vitro source of RA. In the experiments presented here,
the concentration of RA produced by these cells was quantified using ELISA, and the results
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Figure 27: HGF11-derived MNs produce a consistent concentration of RA and Raldh2.
Over 5 consecutive days, RA and Raldh2 were present in the medium. (a) the concentrations
of Raldh2 varied between wells but did not vary significantly over 5 days of culture p=0.939;
(b) the concentration of RA did not vary significantly from day 8 to day 12 p=0.234,
indicating the cells are a stable source of RA for future experiments; (c) there was no
correlation between the concentration of Raldh2 and RA p=0.337. Error bars: mean and
SD. n=3-4, 2-3 technical replicates per experiment
showed that the culture medium from HGF11-derived MNs contained both Raldh2 and RA.
The concentration of Raldh2 and RA did not vary significantly over the 5 timepoints tested,
indicating that these cells can be used as a stable concentration of RA in vitro for a 6 day
neural differentiation protocol. In demonstrating this, the experimental system described
here has produced a novel tool for in vitro research. If the feedback loop between Raldh2 and
RA concentrations can be characterised, it would provide a novel avenue for investigating cell
differentiation. The cell-generated source of endogenous RA is a novel experimental tool and
and further experiments to determine whether there is an observable or predicatable corre-
lation between Raldh2 and RA concentrations over time would be useful for regulating the
concentrations of RA produced by the cells. The HGF11-derived MNs could subsequently be
incorporated into biomaterials platforms to investigate the temporal effects of gradients of
RA and Raldh2 cross-inhibition on ESC differentiation. This type of experiment is not pos-
sible using 2D or monolayer cell culture protocols as morphogen gradients cannot be created
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using the standard cell culture methods. The combination of biomaterials platforms with
controlled morphogen release holds potential for investigating cell development in response
to gradients of signalling factors.
These LMCs hold significant potential for investigating (i) the intricate relationship be-
tween Raldh2 concentration, RA synthesis and subsequent Raldh2 downregulation, and (ii)
neural differentiation using a stable and endogenous source of RA. Several studies have pro-
posed that endogenous RA may induce differentiation patterns that differ from those gen-
erated using exogenous RA, because unlike exogenous RA, the metabolites of endogenous
RA are believed to activate both RA receptors and retinoid X receptors.71,76,78 This al-
lows propagation of receptor activation after the RA has been metabolised and is believed
to activate downstream signalling pathways that are not activated by exogenous RA. There
is also evidence that exogenous RA may have in vitro effects that are not observed in vivo
by initiating off-target effects via FGF871 or by failing to inhibit Raldh2 and subsequently
teratogenicity.212 FGF8 contains an RA-response element that is activated by endogenous
RA during embryogenesis and is involved in inhibition of caudal FGF8 signalling; when ex-
ogenous RA is added to the medium, the supra-physiological concentrations (1-10µM86) can
force FGF8 activation to induce off-target effects.71 Opposing gradients of RA and FGF8
are involved in midbrain-hindbrain patterning thus the incidence of off-targets effects in vitro
can have significant effects on cell development.
5.4.2 Applications of a cell-derived source of retinoic acid
Okada et al., (2004) reported that RA concentrations from 1nM to 1µM were sufficient to in-
duce ESC differentiation toward the three germ layers, however 1nM concentrations induced
more mesodermal differentiation, and higher concentrations induced more neural differentia-
tion.31 In the present experiment, the observed concentration range of RA produced by the
HGF11-derived MNs (215-290pM) was lower than the reported in vivo range (1-300nM)217
and the concentration range of 1nM to 1µM exogenous RA used in vitro.24,31,58 The previ-
ously reported physiological concentrations were determined using HPLC from whole tissues:
Horton et al., (1995) dissected E10.5 embryos and quantified RA per region: spinal cord
(250nM), forebrain (8nM), midbrain (10nM), hindbrain, somites and mesenchyme or limb
buds (alll 30-40nM) and neural tube (122nM).217 Ulven et al., (2001) quantified RA in the
E12.5 spinal cord: brachial (74nM), thoracic (36nM) and lumbar (200nM).76 These concen-
– 106 –
5.4 Discussion A novel source of retinoic acid for in vitro cell culture
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
trations are all substantially higher than the concentrations of RA observed in the present
experiments, however the present experiment tested the culture medium using ELISA, which
can only detect the concentration of free RA in the medium and cannot quantify RA se-
questered inside the cells (bound to cellular RA binding proteins or RARs).76 Thus it is
possible that the concentration of RA produced by the HGF11-derived MNs would closer
the physiological range if the RA was quantified from whole cells and not isolated from the
medium.76 During embryogenesis, the cross-repressive actions of localised RA, FGF8 and
Wnt signalling gradients within subregions of the neural tube are responsible for patterning
the progenitor domains, and as the physiological concentrations previously reported were
collected from whole tissue, they did not capture any localised concentrations of RA within
the tissues.224,225
In the present experiments, each well contained 2mL of culture medium, refreshed by
50% every two days. Despite the volume and medium changes, the concentration of RA
quantified by ELISA analysis was not significanly different throughout days 8 to 12. This
provided evidence that the HGF11-derived MNs were producing sufficient RA within a 48h
period to compensate for the dilution of RA due to medium changes, and maintain a stable
concentration over several days. The ability of the cells to replenish the concentration in
such a large volume of medium indicated that the concentrations of RA obseved in the
present experiment may be substantially higher near the source HGF11-derived MNs before
they dilute into the medium. This indicated that this endogenously produced source of RA
holds the potential to induce ESC differerentiation if the RA source (HGF11-derived MNs)
is placed in close proximity to the target ESCs. This would mimic the in vivo environment
where localised concentrations of RA are responsible for patterning cell differentiation.
Commonly used in vitro RA-induced differentiation protocols supplement exogenous RA
into the culture medium every 2-3 days to induce ESC differentiation using EB suspension
culture.43,117 The current RA differentiation protocols are limited by the instability of RA
in the culture medium, and RA degradation in response to light, which both result in a
decreasing concentration of RA during changes of medium. This unstable concentration
of RA introduces an uncontrolled variable and fails to provide stable morphogenic action in
vitro. The effects of RA in vivo are tightly regulated by cross-repressive actions of RA, Raldh2
and Cyp26a, the enzyme responsible for metabolising RA.212 The uncontrolled degradation
of RA throughout the course of an in vitro experiment cannot recapitulate the tight control
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that exists during embryogenesis. The novel method presented here has produced an in vitro
tool that provides a source of RA that remains at a stable concentration over at least 5 days
of culture. This source of RA was endogenously produced by HGF11-derived MNs which
replenish the RA concentration between medium changes, which offers a distinct advantage
over the standard protocols which are prone to light-induced degradation of exogenous RA.
This source of RA can therefore be applied to in vitro experiments of cell differentiation, and
hold the potential to build new protocols for investigating ESC differentiation.
5.4.3 HGF11-derived motor neurons are a novel tool for differentiation
Several studies have loaded morphogens into biomaterials scaffolds to investigate cell dif-
ferentiation, morphogen release rates, or to create EBs or cell aggregates that incorporate
microbeads of RA inside the aggregate. Willerth et al., (2008) created a fibrin scaffold de-
livery system that incorporated NT3 and Shh, or NT3 and PDGF, into the fibrin fibres,
and used the fibrin delivery systems to culture mouse ESC-derived neural precursor cells.219
Their results showed that the cells cultured on the fibrin scaffold with an incorporated deliv-
ery system had significantly higher numbers of cells positive for Nestin, β-III-tubulin, and O4
but significantly lower numbers of cells positive for GFAP compared to the unmodified fibrin
scaffolds.219Of note, the authors aimed to implant the scaffold into the damage spinal cord
to aid regeneration, thus specifically engineered their fibrin delivery system to inhibit astro-
cyte differentiation and prevent astrocyte-induced inhibition of neuronal regeneration. Their
results demonstrated that their fibrin delivery system could increase differentiation efficiency
if the growth factors and morphogens were released to the encapsulated cells from within
the scaffolds, relative to the cells which received the signalling morphogens in the medium.
Carpenedo et al., (2010) created RA-loaded PLGA microspheres that were incorporated into
EBs by suspension culture. Their results showed that localised RA signalling inside the
EBs caused accelerated re-organisation and stratification of the EBs, and development of the
primitive streak, compared to the standard EB protocol.175 Binan et al., (2014) used RA-
loaded PLGA fibres to control differentiation of neural stem-like cells: their results showed
a significant increase in neurite length for the cells differentiated on RA-loaded fibres versus
unloaded fibres. All of the above 3D platforms demonstrated that when ESCs were exposed
to localised sources of signalling factors and morphogens, the 3D platforms were capable
of increasing the efficiency of the differentiation protocol. They further demonstrated that
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growth factor- or morphogen-loaded scaffolds hold potential as in vitro tools for manipulating
cell differentiation in a manner that is not possible using standard protocols. In the standard
protocols, all cells have access to a uniform concentration of the soluble factors present in the
medium, and cannot only extend neurites within a single plane. Biomaterial 3D platforms
introduce the potential to incorporate localised gradients and support extension of neurites
into multiple planes, which supports the formation of more complex cell morphologies and
subsequently the formation of complex and long-range neuronal networks that more closely
mimic the physiological microenvironment, relative to cells cultured on 2D tissue culture
plastics.4,226
The studies discussed above reported positive results, using localised sources of signalling
factors in biomaterials, but a major limitation of their experimental designs was the burst
release of the loaded growth factor or morphogen over time. Carpenedo et al. (2010),
did not report the concentration of RA that was loaded into the microspheres or directly
investigate the burst release, however the authors conducted a burst release profile for Cell
Tracker Red-loaded microspheres formed using the same method. Their microspheres had
a burst release from the microspheres within the first 24h, indicating that the RA-loaded
microspheres would have a rapidly decreasing concentration when incorporated into the EBs.
Similar to the burst release observed in the Carpenedo study, the RA-loaded PLGA fibres
generated by Binan et al., (2014) had significant burst release of RA from the fibres into
the culture medium in the first 24h, resulting in a 75% decrease in RA concentration from
200nM to 50nM. This concentration decreased by a further 50% over a subsequent five days
resulting in a final concentration of 25nM.11 Willerth et al., (2008) used a heparin-based
system to maintain the NT3 within the scaffolds, but their most efficient result only retained
40% of initial concentration of NT3 within the scaffold. The platforms described above
exposed the encapsulated cells to an initial peak of high-concentration RA followed by a
decreasing concentration of RA throughout the culture period. This is not representative
of physiological environment, where RA concentrations are tightly regulated. Although the
physiological concentration of RA ranges from 1nM to 300µM, not all cells are exposed to the
highest concentration in vivo thus for the previously described platforms, it is possible that
the initial burst release exposed some cells to teratogenic concentrations of RA. The novel
source of RA presented here can address that limitation by providing a stable, consistent
source of RA that prevents any uncontrolled, burst release or teratogenic effects.
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Despite the burst release of RA from the above scaffolds, the concentration was still
substantially higher than the concentration of RA released by the HGF11-derived MNs but
there is still potential for the novel source of RA to induce ESC differentiation in vitro. ESCs
can be differentiated toward fates from the three germ layers in vitro using concentrations
of exogenous RA as low as 1nM supplemented to the culture medium.31 The concentration
presented here was five times lower but (i) was an endogenously produced source of RA
which makes it inherently cytocompatible, and (ii) remains at a stable concentration over
time which more closely recapitulates the in vivo environment. This novel source of RA
addresses the limitation of the burst release observed for the existing platforms. In addition,
as the source of RA was constantly replenishing the RA concentration in the medium, it also
reduces the implications of light-induced degradation of exogenous RA for both the efficiency
and reproducibility of in vitro protocols. Finally, as the RA was produced by LMC MNs,
these cells can be incorporated into existing, or novel, 3D platforms to investigate the effects
of localised RA gradients on ESC differentiation. Given the number of platforms that have
been developed to investigate this effect, and the results showing enhanced differentiation
efficiency when localised signalling gradients were provided to encapsulated cells, the novel
source of RA outlined in this chapter holds great potential for 3D in vitro investigation of
cell development in response to gradients of signalling morphogens.
5.5 Conclusion
There is an unmet need for in vitro 3D platforms that can deliver concentrations gradients
of signalling morphogens to ESCs and mimic the in vivo environment during development.
Currently used platforms are limited by burst release of the loaded morphogen or signalling
factor, which introduces an uncontrolled variable into those protocols. The experiments
presented in this chapter have produced a novel in vitro tool that addresses the limitation of
burst release. The HGF11-derived MN source of RA can be incorporated into a 3D platform
to provide sustained, controlled release of a stable concentation of RA over at least 5 days.
This tool offers novel avenues for investigating the effects of RA on cell differentiation in
vitro. Previously described 3D platforms reported that differentiation efficiency was increased
when the encapsulated cells were exposed to localised concentrations of growth factors or
morphogens. The source of RA presented here can be used to create new 3D platforms that
offer localised concentrations of RA, without the limitation of burst release of RA during
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the initial stages of cell culture. The previous chapters have demonstrated that alginate is a
suitable 3D biomaterial for ESC encapsulation and differentiation. Based on the experiments
presented in the current and previous chapters, the next chapter presents experiments to
create a novel 3D platform for inducing patterned differentiation.
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Chapter 6. Creating a novel 3D platform to promote patterned
neuronal differentiation of embryonic stem cells
6.1 Introduction
Tissue engineering has combined biomaterials with cell cultures, growth factors or signalling
morphogens for a range of applications. Hydrogels have been used to promote axonal regen-
eration in peripheral nerves in rats,227 neurons have been observed to extend their axons from
a fibrin scaffold implanted into the spinal cord of rats,228 growth factor-loaded scaffolds have
induced osteogenic regeneration in vitro,6,150 and implanted 3D scaffolds have been used to
promote host cell infiltration and regeneration with the spinal cord.219 The ability to engi-
neer personalised, functional tissues has real-world applications, both for investigating tissue
regeneration after spinal cord injury or neurodegenerative disorders, and for developing novel
platforms for stem cell therapy.17,105,115
3D cell cultures using biomaterial scaffolds can recreate the in vivo cell microenvironment
allowing us to gain a deeper understanding of the mechanims of cell differentiation, disease,
degeneration and regeneration.3 Smith et al., (2015) investigated gene expression and func-
tional activity of human neural stem cells differentiated in 2D versus 3D cell cultures, and
observed significantly greater spontaneous activity, and a significant upregulation of genes
related to cytoskeletal activation of the neurons cultured in 3D platforms.27 In a landmark
study, Meinhardt et al., (2014) generated a 3D model of neural tube patterning using a
Matrigel scaffold. Their neural tube formed a floor plate with dorso-ventral patterning and
represents a novel system for investigating morphogen activity in 3D, specifically the process
of neuroectoderm differentiation and gastrulation.32 Engler et al., (2006) demonstrated that
the elastic modulus of a substrate affects cell development,6 and Poh et al., (2014) showed
that embryogenesis could be controlled in vitro by varying substrate stiffness.81 Despite these
breakthroughs and advances, the influence of the cell microenvironment on cell behaviour and
cell fate specification is still poorly understood. To date, no 3D platform has been reported
that can control all of variables that exist in vivo, including substrate stiffness, localised
signalling gradients, cell-matrix interactions and paracrine signalling, making it difficult to
capitalise on these protocols and create functional tissue with therapeutic value.205,229,230
The development of the nervous system is the result of finely-tuned, temporo-spatial
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control over cell differentiation, axonal migration, and synapse formation.8 The large diversity
of cell types are the result of region-specific patterned differentiation, resulting from localised
changes in morphogen signalling. Cell fate specification is determined by the specific actions
of gradients of signalling morphogens within the cell microenvironment.57,58 During neural
tube differentiation, specification of the rostro-caudal and dorso-ventral axes is dependent on
cross-repressive gradients of signalling morphogens, such as RA, which determines cell fate
specification by regulating gene expression.63,64 These signalling gradients are lost in vitro,
as signalling factors such as RA or BMPs are supplemented into the culture medium, thus all
of the cells are exposed to a uniform concentration of that soluble factor. Without temporo-
spatial gradients of signalling factors, these tissue culture protocols cannot establish a vital
component of in vivo neural tube development. To combat this, 3D biomaterial platforms
have combined signalling morphogens with cells in vitro to induce localised effects on cell
behaviour or patterned differentiation.11,17,219
Alginate has previously been used for 3D cell culture using growth factor diffusion,143 cell
delivery,180 and cell guidance cues;144 alginate is a suitable material for these applications
due to its cytocompatability140,150 and the ease of diffusion of soluble factors throughout
the gels.122 Kuo and Wang (2013) described controlled acceleration of stem cell differen-
tiation into neurons on 3D alginate-chitosan scaffolds by incorporating nerve growth factor
(NGF) into the 3D platform to promote stem cell differentiation.231 Lin et al., (2017) used
macroporous alginate scaffolds to control neurite outgrowth indicating that alginate could
be a host scaffold for aiding neural regeneration.178 Zhang et al., (2013) showed increased
gene expression for markers of the three germ layers, and greater mesoderm differentiation
in soft core alginate-chitosan-alginate microcapsules.174 These findings, in combination with
the results from Chapter 3 and Chapter 4, are strong indicators that alginate is a suitable
scaffold for tissue engineering applications, and for protocols investigating embryogenesis,
self-organisation of the embryonic germ layers, and patterened differentiation.
The current chapter outlines a set of experiments used to develop a novel alginate platform
for 3D cell culture applications by combining the 3D alginate beads and the LMC-derived
source of RA developed and validated in the previous chapters. The previous chapters have
demonstrated successful survival, aggregation and differentiation of ESCs encapsulated in
alginate hydrogels. The encapsulated cells were shown to form EBs which differentiated into
cells from all three primary germ layers. The previous experiments characterised a stable
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source of RA, produced by HGF11-derived LMC MNs, which has the potential to drive ESC
differentiation in vitro. As this is a cell-produced source of RA, the LMC MNs can also
be incorporated into 3D platforms for investigating the influence of localised RA gradients
on ESC differentiation. The present chapter aimed to develop a novel 3D alginate platform
for creating localised RA signalling gradients, and subsequently investigating the effects of
the localised concentration of RA on ESC differentiation in vitro. This chapter outlines
experiments to test the physiological activity of the endogenous RA and determine if this
cell-derived source of RA can differentiate mouse ESCs to a neural cell fate. The experiments
combined these findings with the results from previous chapters to create a novel 3D platform
for patterned cell differentiation using a co-culture technique. This novel platform was created
using an adapted gradient maker protocol142 and the resulting alginate tube 3D platforms
were tested for patterned ESC neuronal differentiation by investigating the presence/absence
of cells from each of the three germ layers at each end of the scaffold.
6.2 Methods
6.2.1 Co-culture experiment to test the physiological activity of HGF11-motor
neuron produced retinoic acid
A co-culture experiment was designed to test the ability of an LMC MN produced source
of RA, secreted into the medium, to induce differentiation of ESCs encapsulated in alginate
beads. Alginate beads of LMW and HMW were produced using the standard method (see
subsection 2.5.1), and the alginate beads were transferred into a Boyden chamber well-insert
at 8-10 beads per well. The beads were cultured in ADFNK without RA for 2 days. On
day 2 of differentiation, the Boyden chambers were transferred into 12-well plates where each
well contained HGF11-derived MNs on day 8 of differentiatio. This setup was used so that
the encapsulated ESCs in beads were exposed to the RA produced by the MNs but were not
in close proximity to the source of the RA. The Boyden chamber setup for the co-culture
experiment is shown in Figure 4, p.41. The beads were cultured for 4 days in co-culture
with the HGF11-derived MNs, with half of the medium changed every 2 days. This protocol
thus mimicked the 2-/4+ RA differentiation protocol, with 2 days in ADFNK only, and 4
days in medium containing the cell produced RA. On day 6, the beads were collected from
the Boyden chambers, fixed and cryopreserved for immunostaining. The beads were serial
sectioned at 15µm, and stained for Nestin and β-III-tubulin.
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6.2.2 Generation of retinoic acid gradients in alginate hydrogel tubes
To investigate the effect of a localised concentration gradient of RA on ESC differentiation,
a gradient maker was used to create alginate tubes with a graded cell density of HGF11-
derived MNs (to produce a graded concentration of RA), and a constant cell density of CGR8
ESCs. Figure 5 (p.43) shows the gradient maker setup used to form the alginate tubes. In
brief, HGF11 ESCs were differentiated toward a MN lineage by EB suspension culture (see
subsection 2.2.1), the cells were dissociated to form a single cell suspension, and this single-
cell suspension was mixed with an equal cell density of CGR8 ESCs. This CGR8:HGF11-MN
cell suspension was pelleted by centrifugation (5min, 200g) and resuspended at 6x106/mL in
0.5% LMW alginate. This cell density is equivalent to 3x106/mL for each cell type. A second
cell suspension of CGR8 ESCs, without HGF11-derived MNs, was pelleted and resuspended
at 3x106/mL in 0.5% LMW alginate.
To create the tubes, 1.5mL of each alginate-cell suspension (CGR8 only or CGR8:HGF11-
derived MNs) was loaded into each chamber of the gradient maker (A and B). Chamber
A contained the CGR8 only cell suspension, and chamber B contained the CGR8:HGF11-
derived MNs cell suspension. The tubes were formed as per the protocol in subsection 5 and
resulted in an alginate tube with a consistent cell density of CGR8, and an decreasing cell
density of HGF11-derived MNs from the leading edge to the trailing edge of the tube (see
Figure 6, p.44). The alginate tube was polymerised in CaCl2 for 5min at room temperature.
The tube was cultured in ADFNK supplemented with GDNF (5ng/mL) for 6 days, with
medium changes on days 2 and 4. On day 6, the tube was collected, fixed, cut into sections
of approximately 1cm length and cryopreserved in OCT. For immunostaining, the first and
last section of each tube was stained for markers of the three germ layers (AFP, SMA, β-III-
tubulin), and the cell types present at each end of the tube were compared. The results were
collected for n=2 independent experiments where tube 1 = 8cm, tube 2 = 5cm.
6.3 Results
6.3.1 HGF11-motor neuron retinoic acid in the medium did not induce differ-
entiation of encapsulated embryonic stem cells
The results from the co-culture/Boyden chamber experiment showed that the concentration
of LMC-produced RA in the culture medium was not sufficient to induce differentiation of
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Figure 28: Brightfield images of alginate beads after 6 days of co-culture with HGF11-
derived MNs. Low and high magnification images of the alginate beads showed that the
encapsulated cells generated very few aggregates by day 6 in both HMW and LMW beads.
Scale Bar: 4X magnification, 1mm; 10X magnification, 400µm
ESCs encapsulated within alginate beads, when the beads were physically isolated from the
source of RA. Brightfield images showed that cells encapsulated in LMW and HMW alginate
contained very few aggregates by day 6 of co-culture with HGF11-derived MNs (see Figure
28). These aggregates were visible near the exterior of the beads and were long and tubular
shaped, which contrasts to the circular EBs formed in beads differentiated using exogenous
RA (see Figure 12, p.59).
As it was difficult to confirm aggregate formation by brightfield images, the beads were
fixed and cryosectioned to investigate the extent of aggregate formation inside the beads. Nu-
clear staining using Hoechst showed that the beads contained single cells or small aggregates
with the aggregates clustered near the exterior edges of the bead, consistent with what was
observed in brightfield images (see Figure 29). This result demonstrated that the 215-290pM
range of endogenous RA produced by the HGF11-derived MNs was not sufficient to induce
aggregate formation within the beads, in both LMW and HMW alginate beads. This result
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Figure 29: Endogenous RA did not induce EB formation from encapsulated ESCs. The
results from ICC of cryosections of beads co-cultured with HGF11-derived MNs showed that
there were very few aggregates within the beads, and that these aggregates were clustered
near the edges of the beads. White dashed lines indicate the exterior edge of the alginate
beads. Images were collected for n=4 independent experiments. Scale Bar: 200µm
was not unexpected given that the standard concentration range of RA used for in vitro
differentiation is 1nM to 1µM.
EBs differentiated using RA were used as a positive control for the experiment to show
the immunostaining was successful, and to demonstrate that the ESCs encapsulated in the
alginate came from a cell population that was viable and capable of forming aggregates. The
results from immunostaining showed that the cells encapsulated in the beads were negative
for AFP, SMA, Nestin and β-III-tubulin, whereas the cells in EBs were positive for all four,
indicating that the cells in the beads were not differentiating (see Figure 30). This was
expected as there were very few aggregates present in the beads, and single cells are known
to lose viability in alginate hydrogels.150 Due to the expected cell death of single cells within
alginate beads, and the limited numbers of aggregates observed encapsulated in the beads,
the immunofluorescent images were only collected from areas of the beads that contained
aggregates.
6.3.2 A localised retinoic acid gradient induced embryoid body differentiation
To investigate whether a more localised concentration gradient of RA, produced by the
HGF11-derived MNs, could induce patterned differentiation, CGR8 ESCs and HGF11-derived
LMC MNs were encapsulated together within alginate tubes. Preliminary tests of the gradi-
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Figure 30: Encapsulated cells were not differentiated by the HGF11-MN source of RA.
The results from immunostaining of cryosections of beads co-cultured with HGF11-derived
MNs were negative for neural markers Nestin and β-III-tubulin, but EB positive controls
had clear staining for both indicating neural differentiation. This demonstrated that the
encapsulated cells were not differentiating toward a neural lineage. Images were collected
for n=4 independent experiments. Scale Bar: 50µm
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ent maker/tube formation using 1% w/v solutions of LMW and HMW alginate found that
both solutions were too viscose to form alginate tubes using this protocol. During the tube
formation, one chamber of the gradient maker was emptied rapidly, followed by the second
chamber, thus the solutions were not mixed before being drawn through the tubing to form
an alginate tube. To address this, the LMW alginate was diluted 1:2 in DMEM to form a
0.5% solution; the experiments prior to this point did not observe a significant difference in
differentiation or viability between the LMW and HMW alginates, thus LMW alginate was
chosen for its lower viscosity compared to HMW alginate.
Using the new 0.5% w/v alginate solution, the gradient maker functioned as expected,
mixing the cell suspensions in chamber A and B, before drawing the alginate into the tubing.
The resulting alginate tubes contained a constant cell density of CGR8 ESCs along the
length of the tube, and a graded cell density of HGF11 LMC MNs, to provide a localised
concentration gradient of RA within the tubes. The alginate tubes formed had a variable
diameter along the length of the tube, and swelled over the course of the cell culture, but
the majority of tube remained intact at day 6 (compare Figure 31a and 31b). Brightfield
images of the leading and trailing edges, and the centre portion of the tubes, showed that the
encapsulated cells had formed aggregates inside the tubes; there were also some free floating
aggregates in the culture medium, as previously observed in experiments using alginate beads
(see Figure 31c-e).
The presence of the aggregates inside the tubes indicated that unlike the encapsulated
ESCs in the Boyden chamber co-culture experiments, the mouse ESCs encapsulated in algi-
nate tubes alongside HGF11-derived LMC MNs, were exposed to sufficient levels of RA to
induce aggregation. To determine whether the localised RA had induced ESC differentiation,
and to investigate if the opposing concentrations of LMC MNs and the LMC-derived RA
affected the level of differentiation, the trailing and leading ends of the alginate tube were
cryosectioned and immunostained for markers of the three germ layers. The results observed
the presence of cells from all three germ layers in both the trailing and the leading edge of the
tubes. Figure 32 shows a comparison of AFP and SMA positive cells, and Figure 33 shows a
comparison of the GFP and β-III-tubulin positive cells encapsulated in each end of the tube.
The outcomes from this experiment iindicated that although the concentration of RA in
the medium was lower than the physiological concentration, the localised RA concentration
was sufficient to induce cell differentiation of the encapsulated aggregates. This was a novel
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Figure 31: Brightfield images of alginate tubes formed using a gradient maker: (a) the
diameter varied across the length of the tube, (b) at day 6, the tube was intact and aggre-
gates were observed floating in the medium (white arrowheads). Low and high (red box)
magnification images of the (c) leading, (d) central, and (e) trailing sections of a tube on
day 6 showed encapsulated aggregates (white arrowheads), and escaped aggregates in the
medium (blue arrowheads). Scale Bars: left panels 1mm, right panels 400µm
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Figure 32: Alginate tubes contained markers for endoderm and mesoderm. The alginate
tubes contained markers of endoderm and mesoderm germ layers at day 6 of differentiation.
These were present at both the trailing and leading end of the tube. Scale Bar: 50µm
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Figure 33: Alginate tubes contained ectoderm marker β-III-tubulin. The alginate tubes
contained β-III-tubulin at both the trailing and leading end of the tube at day 6 of dif-
ferentiation. The tube also contained GFP+ cells at both end of the tube. Scale Bar:
50µm
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result that indicated that this alginate platform holds potential for investigating the effects
of a localised gradient of RA signalling on cell differentiation. The results also indicated
that the encapsulated ESCs had differentiated toward cells from the three germ layers which
was evidence that this hydrogel platform may be adapted and optimised for in vitro studies
of embryogenesis. This experiment was a preliminary investigation to verify whether this
novel co-culture platform was suitable for creating alginate tubes that remained intact in
cell culture, could encapsulate gradients of cell densities within the tube and permitted the
formation and differentiation of cell aggregates. Based on the results from Chapter 4 and
Chapter 5, it was expected that the cells would only differentiate if they had a sufficient
concentration of RA to initiate aggregate formation.
The results from Chapter 4 showed that the encapsulated ESCs exposed to 1µM of exoge-
nous RA differentiate into cells from the three germ layers. Contrastingly, as observed in the
Boyden chamber co-culture experiment, the encapsulated ESCs do not spontaneously differ-
entiate with low concentrations of RA. These findings indicated that the ESCs within the
scaffold can successfully form aggregates in the absence of exogenous RA and indicated that
the concentration of 215-290pM RA was sufficient to differentiate ESCs. This supports the
theory that the physiological concentrations reported for RA (1-100nM) may be considerably
higher than the actual concentration(s) of RA available to the cells in vivo as the previously
reported RA concentrations were quantified from whole tissues and do not account for the
RA sequestered in the nuclei or by cellular RA binding proteins.76,224,225 The formation of
aggregates observed in these experiments could be the result of ESC response to the localised
production of RA by the HGF11-derived MNs co-encapsulated within the scaffold, or might
be due to cell-cell interaction or perhaps paracrine signalling from the encapsulated MNs
not via RA signalling. It was also possible that the combination of these three and other
unknown variables contributed to the formation off aggregates.
The immunofluorescent images did not indicate whether there was variation in the level
of differentiation at the trailing and leading edges of the tubes. A major limitation of this
experiment was that the platform did not incorporate a method to track the previously
differentiated HGF11-derived MNs or the CGR8, so the previously differentiated HGF11-
derived MNs could not be isolated from cells that differentiated from the CGR8 ESCs. Future
experiments could incorporate CellTracker or time-lapse imaging to record which cells were
originating from each of the encapsulated cell populations. Although the results demonstrated
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that there were GFP+ cells in close proximity to GFP-/β-III-tubulin+ cells, which indicated
that ESCs differentiated within the platform, there were no instances of GFP+/β-III-tubulin+
cells from the HGF11-derived MNs. It was possible that within the scaffold, the endogenous
GFP was not visible in the images, and antibody staining for GFP may locate the HGF11-
derived MNs. In addition, without incorporating a method to track which cells originated
from which encapsulated population (CGR8 or HGF11-derived MNs), it was not possible to
know whether cells that were postiive for markers of the three germ layers differentiated from
CGR8 or if they differentiated from carry-over ESCs in the dissociated MN population. As
the EB differentiation protocol only generates 30% MNs, 70% of the population remained
uncharacterised, thus the EB-generated MN populations may also have contained ESCs or
cells from the three germ layers which were subsequently visualised in the alginate tubes.
6.4 Discussion
6.4.1 A cell-produced source of retinoic acid can be used for differentiation
Biomaterials have previously incorporated RA-loaded microcapsules or fibers into the bioma-
terial scaffolds to induce differentiation or patterned migration of the encapsulated cells.11,175
As discussed previously (see subsection 5.4.3), the largest limitation of these studies was the
inability to control the release of RA from the scaffold. The previous chapter reported that
the HGF11-derived MNs could produce endogenous RA, and the present chapter has demon-
strated ESCs cultured in close proximity to these RA-producing cells was sufficient to support
differentiation of the encapsulated ESCs towards cell fates from the three germ layers. This
was a novel result and has provided evidence that HGF11-derived MNs are a tool for in vitro
biomaterial differentiation protocols.
The results of these experiments were interpreted with caution as there were no control
conditions for these tubes. The formation of aggregates and/or differentiation towards cell
types from the germ layers might be due to a cell-cell interaction, a cell-matrix interaction or
an RA-induced effect promoted by the HGF11-derived MNs. The results from the Boyden
chamber experiment demonstrated that the presence of the HGF11-MNs in the medium was
not sufficient to induce aggregate formation or differentiation of ESCs towards the three germ
layers. These results indicated that the aggregate formation observed in the alginate tubes
was linked to the presence of the HGF11-derived MNs in close range to the encapsulated ESCs,
and this close proximity was responsible for the cell differentiation. Experiments to compare
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ESC differentiation in the present platform, with a control group of ESCs co-cultured with a
non-transgenic, non-RA producing MN population would distinguise between the influence
of RA produced by the LMCs and the presence of the MN populations in the tubes.
Neural-antigen 2+ glia can produce RA in the spinal cord, and astrocytes can regulate
RA signals in the brain.232,233 The present experiments did not investigate the presence of
astrocytes in the alginate platform and thus an astrocyte-derived source of RA may have con-
tributed to differentiating the encapsulated ESCs. In addition, the experiments did not test
the concentrations of RA released locally within the tubes, thus there is no information on the
extent of paracrine signalling from neighbouring sections of the tubes on ESC differentiation.
A recommended approach to determine these effects is to utilise hybrid biomaterial scaffolds
that allow layers of spatially distinct cell-laden biomaterials to be combined. This could
easily be achieved by adapting the protocol characterised in these experiments, by swapping
the alginate-cell suspension from one gradient maker chamber with a cell suspension in an-
other biomaterial, thus separating the RA source (HGF11-derived MNs) and the pluripotent
stem cells (CGR8) but continuing to allow diffusion of the RA through the scaffold. By
introducing cell labelling to track the cells from each population (CGR8, LMCs) this layered
platform would identify any cell migration in response to cell-cell or cell-matrix interaction.
In addition, the layered scaffolds can be immunostained for astrocytes to determine whether
an astrocyte-induced source of RA might be inducing cell differentiation. This approach
would be possible with alginate-chitosan layered scaffolds,231 fibrin layered scaffolds234 and
alginate-collagen hybrid scaffolds.190
Despite the limitations of the protocol, the results were promising for future research as
using HGF11-derived MNs as a source of RA produced that was physiologically active within
the scaffold. The results from chapter 5 showed that the concentration of RA was stable
over time, which addresses the limitation of RA burst release into the culture medium as
observed in the platforms reported by Binan et al., (2014) and Carpenedo et al., (2010).11,175
The cell-derived source of RA means that the RA concentration will be replenished by the
encapsulated HGF11-derived MNs between medium changes, and addresses the limitation of
light-degradation of RA. These cells are thus a novel tool for producing RA in vitro and can
be exploited to investigate many aspects of cell development, and to examine the proposed
varied signalling pathways activated by exogenous versus endogenous RA.71,73,212,235
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6.4.2 Alginate tubes are a novel platform for studying differentiation in vitro
Cell-laden alginate hybrid scaffolds are a current focus in biomaterials research due to their po-
tential to support tissue regeneration. Seol et al., (2015)134 used chondrocyte-laden alginate-
ceramic hybrid hydrogels to regenerate cartilage tissue in rabbits, and Pfister et al., (2007)236
developed an alginate-chitosan hybrid nerve conduit that promoted cell infiltration into the
conduit, and had low immune response to the conduit after it was implantaed in vivo. Hybrid
scaffolds have been used to alter the substrate stiffness throughout the cell culture period,
and examine the subsequent changes in cell behaviour.166,202 Some protocols have exploited
the properties of hydrogel scaffolds to regulate the dissolution of the scaffold in vivo and
investigate the cell response.122 Alginate hydrogels can be adapted to regulate growth factor
release from the scaffolds,143,168 to control the diffusion of growth factors toward the encap-
sulated cells150 and can be loaded with signalling morphogens to induce localised changes in
cell behaviour.143,180 The results from the current chapter have contributed a novel platform
to the field of tissue engineering, that has the capacity to incorporate many of the above
features in a single self-contained platform.
The platform presented here can be optimised for investigating cell behaviour and cell
differentiation by capitalising on the inherent characteristics of alginate, including the ability
to regulate alginate hydrogel substrate stiffness, cell adhesion molecules, diffusion through
the hydrogel, and the dissolution rate of the hydrogel in vivo. The platform created here
has the capacity to allow patterned differentiation of the encapsulated cells, using a novel
endogenous source of RA. This platform is unlike the previously reported biomaterial scaffolds
incorporating RA as it utilised a cell-produced endogenous source of RA that maintained a
consistent concentration over several days. The findings were preliminary, and there are
many factors that would need to be optimised to precisely investigate the extent of patterned
differentiation capable using this platform but immunofluorescent images provided strong
evidence that this platform can adapted for studying embryogenesis in vitro.
6.4.3 Alginate tubes with graded cell densities are novel platforms for investi-
gating gradients of signalling factors in vitro
There was high variability in the methods and protocols currently used for culturing cells in
3D biomaterials. These methods include: (i) encapsulating the cells,43,117,150,159 (ii) seeding
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cells onto freshly formed biomaterials,180,204,237 (iii) adding cells to the biomaterial after
pre-processing the scaffold to control porosity or topography,165,166 and (iv) changing the
adhesive factors added to the scaffold238–240 to investigate cell behaviour. To record all of
the potential effects of 3D culture or biomaterials culture on cell development or behaviour
would be a highly labour-intensive process. Even within one 3D cell culture experiment,
the studies cannot investigate all of the potential factors affected by the biomaterial-cell
interaction, and typically select from a range of variables of interest such as cell viability,
cell-cell interaction, cell-matrix interaction, matrix subtype interaction, variability between
cell lines, cell fate specification and cell migration within the scaffold. Specifically in studies
that used alginate, previous studies have examined the influence of substrate stiffness on
cells seeded on a pre-polymerised scaffold,165,166 differentiation of ESCs within one type of
alginate,43,159 or have examined the behaviour of differentiated cells on alginate scaffolds of
varying molecular weight.188
The platform presented here offers the potential to manipulate and control several mi-
croenvironment factors within an individual experimental platform. Future experiments to
investigate the concentration of RA produced at the trailing/leading edge, across of range of
cell seeding densities, and a range of alginate compositions, may shed light on the process
of patterned ESC differentiation within alginate tubes. Additionally, the physical structure
of the tube changed between the first and second experiment, with the second tube being
shorter. This was the result of uneven extrusion of alginate from the tubing into the CaCl2,
which resulted in breakages of the initial portions of the tube. These are limitations that
can be addressed by altering the viscosity of the alginate, the diameter of the tubing and the
extrusion rate of the peristaltic pump, to create tubes of varying length, diameter, and cell
density gradients. These varied tubes can then be characterised to identify the optimal con-
ditions for a range of ESC differentiation experiments or to investigate aggregate formation
and differentiation in a 3D platform. Alginate hydrogels are limited in their use for longer
term culture, as they dissolve over time in culture medium, but layered alginate scaffolds with
collagen or chitosan can be cultured for longer periods, and can be used to adopt this method
for extended in vitro experiments. The method of tube fabrication is easy to manipulate by
changing the soluble hydrogels loaded into each chamber of the gradient maker, for example
to vary the porosity or substrate stiffness, or alternative the cell types encapsulated ton alter
the method of differentation.
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Previous studies have generated outputs that can be combined with the results presented
here to build alternate scaffolds for investigating cell behaviour or differentiation. Chatterjee
et al., (2011)241 used an adapted gradient maker to produce a 3D PEG-dimethacrylate scaffold
with an elastic modulus gradient from 10kPa to 300kPa, and encapsulated osteoblasts. They
demonstrated selective osteogenic differentiation and mineral deposits at an elastic modulus
of 225kPa and higher. Their platform demonstrated that an adapted gradient maker proto-
col can be used to modulate many of the variables involved in cell-matrix interaction, and
highlights the potential for the gradient maker platform presented here to be expanded to
include multiple microenvironment variables. Soundarajan et al., (2007)34 generated a cell
line that produces an endogenous form of Shh. This cell line can be incorporated into the
gradient maker platform from this chapter to co-culture pluripotent stem cells with (i) the
HGF11-produced source of RA characterised here, and (ii) the Shh producing cells. This
hybrid platform could then form a model for neural tube patterning in a 3D biomaterial mi-
croenvironment. The gradient maker protocol outline by Chaterjee et al., (2011) produced a
flat, rectangular scaffold that could be sliced into sections.241 This protocol may be optimal
for modelling the neural tube as cells could initially be cultured on top of the scaffold to
examine the differentiation patterns, before incorporating the added variable of cells cultured
in 3D (i.e. encapsulated in the scaffold). Developing such a neural tube model would require
precise optimisation of the characteristics of the scaffold. A limitation of the alginate for
that purpose was the lack of cell adhesion sites, thus manipulation of the attachment factors
added to the alginate, or use of an alternative biomaterial allowing controlled cell adhesion
would produce more tightly controlled results.149
6.5 Conclusion
The experiments from this chapter have combined the tools developed in previous chapters to
create a novel 3D platform for investigating patterned stem cell differentiation. The HGF11-
derived MNs were shown to produce an endogenous source of physiologically active RA,
capable of producing a localised source of RA inside alginate tubes. The alginate tubes were
a prototype for a novel 3D platform to generate signalling morphogen gradients in vitro. The
tunability of alginate as a biomaterial means that the 3D platform can be optimised to further
investigate the influence of a localised RA gradient on ESC development in 3D. There is an
increasing need for reproducible, in vitro models of embryogenesis, neurodevelopment, and
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tissue regeneration, and the 3D platform presented in this chapter can contibute to each of
these - by adapting the platform and incorporating different cells types, or different growth
factor gradients, these 3D tubes can mimic the localised signalling gradients that occur in
vivo and allow us to examine the response of encapsulated cells to a range of growth factors
or cell-cell interactions in a 3D microenvironment.
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Summary discussion
8.1 Summary of results
The experiments presented in the current thesis have optimised and characterised alginate
hydrogel beads as a scaffold for the 3D culture of mouse ESCs (Ch. 3), showed comparable
levels of neural differentiation in LMW and HMW alginate beads versus EB suspension
cultures, (Ch. 4), characterised a novel cell-produced source of endogenous RA from HGF11-
derived LMC MNs (Ch. 5), and produced a novel 3D platform for investigating patterned
ESC differentiation in response to morphogen gradients in vitro (Ch. 6).
8.2 Importance of the current results for 3D cell culture applications
8.2.1 Applications of embryoid body culture within alginate hydrogels
This thesis demonstrated for the first time that aggregates formed by ESCs encapsulated in
alginate beads are canonical EBs containing cells from the three germ layers. In demonstrat-
ing the presence of the three germ layers, these experiments showed that alginate beads are
suitable biomaterial for investigating EB differentiation in 3D. The implantation of EBs to a
3D gelatin scaffold was previously demonstrated to promote self-organisation of the embryonic
germ layers.55 As mentioned previously, one study allowed mouse ESCs to undergo extended
differentiation in suspension culture, and showed that the resulting organoids contained tis-
sues from the neural plate and spinal cord.32 More recently, a study combined mouse-EB
cell cultures with extraembryonic trophoblast stem cells using a 3D Matrigel scaffold.242 The
study showed that the resulting embryos were a precise 3D model of embryogenesis that
mimicked the self-organisation of embryogenesis in vivo, both temporally and spatially. The
study also demonstrated that the in vitro scaffolds could be used to investigate the self-
organisation of the embryos in response to Wnt, BMP and Nodal signalling.242 The above
studies demonstrated that a combination of 3D culture with EB differentiation holds poten-
tial to discover new information about the mechanisms of cell development. In verifying that
alginate hydrogels support EB differentiation in 3D, the current thesis showed that alginate
scaffolds are an alternative biomaterial for similar experiments. The tunability of alginate
provides an additional benefit for choosing alginate hydrogels over alternative biomaterials
for 3D culture applications. The properties of alginate hydrogels makes them highly tunable
– 130 –
8.2 Importance of the current results for 3D cell culture applications
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
for a given experimental paradigm, such that the characteristics of the hydrogel can be se-
quentially adapted to investigate the self-organisation of the EB germ layers in response to
different microenvironments. In doing so, alginate:EB differentiation could be a new research
tool for examining cell-matrix interaction effects on cell fate specification.
8.2.2 Co-culture experiments are important for 3D culture
HGF11-derived LMC MNs were established as a novel in vitro source of endogenous RA.
The novel cell-produced source of RA is easy to generate, as it requires only basic cell cul-
ture equipment, a 6 day differentiation protocol and inexpensive reagents, thus can be easily
adopted by other research groups as an in vitro tool. The MNs provided stable concentra-
tions of RA, and furthermore, co-culturing the HGF11-MNs alongside ESCs within alginate
tubes demonstrated that a localised source of RA influenced ESC aggregation and differen-
tiation. The concentrations of RA produced by the MNs were low relative to the standard
concentrations used in vitro (100nM to 1µM) and the reported concentrations in vivo (1-
300nM) however the ability to introduce the RA in close proximity to the ESCs was a more
important feature of this source of RA. As mentioned above, one study combined EB culture,
trophoblast stem cell culture and biomaterial scaffolds to investigate the development of em-
bryonic and extraembryonic tissues within the 3D platform. Their results are an example of
the advantages of using co-culture methods to investigate cell behaviours.242 In showing that
co-encapsulation of LMC MNs and ESCs induced cell differentiation to fates from the three
germ layers, this thesis provided further evidence that 3D co-culture experiments may pro-
vide new methods for examining the influence of cell-cell interaction, or paracrine signalling
from neighbouring cells, on ESC differentiation.
In the Boyden chamber experiment (Ch.6, p.115) HGF11-MNs were cultured in the same
medium as ESCs encapsulated in alginate beads. Over 6 days of cell culture, the encapsu-
lated ESCs did not aggregate within the alginate beads, but when the two cell types were
co-cultured, the ESCs aggregated and differentiated to cell types from the three germ layers.
RA acts in a paracrine manner in vivo and the observed differentiation in the current ex-
periments may have been an ESC response to the low levels of RA produced by the LMCs.
Alternatively, the LMC MNs were encapsulated in close proximity to the ESCs in the plat-
form so it is possible that the observed cell differentiation was the result of an uncontrolled
variable occuring through cell-cell interactions, or signalling via another soluble factor re-
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leased by the LMCs.64 A previous study on ESC-derived germ layer cells reported that the
cell-cell interactions and cell-matrix interactions were important for specifying cell fate,81
thus the same effect may occur within the platform described here. As the Boyden chamber
experiment showed that ESCs did not aggregate when encapsulated alone (without LMCs),
it was unlikely that a cell-matrix effect was responsible for the ESC aggregation and differ-
entiation observed in the co-culture tube experiments. This instead points toward a cell-cell
interaction through the actions of the LMCs. DEAB is an inhibitor of Raldh2 and could
be used to interrupt the LMC MN-produced RA within the scaffolds, to observe any effects
from non-RA induced effects by the co-culture paradigm.77 Inhibiting Raldh2-synthesis of
RA would determine if there are other non-RA induced, cell-cell interactions influencing ESC
aggregation and differentiation.
8.2.3 The 3D platform for patterned differentiation addressed the limitations
of previously reported 3D gradients of soluble factors
The novel alginate tubes created cross gradients of HGF11-derived MNs with stable cell den-
sities of ESCs to investigate the influence of morphogen gradients on ESC differentiation. As
mentioned previously, a major limitation of 2D cell culture is the inability to introduce soluble
factor gradients to the cells.4 Gradients of signalling morphogens are challenging to produce
in 3D, due to the burst release of soluble factors from biomaterials. One study reported a
loss of 15% of the original concentration of NGF in a biomaterial scaffold after 1 day, and
35% after 1 week in culture medium.243 A second study used photopolymerisation of PEG-
dimethacrylate hydrogels to incorporate IKVAV gradients within the scaffold, however the
requirement for UV exposure (6min) makes these scaffolds unsuitable for cell encapsulation,
but suitable for experiments were cells are seeded onto the scaffold after the gradients are
introduced.138
The LMC MN source of RA established in this thesis was stable over at least 5 days of
cell culture thus addressed the limitation of burst release from biomaterials scaffolds as the
source of RA originated within the scaffolds. In addition, the LMC-produced source of RA
also reduced the variability introduced by light-induced degradation of exogenous RA, as
the cells can replenish the RA concentration between medium changes after being replaced
into the incubator. The concentration of RA released along the slope of the alginate tubes
was not tested, but the 3D platform set a foundation for future experiments to optimise this
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protocol. For example, Purcell et al., (2009) investigated the rates of growth factor release by
encapsulated cells in G-rich and M-rich alginate hydrogel scaffolds.169 They showed that the
rates of growth factor release could be controlled using the alginate G:M ratio and whether
the beads were coated or uncoated: (i) neural stem cells in G-rich alginates produced 3-
fold more NGF relative to neural stem cells in M-rich alginates, (ii) PLL coated M-rich
alginates produced 2-fold more NGF relative to uncoated M-rich alginates. Their results
suggested that the 3D platform described here can be adapted to offer increased control over
the concentrations of RA released, by changing the composition of the hydrogel tubes to
promote RA synthesis by the encapsulated LMC MNs. This contributed to novel avenues for
investigating the influence of 3D soluble factor gradients on ESC differentiation.
8.2.4 In vivo applications of the 3D platform for patterned differentiation
For in vivo applications, alginate hydrogels can be polymerised in situ123 or can be sur-
gically implanted to a lesion site.184,231 After spinal cord injury, the glial scar creates an
increased elastic modulus in the area surrounding the lesion that inhibits cell differentia-
tion.64 Biomaterials can combat this effect, limiting glial scar formation and supporting
tissue regeneration.139 For example, Shin et al., (2018) surgically implanted a neural stem
cell-laden poly-glycolic acid (PGA) scaffold at the site of spinal cord lesions in neonatal
mice.244 Their results showed that the implanted scaffold reduced the formation of glial scar-
ring at the site of injury, and that the encapsulated neural progenitor cells had migrated from
the scaffolds, into the infarct, and differentiated into neurons and astrocytes. The authors
also reported functional benefits to the cell:biomaterial implant: mice who received the com-
bined cell:scaffold implant had improved motosensory recovery compared to mice receiving
a cell-only or scaffold-only implant.244 Another study used a hybrid HA:astrocyte-derived
ECM scaffold to promote V2a interneuron migration from the scaffolds and into the lesion
site in mouse spinal cord.245 This study, and the studies discussed above highlight the need
for 3D cell-laden scaffolds that are capable of delivering cells to the point of injury, and also
permitting the implanted cells to penetrate the site of injury and promote regeneration or
functional recovery of host tissue.
Within the peripheral nervous system, RA-induced activation of RARs after nerve injury
promotes regeneration and previous in vitro studies demonstrated that RAR activation is
sufficient to promote axonal regeneration of rat cortical neurons.64 The 3D platform for
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patterned differentiation can be used in a similar manner to the above studies, delivering a
source of MNs to the site of spinal cord injury, and simultaneously a cell-produced source
of RA. By implanting an LMC-laden alginate scaffold at the site of a spinal cord lesion (or
polymerising the hydrogel in situ), the effects of endogenous RA on the regeneration of cells
after injury in the CNS can be investigated. Optimised versions of the platform presented
here, containing high purity LMCs and vitamin-A loaded microspheres, could monitor the
effects of local peaks and troughs of RA on cell differentiation, regeneration and axonal
guidance of limb-innervating MNs in vivo. The HGF11-derived MNs have previously been
demonstrated to migrate towards the correct muscle targets after implantation.12 This is
evidence that delivering in vitro derived cell-analogues for in vivo cell types could be used
to promote regeneration of the spinal cord after injury. In the paradigm outlined here,
the LMCs would be capable of mimicking their in vivo counterparts and correctly projecting
axonal trajectories to their target muscles. To build upon the platform presented here, further
investigation of the concentration of RA produced along the slope of the cell density gradient
could permit more fine-tuned investigations of cell development in the scaffold and be used
to predict the in vivo response of the host tissues to the concentration gradient.
8.2.5 A novel platform for investigating 9-cis-RA activation of RAR/RXRs
RXRs are highly abundant at the limb-levels of the spinal cord, which indicates a relationship
between the LMC MN-derived source of RA and activation of RXR/RAR complexes during
limb innervation.100,221,246 As RARs form heterodimers with RXRs, there may be a role
for 9-cis-RA in specificying LMC positional identities and muscular targets during limb-
innervation.74–76 As mentioned previously, 9-cis-RA is only detected in vivo when embryos are
exposed to supraphysiological concentrations of RA, thus 9-cis-RA may prevent teratogenic
concentrations of RA from inducing off-target effects during LMC differentiation, such as
abnormal cell fate specification or LMC innervation of the incorrect muscle.74,76
The 3D platform for patterned differentiation described here is uniquely situated to inves-
tigate whether the effects of 9-cis-RA in response to supraphysiological concentrations of RA
are a protective measure against RA-induced teratogenicity, or if there is another function for
9-cis-RA that has not been discovered. In vitro MN differentiation protocols use supraphys-
iological concentrations of exogenous RA, which are known to produce supraphysiological
concentrations of 9-cis-RA, and are proposed to activate off-target signalling pathways.75 By
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supplementing increasing concentrations of retinal to the medium of HGF11-derived LMCs,
the LMCs may produce a supraphysiological concentration of RA.76 The subsequent concen-
trations of endogenous 9-cis-RA in the medium, metabolised from supraphysiological concen-
trations of endogenous RA could then be quantified. Using the novel co-culture 3D platform
presented here, the effects of supraphysiological levels of LMC-produced endogenous RA on
9-cis-RA concentration, RAR/RXR activation, and ESC differentiation can be examined.
This would provide new information about the relationship between RA and 9-cis-RA con-
centrations in vitro that cannot be investigated using exogenous RA.
Alternatively, using the same methods as above to create supraphysiological concentra-
tions of RA, and simultaneously antagonising RARs or RXRs in the encapsulated cells, the
platform could be used to investigate whether RAR, RXR or combined RAR/RXR activa-
tion is necessary for inducing ESC differentiation in vitro. The rate of receptor activation
in response to increasing concentrations of endogenous RA (due to supplementing retinol or
retinal to the medium), and subsequently to the increasing concentrations of 9-cis-RA would
provide new information about the relationship between teratogenic concentrations of RA
and activation of RXRs. A previous study reported that 9-cis-RA and RA were capable of
inducing differentitaion in P19 embryonic carcinoma cells, but that 9-cis-RA was 50-100 times
more potent compared to all-trans retinoic acid.224 Alternatively, another study showed that
P19 cells expressed different RARs depending on the stage of development,247 which suggests
there may be differential rates of RAR and RXR activation in differentiating ESCs, in re-
sponse to either RA or 9-cis-RA, depending on the stage of differentiation. RARα, RXRαand
RXRβare widely expressed during development whereas RARβ, RARγand RXRγhave tissue-
specific expression,67 further suggesting that ligand binding of 9-cis-RA or RA to RAR/RXR
receptor complexes has a stage-dependent effect on development. The influence of the RA
in the medium on activation of LMC-specific RXRs and RARs, or the ESC-specific RXRs
and RARs could further determine if there are differences in the rates of receptor activation
depending on the cell type or cell stage of development. These experiments would answer
some long standing questions about the role of 9-cis-RA in RA-induced differentiation in
vitro, and can provide important information about the on-target and off-target effects of
exogenous and exogenous RA during differentiation.
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8.2.6 Concluding remarks
This experiments presented within this PhD thesis have contributed several novel results to
the field of 3D cell culture. The 3D platform for patterned differentiation is a new tool for in
vitro 3D cell culture that provides a foundation for a wide range experiments investigating
patterned ESC differentiation. The platform can be optimised and adapted to investigate the
impact of co-culture methods on ESC differentiation, to examine the RA specific and non-RA
specific mechanisms involved in ESC differentiation and to examine the role of 9-cis-RA in
in vitro neuronal differentiation protocols. The ability to introduce additional or alternative
cell types, combined with growth factor gradients, makes the 3D platform a suitable tool
to investigate the interdependence of cell-matrix, cell-cell and soluble factor effects during
differentiation. The use of an adapted gradient maker protocol provides a technical benefit,
as alternative biomaterials can be combined or interchanged with alginate; this would allow
cell types that are not easily cultured in alginate to be combined with the 3D platform in an
alternate biomaterial. The research opportunities provided by the 3D platform for patterned
differentiation are substantial and the platform is thus an important tool that this thesis
contributed to 3D cell culture applications.
The individual components of the platform also contributed novel tools and insights to in
vitro cell culture. The cell-produced source of endogenous RA was used to provide a localised
concentration gradient of RA to the encapsulated ESCs, and although the all or some of the
observed patterned differentiation may be due to non-RA induced effects, the results have
demonstrated that a co-culture paradigm is important for inducing ESC differentiation in 3D
cultures. By validating that the LMC MNs are a stable source of RA, this thesis contributed
a useful tool for providing localised, low level RA concentrations to ESCs. Although the
protocol requires characterisation to determine the production rate and upper concentration
of RA that can be achieved, the results as they stand have contributed towards new research
avenues in 2D and 3D cultures, such as comparing the rates of ESC differentiation towards
cell fates from each of the germ layers using cell-derived and exogenous RA, or creating RA
gradients in alternative biomaterials to investigate if ESC differentiation can be induced in
alternate scaffolds with differing properties.
A driving hypothesis behind the experiments comparing LMW and HMW alginate was
that a direct comparison of alginate hydrogels of different G:M ratios would identify whether
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high-G or high-M alginate hydrogels were optimal for ESC differentiation to cells from the
germ layers. The results showed no significant difference between the two alginate com-
positions, which suggests that in contrast to the published studies, ESC differentiation in
alginate may not be as sensitive to the 3D culture conditions as previously reported. The re-
sults showed, for the first time, that EBs in alginate beads are canonical EBs and contain cells
from each of the three germ layers. The results definitively showed that cell fates from each
of the three germ layers can be investigated in alginate, which demonstrated that alginate
scaffolds are not only suitable for ESC encapsulation, but also that ESCs can be induced for
form EBs in alginate hydrogels of different G- and M-residue content. Experiments building
on this knowledge can investigate ESC differentiation towards derivatives of each germ layer
in scaffolds of different G:M types, where the scaffold properties can be tuned to support the
terminal cell fate. As the ESCs will differentiate in both high G- and high M-residue algi-
nates, this allows for long term culture by creating hydrogels characteristics that will support
the mature cells, and thus allows the influence of cell-matrix on later stages of development
to be examined.
To conclude, this thesis answered questions about the utility of alginate hydrogels as
3D biomaterials, demonstrating that alginate can be used to support EB formation and
differentiation from encapsulated ESCs. The thesis provided a novel solution that addresses
the limitations of exogenous RA differentiation protocols, and can be applied in both 2D and
3D culture applications. This PhD created novel tools for in vitro culture that are easy to
produce, affordable, adaptable and scalable, and in doing so contributed new knowledge to
the field of 3D cell culture that will inform future experiments using alginate hydrogels.
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Appendix 1
Item Supplier Code
Advanced DMEM-F12 Gibco 11540446
Alginate, high molecular weight Acros Organics 17777
Alginate, low molecular weight Sigma-Aldrich 71238
β-mercaptoethanol Gibco 11528926
Calcium chloride, salt Fisher Scientific 10161800
CF1 mouse embryonic fibroblasts Merck PMEF-CFL
CGR8 wildtype mouse ESCs Sigma-Aldrich 08032901-1VL
DMEM , high glucose, no l-glutamine Gibco 11500416
dPBS +MgCl2, +CaCl2 Gibco 11580456
dPBS -MgCl2, -CaCl2 Gibco 12559069
EDTA, disodium salt Fisher Scientific S311500
ESGRO mouse LIF, concentrated Merck ESG1107
ESGRO mouse LIF, non concentrated Merck ESG1106
FBS South American, EU Approved; Lot: FB-1001H Gibco 11550356
Fluorescein diacetate Sigma-Aldrich F7378-5G
GDNF from mouse Sigma-Aldrich SRP3200
Gelatin 2% type B, porcine Sigma-Aldrich G1393-100ML
Gradient maker Sigma-Aldrich GESG100
Hepes Fisher Scientific 10397023
ImmEdge hydrophobic pen Vector Labs H4000
Knockout serum replacement Gibco 10828028
Laminin Merck CC095-5MG
L-glutamine Gibco 11539876
Mitomycin C Sigma-Aldrich Y0000378
Mouse Raldh2 ELISA Kit MyBioSource MBS7237205
Mouse RA ELISA Kit MyBioSource MBS706971
Neurobasal medium Gibco 11570556
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Item Supplier Code
Non-essential amino acids Gibco 11140050
Normal goat serum Gibco 16210072
Parafilm Fisher Scientific 1535088
Paraformaldehyde 37% Sigma-Aldrich 252549-500ML
PBS 1X tablets Fisher Scientific 10388739
Penicillin/streptomycin Gibco 11548876
Purmorphamine Sigma-Aldrich SML0868-5MG
Quantinova SYBR green kit Qiagen 208054
Quantinova reverse transcription kit Qiagen 205411
Retinoic acid Sigma-Aldrich R2625-50MG
RNeasy mini kit Qiagen 74106
RNeasy min ELUTE Qiagen 74204
Sodium chloride Fisher Scientific S271500
Sodium citrate Fisher Scientific S279500
Thiazole orange Sigma-Aldrich 390062-250MG
Tissue-Tek OCT VWR 62550-01
Triton X-100 Sigma-Aldrich X100-100ML
Trypan blue Gibco 15250061
Trypsin-EDTA Gibco 11570626
Vectashield mounting medium Vector Labs H1000
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